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Abstract
Tuberculosis (TB) is a deadly, yet curable, infectious disease that continues to be a global
health threat. Armenia suffers from rising TB incidence and mortality rates. Armenians
living in Los Angeles (LA) County, where TB incidence is higher than national averages,
is the second largest Armenian community in the world; therefore implications are that
many TB cases are attributed to this group. Using the social ecological model as a
theoretical framework, this concurrent, mixed-methods study compared Armenians to
non-Armenians in LA County about their knowledge of TB and perceived barriers to
seeking and adhering to treatment. Bivariate chi-square analysis from online surveys of
55 Armenians and 72 non-Armenians revealed significant differences in their source of
TB knowledge and compliance upon diagnosis. Multinomial logistic regression analysis
was completed using the following significant predictor factors: classification, home
remedy use, age, education, and primary household language. Parallel, in-depth
interviews of 10 Armenians and 8 non-Armenians further corroborated that, although
both populations were aware that TB exists, knowledge relating to TB mode of
transmission, global incidence, and treatment options was generally lacking. However,
the Armenian population was more eager to help others and urge seeking treatment when
receiving a positive diagnosis, whereas non-Armenians expressed lack of willingness to
physically assist patients. These findings have implications for positive social change, as
they can inform the efforts of public health and health care entities in more effective
disease management, resource allocation, and patient care. Such efforts should help
decrease TB prevalence in the U. S. Armenian population and potentially Armenia.
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1
Chapter 1: Introduction to the Study
Introduction
Tuberculosis (TB) is an ancient, communicable disease that has adversely
affected humanity for centuries. Antiquated terms used to describe this disease
characterized by wasting include phthisis by the ancient Greeks, tabes by the Romans,
rajayakshma by the Hindus, and consumption in Victorian England (Nelson & Williams,
2007, p. 653). Despite medical advances and extensive research into biological
characterizations of the disease and the causative agent, Mycobacterium tuberculosis, TB
continues to be a detriment to the health of modern society.
TB is one of the world’s deadliest, yet curable, diseases. In 2014, there were an
estimated 6.0 million new cases of TB and 9.6 million total who fell sick with the disease
(either from active or latent forms), 5.4 million of which were men, 3.2 million were
women and 1.0 million were children (World Health Organization, 2015). In total, there
were 1.5 million TB-associated deaths, ranking alongside HIV as the leading cause of
death worldwide, primarily afflicting those living in low- and middle-income countries
(Centers for Disease Control and Prevention, 2012b; WHO, 2015). In developed
countries, disease management has improved and therefore new infections have declined;
however, significant morbidity and mortality associated with disease persists, particularly
in susceptible populations (WHO, 2012b). In both developed and developing countries,
the populations most susceptible to TB infection and complications with treatment
include HIV/AIDS patients, immigrants, the homeless, low socioeconomic populations,
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and those in correctional facilities. In 2014, of the 1.2 million deaths associated with
HIV, 400,000 (one-third) were co-infected with TB (WHO, 2015).
In particular, the Eastern European country of Armenia is adversely affected by
tuberculosis and complications associated with the emergence of multi-drug resistant
(MDR-TB), extensively drug resistant TB (XDR-TB), and total drug resistant TB (TDRTB). The World Health Organization (WHO) has designated Armenia as one of the 18
high-priority countries for TB control among the WHO’s European Region and the top
27 in MDR-TB burden countries in the world (Hayrapetyan, 2012). In 2010, Armenia’s
Ministry of Health (MOH) began working in conjunction with Stop TB in order to reduce
TB incidence in the country by taking control of the National Tuberculosis Programme,
NTP, (WHO, 2013). Furthermore in 2011, Armenia’s MOH joined and participated with
other health ministries from at-risk Eastern European countries in establishing annual
TB-related symposia (Medecins Sans Frontieres, n.d.). Efforts in Armenia are ongoing to
improve the national health care infrastructure in order to strengthen the program’s
impact on disease incidence and associated morbidity and mortality.
TB incidence in Los Angeles County (LA County) is higher than national
averages. In 2013, there were 667 confirmed cases (7.0 per 100,000), which is higher
than California’s case rate of 5.7 per 100,000 and more than twice the national of 3.0 per
100,000 (California Department of Public Health, 2015; County of Los Angeles Public
Health, 2015; Salinas et al., 2016). Furthermore, the Armenian population in this area,
particularly in the City of Glendale, is the second largest Armenian community in the
world, second only to Yerevan, Armenia (Hayk the Ubiquitous Armenian, 2012). Based
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on the high Armenian population and high disease incidence in the community, the
implications are that many of the TB cases are attributed to Armenians living in the area.
Therefore, the study explored the perceived barriers to TB treatment-seeking and
treatment-adherence among Armenians living in LA County, barriers that could impact
TB incidence among the target population. Using a concurrent, mixed-methods study
including in-depth surveys, ethnography (qualitative), and questionnaires (quantitative),
Armenians and non-Armenians living in LA County were interviewed to gain a better
understanding of their TB knowledge and perceived barriers to treatment. Differences
between Armenians living in LA County and non-Armenian populations with respect to
physical, psychosocial, cultural, or behavioral factors and beliefs may impact TB
knowledge, treatment-seeking, and treatment-adherence. Thus, public health approaches
to treating and decreasing TB incidence in this population would be influenced. The
implications for social change involve decreasing TB incidence and prevalence in the
Armenian population within the United States, and potentially within native Armenia,
through more effective disease management, resource allocation, and patient care efforts.
Such approaches and efforts may be extended to other diseases as well.
The following overview covers disease history, current trends in TB research,
including diagnosis, genetic variants, treatment and therapy, susceptible populations, and
major barriers to treatment seeking and treatment compliance, both in developing and
developed countries, particularly Armenia and the United States, respectively. A more
thorough review of many of these topics is presented in Chapter 2. Next, brief
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descriptions of the study’s purpose, theoretical framework, research questions and
hypotheses, assumptions, limitations, scope, and significance will be discussed.
Chapter 3 is devoted to a more thorough discussion of research methodology for
this study. Chapter 4 is centered on addressing the research questions and hypotheses,
including data collection and detailed analysis using statistically-derived findings.
Finally, Chapter 5 is a review of the study’s purpose, methodology, and research
questions with interpretations of the data and the study’s implications for social change.
Background
Disease History and Etiology
TB has historical negative implications on the health of mankind. Dating back to the
Middle Ages, TB incidence has experienced fluctuations due to associated time-specific
events, for example the HIV/AIDs pandemic in the 1980s, or changes in public health
practices (Beltz, 2011, pp. 208–209). If left untreated, active TB—and latent TB
infection (LTBI) upon reactivation—can be deadly, with mortality rates of up to 50%
(Beltz, 2011, p. 211).
In 1882, Robert Koch discovered the causative agent of tuberculosis, Mycobacterium
tuberculosis (Mathema, Kurepina, Bifani, & Kreiswirth, 2006). M. tuberculosis is a slowgrowing obligate aerobic bacillus with a thick waxy cell envelope that is readily
transmitted through aerosols: coughing, sneezing, laughing, talking, or singing. It’s
primary targets are the lungs and respiratory tract, where only a few viable bacilli are
required to initiate infection (CDC, 2012a). Inhalation of released mycobacteria may
result in active (primary) or latent infection, with one-third of those exposed becoming
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infected and 10% becoming symptomatic (Mathema et al., 2006). Primary active
pulmonary TB may take several weeks from the time of exposure; it manifests as a
persistent illness with bloody sputum and shortness of breath. With latent TB,
mycobacteria are present but go dormant and infected individuals are asymptomatic
(CDC, 2012a). A weakening of the immune system years later may cause bacterial
replication to take over and persist, leading to reactivation and ultimately active
pulmonary TB infection (Paulson, 2013).
Diagnosis, Therapy, and Prevention
TB diagnosis and detection may be achieved through several avenues, depending
upon available resources, infrastructure, extent of infection, and bacterial load. Active
pulmonary TB is traditionally diagnosed through smear microscopy or culture-based
methods of sputum specimens (Ferguson et al., 2016). While microscopic analysis of
sputum samples is rapid, cheap, and specific, it suffers from low sensitivity, particularly
for specimens with low bacterial load (paucibacillary), cases of extra-pulmonary TB, and
analysis in microscopy centers or voluntary counseling and testing centers (VCTs) with
minimal infrastructure (Niemz, Ferguson, & Boyle, 2011). Culture-based methods have a
greater degree of sensitivity but are limited by the time taken to culture the slow-growing
TB bacterium, which may take 4–6 weeks (Nelson & Williams, 2007, p. 656). The longer
turnaround time presents a major hurdle to effective disease treatment and patient case
management (Niemz & Boyle, 2012).
Some nonculture–based methods for TB diagnosis include chest X-rays, Mantoux
tuberculin skin tests, and nucleic acid testing (NAT). For chest X-rays, lesions in adults
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are typically found on the apical or posterior portion of the upper lobes of the lungs
(Beltz, 2011, p. 214). The Mantoux tuberculin skin test reveals a hypersensitive lesion
from the injection of purified protein derivative (PPD) under the skin of the forearm.
Previously exposed individuals or those who have been vaccinated will react to form a
10mm reddened lesion 3 days post-PPD injection (Beltz, 2011, p. 214). While effective,
neither method can discern between active and latent TB infections.
NAT is rapidly emerging as the most sensitive, specific, and rapid method for TB
diagnosis, including MDR-TB, particularly in developed countries, resulting in positive
patient outcomes (Niemz & Boyle, 2012; Niemz et al., 2011; Schumacher et al., 2016).
While gaining regard as the most reliable method for TB detection, NAT may be
complicated by cell physiology (including sample preparation and nucleic acid isolation),
specimen type and pathogen load, patient age, and HIV-1 co-morbidity (Ferguson et al.,
2016; Niemz & Boyle, 2012). Current NAT may use the polymerase chain reaction
(Ling, Flores, Riley, & Pai, 2008) or isothermal amplification schemes such as loopmediated isothermal amplification (Boehme et al., 2007, 2010), cross-priming
amplification (Fang et al., 2009), helicase-dependent amplification (Ao et al., 2012;
Motré, Kong, & Li, 2011; Torres-Chavolla & Alocilja, 2011), or transcription-mediated
amplification (Pfyffer, Kissling, Wirth, & Weber, 1994). Cepheid’s GeneXpert MDR/RIF
is a fully integrated NAT-based system that has received WHO’s endorsement for TB
diagnosis and rifampin-resistant testing in laboratories of developing countries, and has
undergone large-scale rollout in high-TB-burden countries, notably South Africa
(Kingsley, 2011). Since the massive rollouts of the GeneXpert, time to treatment
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initiation, particularly for Rif-resistant MDR-TB, has been decreased significantly,
improving treatment outcomes (Stagg et al., 2016).
Morbidity and mortality are highly associated with a rigorous treatment regimen,
drug resistance, and nonadherence (Phillips, 2013). M. tuberculosis contains a thick waxy
cell envelope that is highly impermeable to antibiotics and the bacilli may be present in
various stages of growth: actively growing, semi-dormant, and dormant (Nelson &
Williams, 2007, p. 666). Therefore, drugs with different modes of action are required for
effective treatment and treatment must be adhered to for 6–12 months. This, in
conjunction with hepatotoxicity from an extensive drug regimen, results in treatment
nonadherence and the emergence of drug resistance (MDR-TB, XDR-TB, or TDR-TB).
First-line TB drugs include isoniazid, rifampicin, pyrazinamide, streptomycin,
ethambutol, and thiacetazone. The first three are bactericidal and the last three are
bacteriostatic (Nelson & Williams, 2007, p. 666). As resistance to the first line of drugs
began to emerge, second-line treatment for TB was developed. Second-line treatment
involves fluoroquinolones or injectable drugs such as amikacin, kanamycin, or
capreomycin (Warren et al., 2009). Worldwide, the incidence of single-drug resistant TB
ranges from 0–56% and MDR-TB from 0–23% of TB cases, with the highest incidence
of MDR-TB cases in the Soviet Union, Eastern Europe, and China (WHO, 2008). XDRTB, which is resistant to fluoroquinolone, rifampicin or isoniazid, and any of the three
injectables and TDR-TB, began emerging in 2006 and 2009, respectively (Udwadia,
Amale, Ajbani, & Rodrigues, 2012; Velayati et al., 2009).
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In 1995, the WHO and StopTB initiated the Direct Observed Therapy Short
Course (DOTS) in an effort to improve adherence through patient supervision by
healthcare workers (Naidoo, Dick, & Cooper, 2009). With DOTS, health care workers
are assigned to monitor patients closely and actively observe that patients are taking each
prescribed dose of the antituberculin medication. While DOTS was initially viewed as an
effective means to manage patient compliance, it is now viewed as flawed. Much of the
inconsistency in DOTS’ success is attributed to lagging government involvement,
insufficient resources, and insufficient support systems (Naidoo & Mwaba, 2010).
Susceptible Populations and Reported Barriers
Populations highly susceptible to TB infection and complications with treatment
in both developed and developing countries include HIV/AIDS patients, immigrants, the
homeless, drug users, low socioeconomic populations, and those in correctional facilities.
Reported psychiatric and psychosocial factors affecting treatment adherence include
poverty, disease coinfection (e.g., cardiovascular, HIV, hepatitis), social stigma,
unsupportive social and work environments, disbelief in the health facility and staff,
helplessness, hopelessness, and depression (Fry et al., 2005; Kandula, Dworkin, Carroll,
& Lauderdale, 2004; Naidoo et al., 2009). Molecular factors also play a role, where
genetic variation in both host and pathogen are highly influential in the efficacy of
disease transmission (Mathema et al., 2006). Many such studies have been conducted on
a variety of susceptible populations, including various ethnicities; however, TB
prevention studies specific to Armenians living within the United States and in their
native country are lacking.
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Current State of TB in Armenia
In Armenia, TB continues to be a major public health challenge, with escalating
incidence and mortality rates. In 2011, there were an estimated 55 newly reported cases
per 100,000 and a mortality rate of 8.8 per 100,000 (WHO, 2012a) with a growing
burden of MDR-TB (WHO, 2014). Of the newly diagnosed TB cases in Armenia,
roughly 9.4% were found to be MDR-TB and 43.0% of previously treated cases became
MDR-TB (Truzyan, Crape, Grigoryan, Martirosyan, & Petrosyan, 2015; WHO, 2015).
The country of Armenia faces several challenges in achieving adequate TB control: (a)
high incidence of MDR-TB, (b) low socioeconomic status among its population, (c)
emigration/immigration, (d) lack of public awareness, (e) HIV/AIDS co-infection, (f)
poor hygiene, (g) unsanitary conditions, and (h) transmission in children (Ministry of
Health of Republic of Armenia, 2007; WHO, 2015). While there is a fundamental
understanding about some of these national hurdles, deficiencies remain. As a result, this
controllable and curable disease is proving to be national health threat to Armenians. As
Armenians immigrate to other countries, including the United States, infected individuals
pose an international health risk to everyone they come in contact with.
Current State of TB in the United States
In the United States, TB is a highly managed disease where all 50 states and U.S.
territories are mandated to report TB cases (Myers, Westenhouse, Flood, & Riley, 2006).
All states have TB control programs that report to the national surveillance systems, the
Online Tuberculosis Information System (OTIS) and the National Prevention Information
Network (NPIN). As a result, TB incidence in the U.S. is at its lowest since the 1950s
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when national surveillance was first implemented. From 1985–1992, the United States
experienced a resurgence of TB, which was accompanied by MDR-TB and to a lesser
extent, XDR. In 2015, 9,563 cases of TB were reported in the United States, an increase
from the 9,406 cases reported in 2014 but a decline from the 10,528 cases reported in
2011 (CDC, 2012d; Salinas et al., 2016). This is promising but falls short of goals set by
the CDC. In 1989, its Strategic Plan for the Elimination of Tuberculosis called for
complete eradication by 2010. However, the goal has been hindered by the resurgence of
TB due to the HIV/AIDS epidemic, increased immigration by individuals from countries
in which the disease is endemic, MDR-TB, and transmission in congregate settings
(CDC, 2011). In 2011, 62% of all TB cases in the United States were attributed to
foreign-born persons, where the case rate for foreign-born persons was estimated to be
11.5 times higher than among U.S.-born individuals. MDR-TB cases has shown a
decrease since surveillance began in 1993 with 1.3% of cases showing resistance to
multiple drug treatments (CDC, 2012d). The cost of hospitalization for an XDR TB
patient in the United States was estimated to average $483,000, approximately twice the
cost for MDR TB patients. Due to TB’s limited response to antibiotics, mortality rates
among XDR patients parallel those of TB patients in the pre-antibiotic era (CDC, 2009a).
California has one of the highest incidence rates of TB in the United States (CDC,
2013). In 2013, TB incidence in California was estimated to be 7 cases per 100,000, of
which 30.5% were located in LA County (County of Los Angeles Public Health, 2015).
LA County has a high population of immigrants, where native countries may have
endemic TB. Many immigrants enter the United States without reporting latent or active
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disease for fear of being deported. Therefore LA County has a high incidence of both
latent and active TB, particularly in clustered communities. Furthermore, the homeless
population is highly susceptible due to a nomadic lifestyle and insufficient tracking for
continuous treatment. LA County is home to one of the largest homeless populations,
particularly in Skid Row, where recent spikes in TB have been experienced
(“Tuberculosis Outbreak Among Homeless In Los Angeles, Calif. [VIDEO],” 2013).
LA County’s Department of Public Health Tuberculosis Control Program (TBC)
has a multifaceted control program that concentrates on disease surveillance and
epidemiology. The program includes vital case reporting into the TB registry, MDR-TB
treatment and monitoring, screening of refugees and immigrants entering the county,
health education for medical staff and at risk communities regarding disease treatment
and recognition (both latent and active forms), and legal enforcement of noncompliant
carriers and offenders who may be putting communities at risk for disease transmission
(including homeless populations). Such an approach is essential for achieving the
program’s vision of eliminating TB from “indigenous and resident populations” (Los
Angeles County Department of Public Health, n.d.). It is a nationally and internationally
renowned program due to essential elements such as assigned Extended Role Nurses
(ERN) who are made available to help ensure treatment compliance. Enlisted specific
health care facilities throughout LA County are equipped with specialized staff and
equipment to support program needs, and provide informational and educational
programs for staff and the community (Nitta & Davidson, 2003).
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Research Gap
A gap exists in understanding the factors that influence treatment-seeking and
adherence among Armenians living in LA County. By better understanding the perceived
barriers to seeking treatment and adhering to it, it is expected that TB health outcomes in
this susceptible population will be greatly improved both domestically and in their native
country, where TB-associated morbidity and mortality is high. There are also significant
public health implications for implementing improved TB prevention efforts in the
Armenian community, as well as other immigrant populations.
Problem Statement
Despite national and statewide efforts to reduce TB, its incidence in California
remains the highest in the United States (CDC, 2013). Of the 2,169 reported cases in
California in 2013, 662 cases (30.5%) were located in LA County (County of Los
Angeles Public Health, 2015). The LA County Department of Public Health’s
(LACDPH’s) Tuberculosis Control Program actively performs surveillance of TB cases,
particularly in immigrant populations, and provides treatment throughout the course of
the disease. The City of Glendale, located within LA County, has experienced the largest
influx of Armenians nation- and world-wide. There are an estimated 80,000 Armenians
and their descendants living in Glendale, making it the second largest Armenian
community on the planet, behind only Yerevan, Armenia (Hayk the Ubiquitous
Armenian, 2012). Despite the availability of publicly funded TB diagnosis and treatment,
18% of all new TB cases (118 cases) in LA County in 2013 were found in Glendale and
surrounding cities within the Service Planning Area (SPA-2) (County of Los Angeles
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Public Health, 2015). While the number of TB cases within SPA-2 hasn’t been clearly
defined as Armenian or non-Armenian, the implication that many of these cases are
attributed to Armenians is based upon their prevalence in the community and the disease
incidence in their native country. Therefore, the overall purpose of this study was to use
mixed-methods research to explore differences in barriers to treatment-seeking and
compliance in Armenians versus non-Armenians, with a potential impact on TB
prevalence within the local Armenian community.
Purpose of the Study
The purpose of this concurrent mixed-methods study was twofold: (a) to explore
the differences in factors (physical, psychosocial, cultural, or behavioral) relating to TB
knowledge, treatment-seeking and adherence in Armenians versus non-Armenian
residing in LA County and (b) how such differences may impact the reduction of TB
incidence in this susceptible population. For this mixed-methods study, a survey was
utilized to explore whether such barriers to treatment-seeking and adherence differed
between Armenian and non-Armenian individuals residing in LA County, with potential
implications for reduction in disease incidence. This was followed by the qualitative
component involving in-depth interviews of both Armenians and non-Armenians living
in LA County to understand general perceptions about TB, along with perceived barriers
to TB treatment and treatment adherence in both groups.
The qualitative portion of this concurrent mixed-methods study was an
ethnography where shared beliefs, behaviors, and knowledge relating to TB treatmentseeking and adherence among Armenians were explored. The study is also aligned with
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phenomenology, where Armenians’ individual experiences of TB were described by the
interviewees and subsequently grouped thematically. In-depth interviews were conducted
using the social ecological model, SEM (discussed below), and the belief or behavioral
patterns of the culture-sharing Armenian group in Glendale and surrounding areas, For
the quantitative portion of the study, the association between the dependent variable—
knowledge about TB treatment seeking and treatment adherence— and the independent
variables—barriers or factors relating to TB treatment seeking and adherence—were
explored using a survey questionnaire. Such factors included demographic (Armenian
versus non-Armenian), socioeconomic, cultural, behavioral, and/or individual beliefs.
Furthermore, (a) differences in such perceived barriers and (b) characteristics of other
non-Armenian populations were assessed.
Research Questions and Hypotheses
This mixed-methods study addressed the following research questions and tested
the associated null and alternative hypotheses:
1. What are the perceived barriers to treatment seeking and adherence for
tuberculosis in an Armenian population living within the United States?
2. Is there a difference in barriers to treatment seeking and adherence for
tuberculosis in Armenian versus non-Armenian populations living in Los Angeles
County and which factors (e.g., physical, cultural, psychosocial, behavioral) have
the greatest influence?
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HA2: There are differences in factors relating to treatment-seeking and
adherence for tuberculosis in Armenian versus non-Armenian populations
in Los Angeles County.
H02: There are no differences in factors relating to treatment-seeking and
adherence for tuberculosis in Armenian versus non-Armenian populations
in Los Angeles County.
In the quantitative study (RQ2), the dependent variable, knowledge about TB
treatment-seeking and treatment-adherence, was explored in relation to the independent
variables, barriers, or factors about TB treatment-seeking and treatment-adherence. A
more detailed discussion of the research questions and associated hypotheses is addressed
in Chapter 3.
Theoretical and Conceptual Framework
Theoretical Framework
The theoretical framework used for this study was the SEM. SEM is widely used
in public health and incorporates key principles from community- and individual-based
approaches of prevention, with emphasis on the environment. Here, four interrelated
factors are addressed: (a) the individual and risk behaviors, (b) relationships, (c)
community and environment, and (d) societal /cultural norms. Several studies involving
TB transmission amongst various populations across the United States have been
reported (Hawker, Bakhshi, Ali, & Farrington, 1999; Myers et al., 2006).
Studies involving decreasing the transmission of TB or other infectious diseases
have also used grounded theory (Daftary, 2012; Daftary & Padayatchi, 2012; de Souza &
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Guerreiro Vieira da Silva, 2011; Dodor & Kelly, 2010; Johansson & Winkvist, 2002;
Onifade et al., 2010); the Theory of Social Stigma (Castro & Farmer, 2005); or the
theory of social determination (de Queiroz, De-La-Torre-Ugarte-Guanilo, Ferreira, &
Bertolozzi, 2012). However, SEM is a more dynamic and applicable model. TB, in
particular, is a dynamic disease that involves personal factors (e.g., biology, personal
competence, resilience), social factors (e.g., family influences, social norms), and
sociocultural-environmental factors (e.g., socioeconomics, cultural identity, knowledge,
and motivation), all of which SEM accounts for.
Conceptual Framework
The qualitative portion of the mixed-methods study is grounded by ethnography,
with aspects of phenomenology. Ethnography-based approaches are well-suited for this
study due to the emphasis on social interactions, behaviors, and perceptions within a
particular group (Reeves, Kuper, & Hodges, 2008). Phenomenology explores what and
how something is experienced by a particular population, as individuals, and are then
universally grouped based on reported experiences (Creswell, 2012, p. 76). For this
study, in-depth interviews of Armenians and non-Armenians living in LA County were
conducted to gain insight into perceived barriers to treatment-seeking and treatmentadherence for TB. Currently, there are no reports in the literature describing this, despite
the high incidence of TB in Armenia. The current literature discusses psychosocial and
psychiatric barriers in other ethnicities and groups living in their native country and upon
immigration to the United States. Such barriers and groups will be discussed in detail in
Chapter 2.
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When conducting ethnography, it is important to engage in cultural immersion to
gain a better understanding of the native language and social norms. Having been raised
with significant Armenian influences throughout my life, these experiences can be
leveraged not only for accessing the population but also relating to participants. Further
immersion involves the ability to converse with participants in their native language, if
need be, and therefore Armenian language classes were taken concurrent with this study
in conjunction with assistance from Armenian speaking family and friends. Both were
critical for preparing the questionnaire and survey, pretesting the questionnaire and
survey, and conducting final interviews with participants.
The ethnography approach complements the aforementioned theoretical
framework guiding the study, SEM. Here, the inter-relationship between intra-personal,
interpersonal, sociocultural-environmental, and behavioral influences guided the
framework. When addressing the independent variables of barriers to treatment-seeking
and treatment-adherence for TB in the Armenian community, cultural influences and
patterns may play an important role in behaviors and outcomes. Depending on the overall
outcome of this study, findings may suggest that observed differences in barriers to
treatment in the Armenian community versus non-Armenian community living in LA
County are critical for effective disease management and subsequent reduction of TB
incidence.
Nature of the Study
The intent of this concurrent, mixed-methods study was to identify differences in
perceived barriers or factors (physical, psychosocial, cultural, or behavioral) in
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Armenians versus non-Armenians (independent variable) for TB treatment-seeking and
adherence (dependent variable), with potential implications for disease incidence and
prevalence. In the study, perceived barriers and factors were explored using in-depth
interviews with Armenians and non-Armenians in the community. The rationale for
combining both quantitative and qualitative data was to better understand this research
problem by converging broad numeric trends and detailed interview data in an effort to
reduce morbidity and mortality associated with TB incidence and prevalence in
Armenians.
For the qualitative aspect of this project, ethnography-focused pursuits were
implemented. Here, interviews were conducted with 10 Armenians and 8 non-Armenians
in LA County to understand perceived barriers and factors relating to TB treatment and
adherence. For the quantitative aspect of this project, 200 LA County residents were
intended to be surveyed for differences in perceived barriers or factors to TB treatment
and adherence; however, due to challenges in recruiting, only 127 LA County residents
were ultimately recruited (55 Armenian and 72 non-Armenian). Initially, convenience
sampling was exercised where Armenian family members and friends acted as
gatekeepers for gaining access to subjects. Subjects for both parts of the study were both
women and men, ranging in age from 21 to > 70 years old. Subjects were not current TB
positive patients; however, patients who underwent treatment and were TB negative were
not discouraged from participating in the study.
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Operational Definitions
Bactericidal: Describes the killing of bacteria; may be achieved by inactivating
metabolic mechanisms or breakdown of cell wall (Nelson & Williams, 2007, p. 666).
Bacteriostatic: Describes the non-killing mechanism that controls or stops
bacterial cell growth or reproduction (Nelson & Williams, 2007, p. 666).
Congregate Setting: Settings where people meet or gather, including the
workplace, shelters, schools, social or recreational settings, or places of worship. They
are treated as high TB-contact areas and special control measures are of interest (New
Jersey Medical School National Tuberculosis Center, 2004).
Direct Observed Therapy Short Course (DOTS): Observed treatment by medical
staff to ensure treatment compliance throughout the required treatment duration, which is
generally four to twelve months (Naidoo et al., 2009).
Extensively Drug Resistant Tuberculosis (XDR-TB): TB resistant to
fluoroquinolone, rifampicin or isoniazid, and any of the three injectables (capreomycin,
kanamycin, and amikacin) (Velayati et al., 2009).
First line antituberculosis drugs: Most commonly used treatment for TB. Drugs
include isoniazid, Rifampicin, Pyrazinamide, Streptomycin, Ethambutol, and
Thiacetazone (Nelson & Williams, 2007, p. 666).
Health Insurance Portability and Accountability Act (HIPAA): Patient security
and privacy act established in 1996 to protect the privacy of individually identifiable
health information including date of birth, any portion of an address, date(s) of service,
and diagnosis (Issel, 2009, p. 533).
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Latent Tuberculosis Infection (LTBI): Asymptomatic form of TB that may
become active at any time. Detectable using the PPD skin test (Nelson & Williams, 2007,
p. 660).
Los Angeles County Department of Public Health (LACDPH): Public Health
Department serving LA County in California whose mission is “to protect health, prevent
disease, and promote health and well-being” (County of Los Angeles Public Health, n.d.a).
Multi-Drug Resistant Tuberculosis (MDR-TB): TB strains resistant to multiple
anti-tuberculin drugs, both first line and second line (Mathema et al., 2006).
Nontuberculous Mycobacteria (NTM): A group of microorganisms within the
Mycobacterium genus that cause an array of diseases that include TB-like lung disease,
lymphatic and systematic diseases, and disease of the bone, skin, or soft tissue. They are
often misdiagnosed as M. tuberculosis (Raju, Raju, Zhao, & Rubin, 2016).
Nucleic Acid Testing (NAT): Detection of a pathogen’s nucleic acids (DNA or
RNA) for the rapid diagnosis of an infectious disease which generally involves sample
preparation, amplification, and detection methods (Niemz et al., 2011).
Paucibacillary: A low bacterial load of Mycobacterium tuberculosis bacilli in
patients which compromises accurate disease diagnosis (Dam & Bose, 2002).
Purified Protein Derivative (PPD): A solution prepared from cultures of tubercle
bacilli. It was originally developed by Robert Koch in 1890 as a cure for TB and is now
used as an intracutaneous injectable diagnostic for the Mantoux tuberculin skin test
(Nelson & Williams, 2007, p. 661).
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Second line treatment: Fluoroquinolones or injectable drugs, amikacin,
kanamycin, or capreomycin (Warren et al., 2009).
Service Planning Area (SPA): A geographic region within LA County of which
there are eight. Due to the enormous size of the county, they are broken down to “develop
and provide more relevant public health and clinical services targeted to the specific
health needs of the residents in these different areas” (County of Los Angeles Public
Health, n.d.-b).
Social Ecological Model (SEM): A prevention framework developed by the CDC
that accounts for interactions between individual, relationship, community, and societal
factors (CDC, 2009b).
Total Drug Resistant Tuberculosis (TDR-TB): Mycobacteria tuberculosis resistant
to all available treatment (Velayati et al., 2009).
Tubercle: Segregated region of the lungs produced by the host’s immune system
for the containment of M .tuberculosis (Beltz, 2011, p. 222).
Tuberculosis Control Program (TBC): LA County’s Department of Public Health
TB prevention program launched in 1996 with a mission of preventing the “transmission
of TB within LA County through early detection of active disease and treatment of latent
infection” (Nitta & Davidson, 2003).
Voluntary counseling and testing centers (VCTs): Primary health care facilities in
high burden low resource settings which administer testing and counseling for HIV/AIDs
and more recently, TB (African Medical and Research Foundation, 2013; Los Angeles
County Department of Public Health, n.d.).
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Assumptions, Scope, Delimitations and Limitations
Assumptions
A key assumption of this study was that Armenians residing in LA County,
particularly in Glendale or SPA-2, are primary contributors to TB incidence in the region
due to their high population in the area. Further collaboration with LACDPH’s TBC
program are necessary to fully characterize case ethnicity specifics, without violating
privacy laws covered by HIPAA, and are recommended for future studies.
A second key assumption was that barriers to treatment-seeking and treatmentadherence for Armenians will be different than what has been reported for other
populations. Current barriers, as discussed previously, include HIV/AIDS status,
immigration, socioeconomic status, disease co-infection, social networks, molecular cofactors, and various psychiatric conditions, such as helplessness and depression. Coming
from a strong Armenian upbringing, it is known that Armenians are a very tight social
group, bound by traditions and internal social norms, many of them brought over from
Armenia. Therefore, it is of great interest to see how these factors may influence
perceptions regarding TB and TB seeking behaviors.
Scope and Delimitations
The study examined TB and barriers to treatment-seeking and treatmentadherence in Armenians in LA County. While LA County houses the largest population
of Armenians in the country and world—aside from Armenia itself (Hayk the Ubiquitous
Armenian, 2012)—generalizability may be compromised. It is believed that this study
involved a representative pool of Armenians living in the United States; however, social
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and economic factors impacting the study may differ in Armenians living in other parts of
the nation or world.
Additionally, assumptions regarding TB incidence in LA County, particularly in
SPA-2 were made, where case reports are being correlated with Armenian dominance in
the area and disease trends in native Armenia. Currently, Armenians are classified with
the White/Caucasian race and thus TB cases in LA County are reported as such.
Therefore, determining patient ethnicity as Armenian on a case-by-case basis may be
challenging and may be worth exploring in future studies.
Limitations
This study suffered from several limitations; they needed to be addressed and
interpreted when deriving final conclusions. One key limitation of this study pertains to
TB case reporting in LA County. While the actual numbers are up to date due to
extensive reporting mandates by the county, determining patient ethnicity as Armenian
on a case-by-case basis may be challenging. Currently, Armenians are classified with the
White/Caucasian race. The current implications of the study rely on the fact that many of
the cases within SPA-2 are attributed to Armenians based upon their prevalence in the
community (Hayk the Ubiquitous Armenian, 2012) and disease incidence in Armenia
(WHO, 2012a).
Another limitation is that this study focused only on Armenians residing in LA
County. LA County houses the largest population of Armenians in the country and world,
aside from Armenia itself (Hayk the Ubiquitous Armenian, 2012); therefore, it is believed
that the study involved a representative pool. However, the social and economic factors
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impacting the study may not be generalizable to Armenians living in other parts of the
world.
Further limitations involve those factors that may threaten validity and reliability
when conducting qualitative studies, including recall bias and sampling strategies
(Creswell & Plano Clark, 2011, p. 211; Frankfort-Nachmias & Nachmias, 2008, p. 150).
Recall bias may severely impact the study and overall outcomes should be addressed
through appropriate instrumentation and surveys. Sampling strategies are another concern
and may severely impact data analysis and results. Surveys and/or in-depth interviews
with Armenians in the community were accessed through gatekeepers from family,
church, and community groups to understand perceived barriers to treatment and followup, including current knowledge base about the disease and accessibility from TBC.
Conducting in-depth interviews also offer challenges including logistics, time, and
rationalization and coding of responses.
A final threat to validity and reliability involved instrumentation, which, in this
case, was a questionnaire. An original questionnaire was generated to ensure cultural
sensitivity and relevance to the Armenian community. This presented some challenges
because there were no assurances about its validity and coherence. Therefore, pretesting
was required to ensure the questionnaire’s appeal and ease of comprehension. To remove
some ambiguity, the questionnaire was provided in English and Armenian. The
questionnaire for the non-Armenian group was also subjected to pretesting to address
some of the same issues and to ensure clarity.
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Significance of the Study
TB morbidity and mortality are highly associated with treatment regimen and
nonadherence. Varying growth patterns and specialized biological characteristics of M.
tuberculosis create complex antibiotic treatments and chemotherapy that require up to 12
months. DOTS was initiated in 1995 and continues to be promoted to improve patients’
adherence through the use of supervision by healthcare workers; however, success has
been inconsistent due to lagging government involvement, available resources, and
insufficient support systems (Naidoo & Mwaba, 2010).
A thorough understanding of barriers and factors relating to treatment-seeking and
adherence is vital for complete disease management and control. Barriers to TB treatment
and treatment compliance for some immigrant populations have been discussed in the
literature. Such barriers include gender (Onifade et al., 2010), social stigma (Daftary,
2012; Dodor & Kelly, 2010), poverty and sub-standard housing, disease coinfection (e.g.,
cardiovascular, HIV, hepatitis), unsupportive social and work environments,
incarceration, disbelief in the health facility and staff, helplessness, hopelessness, and
depression (Fry et al., 2005; Kandula et al., 2004; Naidoo et al., 2009; Tupasi et al.,
2016). However, TB prevention studies are severely lacking for Armenians living in the
United States and Armenia, particularly qualitative studies, which generate firsthand
accounts of the social situation within the Armenian community.
Positive Social Change
This research fills the gap in understanding treatment-seeking barriers in this
susceptible population, with potential public health implications for other diseases in
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addition to TB. Implications for social change involve decreasing TB prevalence in the
Armenian population in the United States—and potentially within native Armenia—
through more effective disease management, resource allocation, and patient care.
Summary
This chapter highlighted TB background and current trends relating to disease
diagnosis, genetic variants, treatment and therapy, susceptible populations, and major
barriers to treatment-seeking and treatment-compliance, in both developing and
developed countries. Furthermore, barriers and factors relating to treatment-adherence for
non-Armenian populations living abroad were discussed. This served to present the
problem statement, research questions and hypotheses, significance of inquiry within an
Armenian population, definition of terms, and the assumptions and limitations within the
literature.
Chapter 2 provides extensive background information on TB and discusses the
literature in light of the current study’s research question, hypotheses, problem statement,
and objectives. Specifically, this chapter will compare the literature on barriers to TB
treatment-seeking and adherence in immigrant populations, though those specific to
Armenians are severely lacking. Literature exploring the health system in Armenia, in
conjunction with studies addressing other infectious diseases in Armenians in their native
country and the United States, will also be explored in an effort to uncover social and
behavioral trends that may be useful for the qualitative surveys.
In Chapter 3, a more detailed discussion of study design, research methodology,
participant sampling and instrumentation will be presented. In Chapter 4, the results and
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statistically-derived findings from the two study components will be presented in detail
and related back to the research questions and hypotheses. Finally in Chapter 5, a
summary and interpretation of the study findings will be detailed, as well as
recommendations for future research and implications for social change.
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Chapter 2: Literature Review
Introduction and Background
TB is a deadly, yet curable, infectious disease. High morbidity and mortality rates
are associated with a rigorous treatment regimen, nonadherence, and the emergence of
resulting drug-resistant strains (Mathema et al., 2006; Sacchettini, Rubin, & Freundlich,
2008). Highly susceptible populations in both developed and developing countries
include the homeless, immigrants, HIV/AIDS patients, low socioeconomic populations,
and those in correctional facilities. Increased susceptibility reflects inadequate medical
care, poor living conditions, high incidence of multidrug resistance, loss to follow-up, or
low treatment adherence (Beltz, 2011, pp. 206–207; Mathema et al., 2006; Sacchettini et
al., 2008). Loss to follow-up and low treatment adherence are of particular interest to
public health where a variety of approaches and barriers have been investigated in an
effort to improve TB outcomes and disease surveillance, most notably DOTS (Nelson &
Williams, 2007, pp. 685–688; WHO, 2010, 2012b), and improved diagnostics (McNerny,
2011; Program for the Appropriate Technology in Health, 2011; Small & Pai, 2010).
Armenia suffers from a high incidence of multidrug resistance TB and has
therefore been by designated by the WHO as one of the 18 highest priority countries for
TB control in the Europe Region (Hayrapetyan, 2012; WHO, 2012b). Furthermore, it is
one of the top 27 countries in the world burdened by MDR-TB (Hayrapetyan, 2012). On
the other hand, the County of Los Angeles in California suffers from relatively high TBincidence trends and ranks one of the highest in the country with 30.5% of the cases
reported in California located in LA County (County of Los Angeles Public Health,
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2015). Additionally, LA County is home to the highest population of Armenians, aside
from Yerevan, Armenia’s capital and largest city. While TB data collected by the
LACDPH’s Tuberculosis Control Program don’t differentiate Armenian as ethnicity,
implications are such that this cultural group may contribute to the inflated incidence
rates with LA County. Therefore, the goal of this study was to utilize a mixed-methods
ethnography approach to explore differences in factors (e.g., physical, psychosocial,
cultural, or behavioral) relating to TB knowledge, treatment-seeking and adherence in
Armenians versus non-Armenian residing in LA County and how such differences may
impact the reduction of TB incidence in this susceptible population.
TB is a dynamic and historical disease that continues to perplex scientists and
researchers seeking to reduce morbidity and mortality relating to the causative agent. As
a result, the body of knowledge is expansive and continues to grow. The literature
relating to TB covers disease epidemiology, breakthrough in diagnostics, hurdles
associated with drug resistance, and problems associated with treatment adherence. Much
of latter is done in the context of general susceptible populations (e.g., HIV positive,
homeless, poor, immigrants, incarcerated), with little emphasis on specific cultures where
familial influences and traditions may have a profound impact on TB knowledge and
treatment adherence behaviors. Armenians, in particular, are a susceptible population
with strong family influences; however, very few studies have been dedicated to this
group. Susceptibility within this population relates to high incidence in their native
country, inadequate health care, poor disease tracking, poor education regarding the
disease, poverty, migrant workers, and immigration to foreign lands where assimilation
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by this “hidden minority” may prove to be a challenge (Bakalian, 2011; Truzyan et al.,
2015; Vink et al., 2005). A few studies exist which explore TB-associated problems in
their native country (Breitscheidel, 2006; Breitscheidel, Stamenitis, & Bosch, 2010;
Ehlman et al., 2007; Grigoryan et al., 2008; Ministry of Health of Republic of Armenia,
2007; Truzyan et al., 2015; Vink et al., 2005); however, to the best of my knowledge, no
studies of Armenians living the United States were uncovered relative to TB or any other
infectious disease where an ethnography approach was utilized for understanding
Armenian patient health care seeking behaviors within an unfamiliar health care system.
The following chapter presents a critical review of the literature in an effort to
establish an understanding of the current state of TB in the developed and developing
world, with particular interest in the Armenian community. The literature search strategy
will be discussed which covers databases and key terms utilized for conducting the
exhaustive search. Furthermore, support for the theoretical foundation and conceptual
foundation will be discussed. Key variable and concepts relating to the study specifically
will also be discussed, including concepts relating to both the qualitative and quantitative
components of the study. A summarization of key findings in the literature will also be
highlighted as a transition into the methodological approaches discussed in Chapter 3 is
made.
Literature Search Strategy
Databases, Search Engines, and Keywords
In conducting this exhaustive literature search, the databases used were Web of
Science, PubMed/MEDLINE, Google Scholar, and Science Direct. The keywords were
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as follows: tuberculosis, Armenia, education, epidemiology, theory, social ecological
model, Eastern Europe, drug resistance, directly observed treatment, disease barrier
Armenia, Armenia health barriers, Armenia United States disease, Armenia culture
health, ethnographic study, Armenian culture, prison, tuberculosis HIV, tuberculosis
immigrant, tuberculosis diagnostic, tuberculosis social determinants, tuberculosis
stigma, tuberculosis treatment barrier, and tuberculosis behavior. Some common
abbreviations included TB, MDR-TB, XDR-TB, TDR-TB, DOTS, and TB-HIV. The
selected literature addressed key research goals, disease epidemiology, and identifying
gaps in the literature. Documents were obtained via electronic download or interlibrary
loan. As relevant documents were being downloaded, cataloging and subsequent
categorization was done using the bibliographic software, Zotero (Roy Rosenweig Center
for History and New Media, Fairfax, VA), which interfaces directly with word processing
software to facilitate proper APA citation formatting throughout the writing process.
Scope of the Literature
A literature review based on the terms described above was an extensive and
iterative process. Peer reviewed articles were searched and read, if they explicitly related
to topics relevant to the scope of the study. Most of the literature searched was very
current, spanning over the past 10 years. However, primary peer-reviewed articles cited
numerous times by the more recent publications were also read in order to get a complete
understanding of the concept addressed. This was particularly true when investigating
theoretical foundation and conceptual framework. Background relating to TB
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epidemiology and initial research in theoretical framework was also obtained from books
addressing infectious diseases and theories in public health, respectively.
Theoretical Foundation
The theoretical foundation for this study is based upon the SEM (CDC, 2009b).
SEM is a dynamic behavioral intervention model which focuses on the individual,
community, the environment, and interactions thereof. TB is a dynamic disease that is
influenced by the interplay of many factors including: personal factors (e.g., biology,
personal competence, resilience), social factors (e.g., family influences, social norms),
and sociocultural-environmental factors (e.g., socioeconomics, cultural identity,
knowledge, and motivation). SEM is adaptable to many public health applications and
has therefore been applied to a variety of public health intervention strategies.
SEM has been used frequently in infectious disease and sociological
epidemiology (Green, Lewis, & Bediako, 2005; Hosek, Harper, Lemos, & Martinez,
2008; Murray, Oxlade, & Lin, 2011; Reifsnider, Gallagher, & Forgione, 2005). SEM
epitomizes social epidemiology with ecological factors at its core that present integral
principles that serve as a foundation for explaining potential causal relationships between
disease and social and biological conditions (Krieger, 2001) and address complex
community-based problems relating to health disparities (Green et al., 2005; Reifsnider et
al., 2005). Here, key principles are incorporated from community- and individual-based
approaches of prevention with an emphasis on the environment. As seen in Figure 1,
SEM addresses four inter-related factors: the individual and risk behaviors, relationships,
community and environment, and societal /cultural norms (CDC, 2009b). The individual
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is central to the model where internal determinants such as knowledge, attitudes, and
beliefs come into play. The next layer considers external forces attributable to
interpersonal processes and relationships such as social interactions with family, partners,
and friends. The next level of community includes individuals, businesses, institutions, or
organizations that collectively form a social construct or community. Finally, the
outermost level, social structure / public policy, incorporates environmental and/or
governmental changes, to effectively influence change (California Department of Public
Health, n.d.; CDC, 2009b).
Societal
(religion, culture,
societal norms,
policy)
Community
(workplace,
school,
neighborhood)
Interpersonal
Relationship
(peers, family,
partners)

Individual
(biological,
personal)

Figure 1. The four levels and main influences involved in the
social ecological model (SEM). Adapted from The SocialEcological Model: A Framework for Prevention - Violence
Prevention - Injury Modified, by CDC, 2009b, Retrieved
February 5, 2013, from
http://www.cdc.gov/violenceprevention/overview/socialecologicalmodel.html.
SEM has been more widely used for studies addressing many facets of TB
transmission, treatment and prevention, including health disparities, ethnic differences,
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socioeconomics, immigration, and psychosocial factors amongst various populations both
nationally and internationally. More specifically, one relevant study by Myers et al.
(2006) explores TB transmission in California using an ecological approach. Using the
U.S. Census data for California, ecological variables such as racial/ethnic distribution,
immigration, education level, employment status, poverty, and crowding were
incorporated and related to new TB cases, using pediatric cases as a measurement of
transmission. Overall, lower median incomes, racial/ethnic minorities, and immigrants
were found to have higher rates of pediatric tuberculosis. While extremely relevant to this
study, there was no differentiation of Armenians as an ethnicity so specific insight into
this group is not provided.
Other groups such as Hawker et al. (1999), Harling et al. (2008), Marx et al.
(2007), Barr et al. (2001), Tupasi et al. (2016), and Holtgrave et al. (2004) have utilized
SEM to investigate the impact of various ecological factors (namely poverty, SES, and
ethnic differences) on TB transmission treatment adherence in a variety of populations in
the United States and abroad. Again, none of these studies explicitly discuss any such
factors within the Armenian community, either in the United States or Armenia. Murray,
Oxlade, and Lin (2011) have expanded upon SEM and used mathematical modeling to
further explore the dynamics associated with social, environmental and biological
determinants of TB in an effort to improve intervention strategies. While the study has
some limitations due to the static nature of mathematical modeling, associations between
TB infection and smoking, indoor air pollution, alcohol use, diabetes, nutrition,
crowding, migration, aging, and economic trends were projected (Murray et al., 2011).
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Conceptual Foundation: Armenian Ethnography Elements
One component of this mixed-methods study involved ethnography in relation to
the Armenian culture. Distinctive with their shiny black hair, prominent nose, and the
tell-tale “ian” (or variations thereof) at the termination of their familial name, Armenians
are rich in close family bonds, cultural quips with ancestral origins, and the strength and
desire to survive. Despite the Armenian genocide in 1915 by the Turks, the Spitak
Earthquake of 1988, and the dissolution of the Soviet Union in 1991, Armenians have
learned to come together in order to survive and move forward. Many of these historical
events also resulted in the immigration of Armenians to other parts of the world,
including the United States, Europe (e.g., United Kingdom), and Latin America. With
immigration comes the desire to assimilate within the host society while also struggling
to also maintain cultural identity. William Saroyan, a well-known American-Armenian
author, epitomized Armenians best in a series of short stories in Inhale and Exhale”
(1936, p. 438):
I should like to see any power of the world destroy this race, this small tribe of
unimportant people, whose wars have all been fought and lost, whose structures
are crumbles, literature is unread, music is unheard, and prayers are no more
answered. Go ahead, destroy Armenia. See if you can do it. Send them into the
desert without bread or water. Burn their homes and churches. Then see if they
will not laugh, sing, and pray again. For when two of them meet anywhere in the
world, see if they will not create a new Armenia.
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The Armenian genocide of 1915 not only is a significant part of the Armenian
history but also contributes to the strong cultural identity and presence of Armenians.
First-generation Armenians and genocide survivors have openly exercised their ability to
share their experiences with next generations of family members and friends in an effort
to keep their stories alive. With these stories and experiences, descendants of the victims
and survivors have yet another common thread with which to weave their Armenian
culture together with others regardless of where they live. Also interwoven within these
stories are traditional beliefs about life, health, happiness, politics, social conduct and
business that seem to transcend time; some with a scientific basis and others more
folkloric. Armenians are also a very spiritual, yet superstitious, group of people and
actively ward off bad or evil throughout their daily events, primarily through the use of
the kapoot achk (blue eye) which wards off ill fortune brought about from the evil eye
(Best Country Reports, 2011, p. 17). Regardless of the validity, such beliefs impact
decisions that are made within their daily lives and must therefore be realized and
understood when attempting to address or improve health outcomes. If a disease like TB
is not understood (including symptoms, modes of transmission, and treatment) and an
explanation is not culturally relevant, Armenians may rely upon the kapoot achk as the
primary means of fighting the disease and therefore result in poor health outcomes. By
integrating kapoot achk as part of the education and intervention plan, disease treatment
seeking and adherence behaviors may improve.
Several other events central to Armenian history which impact their health in
particular are the Spitak Earthquake of 1988 and the crumbling of the Soviet Union in

37
1991. In fact, the fall of the Soviet Union is viewed as a major event that lead to the rise
of TB and MDR-TB in that region (Phillips, 2013). While part of the Soviet Union,
Armenians had access to free health care, though access for women was sparse. Once the
Soviet Union dissolved, resources for the delivery of adequate health care in Armenia
also suffered where much of the burden fell on limited and underpaid physicians and
nurses (Amoros, Callister, & Sarkisyan, 2010). Therefore, the overall health of
Armenians suffered and health-seeking behaviors also changed. In 2002, the Center for
Health Services Research and Development of the American University of Armenia
conducted an assessment to identify vulnerable population groups and specific health
education needs. Four main highly susceptible populations included children under the
age of 5, the elderly, pregnant women, and adolescents. Afflictions ranged from acute
respiratory disease (including TB), poor nutrition, poor reproductive health, poor dental
health, dangers from alcohol and passive smoking, physical inactivity, poor hygiene, poor
mental health, accidents, cardiovascular disease, and cancer (Center for Health Services
Research and Development, American University of Armenia, 2002).
Economic uncertainty following the breakup of the Soviet Union also forced
many Armenians to seek seasonal work in neighboring TB-burdened countries and then
return to Armenia following work completion. As a result, migrant workers have been
found to have higher incidence of TB (particularly MDR), HIV co-infection, delayed
treatment initiation, and increased loss to treatment follow-up due to migration between
affected countries, with inadequate reporting systems to track them (Truzyan et al.,
2015). Poor economic status has also seen a rise in injection drug use in Armenia.
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Injection drug users (IDUs) have a higher incidence of HIV, which is problematic for the
activation of latent TB. According to Ghukasyan (1999), IDUs in Armenia are
misinformed about their TB status, uninformed about TB-HIV synergy, and tend to avoid
TB health clinics for fear of incarceration or involuntary detention.
The earthquake of 1988 also hampered the country’s health status, despite still
being part of the Soviet Union. Significant lives were lost, people were displaced, and
infrastructure was severely destroyed (Doarn & Merrell, 2011). Furthermore, the
aftermath of the earthquake resulted in an increase in post-traumatic stress disorder,
anxiety, depression (Goenjian et al., 2000), along with a breakdown in overall healthcare
services (Doarn & Merrell, 2011).
A major consequence of the aforementioned tragedies in recent Armenian history
is the immigration of Armenians to distant lands. As Armenians flee from their native
country in the hope of a better life, issues and sensitivities relating to assimilation and
maintaining cultural identity surface (Bakalian, 2011). Many immigrant populations such
as Armenians are misunderstood or viewed as clannish and are targeted as being
problematic. The ability to assimilate and assume anonymity may appear to be
advantageous in terms of escaping stereotypes and social stigma, as demonstrated by
Armenians living in London (Talai, 1986). However, Armenian pride and the desire to
preserve their culture seem to supersede taking the easy path where ancestral value
systems, language, food, and religious ideologies are incorporated into their daily lives
and communities. First-generation Armenian parents have to make the decision as to
whether they should raise their children according to Armenian customs and teach them
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their native language or to completely submerge them in English-American lifestyle in
order to simplify their assimilation (Imbens-Bailey, 1996; Phinney, Ong, & Madden,
2000). However, the decision to adopt non-Armenian values and norms may prove to be
challenging when making general life decisions involving community socialization,
education, and workplace policies. Many explanations, or lack thereof, of social norms
may be misconstrued or misinterpreted, thereby compromising the social balance
between cultural beliefs and superstitions and local norms. Such conflict contributes to
the appeal of conducting an ethnographic study in relation to disease and disease
outcomes in the American-Armenian community where ambiguities in health seeking
behaviors and knowledge may exist.
Armenians living in the United States are a rarely studied group and considered to
be a hidden minority. More specifically, studies involving American-Armenians in the
social sciences are quite limited (Bakalian, 2011). Therefore, the ethnographic
component of this study could fill the gap in gaining insight into perceived barriers to
treatment-seeking and treatment-adherence for tuberculosis, particularly those that are
specific to cultural attitudes, influences, and behaviors. Furthermore, studies
incorporating ethnography and TB are limited. Park and Littleton (2008) conducted an
ethnography in New Zealand to explore the impact of immigration on TB incidence
influxes within the country. Overall, it was found that immigrants were responsible for
the increase in active and latent cases of TB within the country. Therefore, the
investigators proposed the use of such information to incorporate social support programs
specific for such groups into their healthcare system. They also found the results to be a
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threat to their national health and have proposed modifications in their immigration
policies. Investigations into barriers to treatment-seeking behaviors in such groups were
not discussed. This study may also set precedence in this area of TB research as well.
Key Variables and Concepts
The causative agent of tuberculosis, M. tuberculosis, is a complicated microorganism that contributes to the complexity of the disease and disease outcomes. Disease
epidemiology, rigorous treatment regimen, insufficient health care and treatment support,
and a variety of social determinants are all dynamic contributors to poor health outcomes
related to the disease. Many of these contributors translate across country borders while
others are unique to specific races or cultures. The studies described herein will highlight
many of these areas in general terms and more specifically as they relate to the Armenian
community, albeit limited.
Disease Epidemiology, Diagnosis, and Treatment
M. tuberculosis is a slow-growing obligate aerobic bacillus with a thick waxy cell
envelope that primarily targets the lungs and respiratory tract (Beltz, 2011, p. 212;
Mathema et al., 2006; Nelson & Williams, 2007, p. 654). The thick waxy cell envelope
presents challenges for TB diagnosis and treatment (Velayati et al., 2009), which will be
also be discussed in detail below. M. tuberculosis is readily transmissible through
aerosolization of only a few viable tubercle bacilli resulting from coughing, sneezing,
laughing, talking, or singing (CDC, 2012a). Upon inhalation of released mycobacteria,
active (primary) or latent (LTBI) infection may result, with one-third of those exposed
becoming infected and 10% eventually becoming active and symptomatic (Mathema et
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al., 2006). Most active cases take several weeks from time of exposure; however
immuno-compromised individuals may experience rapid progressive primary
tuberculosis. If left untreated, active TB can be quite deadly with mortality rates of up to
50% (Beltz, 2011, p. 211). With latent TB, mycobacteria are dormant and individuals are
asymptomatic (CDC, 2012a). LTBI can reactivate years following primary infection;
which may be triggered by the weakening of the immune system as with HIV coinfection, age, malnutrition, poor living conditions, and poor hygiene.
Disease diagnosis varies, depending upon the country, available resources,
infrastructure, and extent of infection. Such variability and potential inadequacies can
prove to be problematic due to the nature and potential lethality of the disease.
Traditional diagnosis of active pulmonary TB is performed using smear microscopy,
culture-based methods of sputum specimens, or chest x-ray (Beltz, 2011, pp. 214–216;
Nelson & Williams, 2007, p. 664; Niemz & Boyle, 2012). Though outdated, these
technologies are amenable to high burden low resource settings due to simplicity and low
cost; however, they suffer from insufficient sensitivity and specificity, inadequate speed,
and inconsistent availability in health clinics or VCTs where many patients first seek care
(Niemz & Boyle, 2012; Niemz et al., 2011; Small & Pai, 2010). Patients are also
requested to produce multiple sputum specimens to confirm a positive result, which may
result in loss to follow-up if the patient does not return due to logistical challenges (Lawn
et al., 2013; Niemz & Boyle, 2012; Niemz et al., 2011). In Armenia, the standard mode
of TB diagnosis is chest x-ray due to the inaccessibility of sputum microscopy. This trend
is attributed to the lack of involvement by health practitioners and nurses, quality
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microscopes, reagent and supply procurement, and adequately trained personnel (Vink et
al., 2005). According to a recent WHO Global TB report, in Armenia there are only 26
laboratories performing smear microscopy with only 4% using LED microscopes, 1
laboratory performing culture and drug susceptibility testing, and 2 performing NAT via
Cephied’s GeneXpert® MTB/RIF (WHO, 2015).
The implementation of NAT is moving to the forefront of TB diagnostics. NAT
has been found to be more sensitive, specific, and rapid than current methods and also
facilitates the diagnosis of multidrug resistant TB, thereby positively impacting patient
outcomes (Niemz & Boyle, 2012; Niemz et al., 2011; Schumacher et al., 2016; Small &
Pai, 2010). While highly advantageous, worldwide implementation of TB NAT is
hampered by complicated cell physiology, specimen type, patient age, HIV-1
comorbidity, expense, and complexity of systems. The waxy bacterial wall makes the
pathogen very difficult to lyse which limits the amount of DNA template liberated for
amplification. Furthermore, HIV-1 co-infected individuals and young children may
produce insufficient volumes of sputum and therefore paucibacillary, which may limit
target yield (Niemz & Boyle, 2012). Current NAT may involve the polymerase chain
reaction (reviewed by Ling et al., 2008) or isothermal amplification schemes such as
loop-mediated isothermal amplification (Boehme et al., 2007, 2010), helicase-dependent
amplification (Ao et al., 2012; Motré et al., 2011; Torres-Chavolla & Alocilja, 2011),
transcription-mediated amplification (Pfyffer et al., 1994), or cross-priming amplification
(Fang et al., 2009). The most prominent and highly endorsed system by the WHO,
StopTB, FIND, and local health ministries is Cepheid’s GeneXpert® MDR/RIF. The
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GeneXpert® MDR/RIF is fully integrated assay system that incorporates TB diagnosis
and rifampin resistance testing. The WHO has recommended its use in areas where rates
of MDR-TB is high and serve as a replacement for smear microscopy, particularly in
district and sub-district level laboratories of developing countries (Lawn et al., 2013).
The adoption of the GeneXpert® MDR/RIF has revolutionized TB NAT testing, with
next generation systems moving toward the patient bedside or point-of-care. This will
further improve patient health outcomes, where diagnosis and treatment can be
implemented in a single visit which is particularly important in areas where patients live
remotely and have to travel great distances to obtain results and receive treatment
(McNerny, 2011; Niemz & Boyle, 2012; Niemz et al., 2011).
Historically, effective TB treatment has proven to be a challenge even when
antibiotics were first introduced in the 1940s. Even then, the emergence of initial
antibiotic resistance was seen almost immediately. The use of a first-line drug regimen of
isoniazid or rifampicin was developed over the subsequent 30 years; however resistance
to both drugs was not labeled as MDR until the early 1990’s (Sullivan & Amor, 2013).
Contributing factors to the complexity of TB treatment include the emergence of multidrug resistant strains (MDR, XDR, and TDR-TB) and biological factors, such as its thick
waxy cell envelope, slow growth, and disease-causing nontuberculous mycobacteria
(NTM). Such characteristics are key contributors to the high morbidity and mortality
rates associated with the disease. The thick waxy coat makes the pathogen highly
impermeable to antibiotics and in conjunction with its slow growth rate, several classes of
antimicrobials are used to target various stages of growth (Nelson & Williams, 2007, p.
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666). Furthermore, the treatment must be adhered to for 6 - 12 months, depending upon
patient treatment compliance, drug resistance status, and HIV status. This may be further
complicated by the improper diagnosis of diseases caused by NTMs as TB, which leads
to the unnecessary and improper treatment administration of TB drugs further selecting
for MDR-TB strains (Raju et al., 2016). The incidence of multidrug resistant TB (MDR,
XDR, or TDR) varies depending upon the region. In 2011, 9.5% of all new TB cases in
Armenia were estimated to be MDR (WHO, 2012b); whereas 1.3% of new cases in the
United States were estimated to be MDR (CDC, 2012d).
Recent challenges in the administration of adequate treatment involve shortages
of first- and second-line drugs and the lack of new anti-tubercule drugs in the
pharmaceutical pipeline. In the United States, there have been recent reports of shortages
of the commonly used first-line drugs, isoniazid and rifampin, and second-line drugs used
to treat MDR. In late 2012, shortages of isoniazid were reported by the CDC and many
state public health departments (CDC, 2012f, p. 13); whereas in early 2013, rifampin
shortages were reported (“Rifampin for Tuberculosis in Short Supply,” 2013). Most of
the shortages have been attributed to failed manufacturing lots and priority given to
global markets. Shortages for second-line drugs in the United States have been reported
since 2005, primarily due to high demand and priorities internationally and
manufacturing problems by major pharmaceutical manufacturers (McNamara, 2013).
Manufacturing problems, in conjunction with very few new developed and FDA
approved drugs, are another hurdle for effective treatment. In the past decade, only 10
potential viable drugs have progressed into the clinical development pipeline, with only 6
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specific to TB (Ma, Lienhardt, McIlleron, Nunn, & Wang, 2010). In late 2012, Johnson
& Johnson received FDA approval for a new class of anti-tubercule, Sirturo or
bedaquiline, which has been shown to be effective against drug-resistant TB strains;
however, it has been shown to work better with combined with other TB therapeutics and
mortality rates from drug toxicity appear to be roughly five times higher than standard
regimens (Thomas, 2012). Furthermore, Sutezolid (Sequella) is also in late stage clinical
trials and continue to show promise, though faces similar hurdles (Maxmen, 2013; “New
TB drug offers glimmer of hope in S.Africa,” 2015). With the help of Doctors Without
Borders, the introduction of bedaquiline to MDR patients in Armenia is bringing hope to
patients who had previously been unsuccessful on other therapies (Al Jazeera, 2014).
While TB diagnostics continue to advance and improve rapid disease diagnosis, treatment
shortages may prove to be yet another hurdle in effective TB disease management.
Current global health systems are not able to effectively diagnose and treat TB,
particularly MDR-TB, primarily due to the inability to prevent treatment interruption
during immigration (Tschampl, Garnick, Zuroweste, Razavi, & Shepard, 2016).
Therefore, national and international surveillance of TB cases has been made top priority
by national health ministries and the WHO. Within the United States, all 50 states and
territories have TB control programs that report to national surveillance systems, Online
Tuberculosis Information System (OTIS) and National Prevention Information Network
(NPIN). Individual counties within the states also have TB control programs that serve to
complement statewide and national systems. In an effort to improve international
surveillance and treatment programs, the WHO has created subgroups or regions to

46
facilitate global case reporting. The WHO subgroups include the African Region, Region
of the Americas, Eastern Mediterranean Region, European Region, South-East Asia
Region, and the Western Pacific Region (WHO, 2012b). The Country of Armenia falls
within the European Region. In 2012, there were a total of 182 Member states and 204
countries and territories actively collecting more than 99% of the world’s TB cases
reported data (WHO, 2012b). In 2003 to 2004, the CDC conducted a study on TB
surveillance efforts in the Republics of Armenia and Georgia to investigate the impact of
the fall of the Soviet Union on disease surveillance efforts. Overall, major improvements
in TB public health efforts for both countries were needed; however, it was noted that in
2007 Armenia’s National Tuberculosis Programme (NTP) was receptive to critique and
stopped charging for TB services (Ehlman et al., 2007). This supersedes when Armenia’s
Ministry of Health began working in conjunction with Stop TB to reduce TB incidence,
which occurred in 2010 (WHO, 2013). Furthermore, Armenia’s MOH has been taking a
more proactive approach by joining other at-risk Eastern European nations and
establishing symposia to discuss TB-related issues. In 2015, Armenia hosted a TB
symposium entitled “New treatments and approaches to Tuberculosis” (Medecins Sans
Frontieres, n.d.).
Also incorporated into the WHO global surveillance program and the Millennium
Development Goal (MDG) are Direct Observed Therapy Short Course DOTS and DOTs
Plus programs in order to ensure treatment adherence. DOTS was first initiated in 1995
by the WHO and StopTB to improve treatment adherence by incorporating a supervisory
healthcare worker to monitor patients taking the prescribed dosage of the treatment
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regimen (Naidoo et al., 2009). Key components of an effective DOTS program include:
(a) governmental commitment to controlling TB, (b) microscopic detection of
symptomatic patients, particularly those seeking care, (c) short-course therapy with
supervised treatment for at least the first 2 months, (d) systematic tracking of cases and
outcomes, and (e) a reliable supply of anti-TB drugs (Nelson & Williams, 2007, pp. 666–
667). While DOTS was initially viewed as an effective means to manage patient
compliance with 20 million lives saved (WHO, 2012b), it is now viewed as being flawed
with improvements needed. Much of the inconsistencies in success may be attributed to
lagging government involvement, insufficient resources, and insufficient support systems
(Naidoo & Mwaba, 2010).
DOTs Plus was initiated in 1999 by the WHO and its partners to monitor,
manage, and improve outcomes for MDR-TB (WHO & StopTB, 2006). One of the main
hindrances with DOTs Plus is the overall expense of the treatment regimen. Unless
medications are supplied for free or at a severely discounted rate, there is no guarantee
that a patient will comply with treatment. In Armenia, those with confirmed MDR or
chronic cases that failed according to DOTS, receive DOTS-Plus. However, due to a
shortage of state funds and anti-TB medications to complete the treatment regimen,
individuals are forced to pay out-of-pocket and may not be able to do so because they are
too expensive (Breitscheidel, 2006). In a pilot study looking into the benefits of DOTS
implementation in Armenia, Georgia, and Azerbaijan in 1999, results looked promising
where TB incidence significantly decreased after 3 months of treatment implementation
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(Zalesky et al., 1999). However, similar studies have not been conducted recently,
particularly after StopTB stepped in to assist Armenia’s NTP in 2010.
With the advent of new virtual technological advances that allow for real-time
communication, such as live streaming and Facetime, and the global availability of
mobile devices, improvements in DOTs is possible. Mobile Direct Observation of
Treatment (MDOT) and Virtually (video) Observed Therapy (VOT) are showing marked
improvements in TB treatment adherence by bridging the gap between patient and
caregiver interactions. Costs associated with travel and work absenteeism, along with the
ability of the healthcare worker to visibly watch the patient take their medication shows
some real promise in combating attrition (Hoffman et al., 2010; Story et al., 2016). While
studies are still in their early phases, the WHO is beginning to incorporate digital product
specifications into their diagnostics profiling requirements.
TB Susceptible Populations
Key populations that are highly susceptible to TB transmission, infection, and
complications with treatment in both developed and developing countries include:
HIV/AIDS patients, immigrants, the homeless, drug users, those in correctional facilities,
and those low socioeconomic populations, of which the latter will be discussed in more
detail in the qualitative and quantitative components below.
Those individuals co-infected with HIV present one of the largest challenges
when trying to reduce TB transmission, morbidity, and mortality. Of the 9.6 million new
TB cases in 2014, 13% were co-infected with HIV. Of the 1.2 million HIV-attributed
deaths, 400,000 were co-infected with TB (WHO, 2015). Furthermore, infected
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individuals with latent TB and HIV are more likely to develop active TB than those who
are HIV negative due to a compromised immune system (CDC, 2012d). Aside from
increasing the possibility of TB transmission, treatment is compromised. For individuals
with drug susceptible TB, a minimum treatment of 6 months of first-line anti-tubercule
drugs is recommended; however rifampicin has been shown to adversely interact with
many anti-retroviral drugs (CDC, 2012c; Maartens & Wilkinson, 2007). Furthermore,
concurrent treatments require a large amount of pills to be taken on a daily basis. Pill
count was found to be a deterrent when complying with treatment for both diseases
(Gebremariam, Bjune, & Frich, 2011).Therefore, DOTS is highly recommended for
disease management for such cases. In an effort to reduce HIV and other co-infections of
opportunistic infectious diseases (e.g., TB, Hepatitis, syphilis), many countries attempted
to restrict travel of HIV positive individuals, Armenia being one of them. Here there were
no restrictions for travelling within the country; however those foreign HIV positive
travelers requesting visas for long term stays were denied visas. Proof of HIV-negative
status was also required for granting of a visa. While the WHO found that such a policy
had no significant impact on disease spread, such policies have remained in place though
Armenia is reportedly working on changing such regulations (Lazarus, Curth, Weait, &
Matic, 2010).
Aside from HIV co-infected individuals, immigrant populations are responsible
for many of the TB cases, particularly in the United States. In 2011, immigrants within
the United States were responsible for 62% of all TB cases with a case rate 11.5 times
higher than U.S. born individuals (CDC, 2012d). This is primarily attributed to
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reactivation of latent TB (CDC, 2012e; Mathema, Kurepina, Bifani, & Kreiswirth, 2006).
Upon reactivation, they have no or insufficient health care to take care of the extensive
treatment regimen. An altered short course rifampin and pyrazinamide is available for
this group but problems with hepatotoxicity and adherence results in no real
improvement. Because of problems associated with hepatotoxicity, there is also a large
distrust of the American medical system for TB care (Kandula et al., 2004). As a result,
the CDC, state and local health departments have mandatory domestic TB screening of
refugees which not only identifies positive LTBI cases but also facilitates effective
treatment for those immigrants directly affected and their family members (CDC, 2012e;
Los Angeles County Department of Public Health, n.d.).
The homeless population also present challenges for controlling TB transmission
rates. The homeless tend to suffer from poor mental and physical health, substance abuse
problems, and insufficient health care that exacerbate the problem of TB transmission. At
the beginning of 2013, spikes in TB were experienced in LA County’s homeless
population, Skid Row (“Tuberculosis Outbreak Among Homeless In Los Angeles, Calif.
[VIDEO],” 2013). Furthermore, as a means of controlling the homeless population, law
enforcement often times incarcerate them with deleterious effects on disease transmission
rates. In a 2004 study by the CDC, the source of a TB infection in Kansas was linked to a
homeless man, whom had presented with bloody sputum to a shelter’s physician. There
was no follow-up by the patient and was subsequently jailed in multiple facilities in
Kansas. While still presenting with bloody sputum in these facilities, a tuberculin test or
chest x-ray was not administered and he was eventually released back into the public

51
while still infected with TB. Contact investigations were conducted and two of his
cellmates had active infections and 19% were diagnosed with latent TB (CDC, 2004).
In the United States and abroad, inmates in correctional facilities rank high among
sources of TB within the infected population. Correctional facilities can be viewed as
“incubators” for disease, where environmental and behavioral conditions contribute to
high TB incidence (Beckwith, Zaller, & Rich, 2006). People from diverse backgrounds
(e.g., immigrants, homeless, drug users, and HIV infected) live in close proximity for
extended periods of time, participate in high risk behaviors, and have poor medical care,
all of which facilitate rapid TB transmission (Dara et al., 2013). As a consequence,
inmates are estimated to have a 17 times higher rate of TB than the general U.S.
population (Lobato, Roberts, Bazerman, & Hammett, 2004). Reported barriers to
treatment adherence among the incarcerated include unemployment, co-morbidity,
malnutrition, and substance abuse and desired incentives for treatment compliance
include financial, food, and employment (Fry et al., 2005). Following an inmate’s release,
there is also great potential for TB to be brought into the general population and
community, particularly when left undiagnosed and untreated. Similarly, workers at
correctional facilities are also at risk for infection and can become vectors for bringing
the infection out into the general population.
Similar trends are seen among incarcerates as compared to the general population
worldwide (Dara et al., 2013). In the former Soviet Union, MDR-TB rates have been
reported to be significantly higher in correctional facilities than the general population
(Stuckler, Basu, McKee, & King, 2008). In an effort to reduce this alarming statistic, the
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investigators proposed that the implementation of PCR-based detection systems, albeit
more expensive, was better in the long run for effectively diagnosing and treating the
disease (Winetsky et al., 2012). In Armenia specifically, TB and MDR-TB rates are
reportedly higher in the incarcerated and former incarcerates (Breitscheidel, 2006;
Grigoryan et al., 2008). This is attributed to poor living conditions, malnutrition, poor
general health and hygiene, and lack of coverage by DOTS. Furthermore, prisoners with
TB enter into the general community and may later be re-incarcerated again, contributing
to the transmission cycle (Figure 2). Family, visitors, and prison staff are also at risk for
developing active pulmonary TB (Breitscheidel, 2006).
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Figure 2. TB transmission cycle in Armenia, relative to the incarcerated
and general population. Adapted from “Tuberculosis in Armenia: still an
open question,” by L. Breitscheidel, 2006. The Internet Journal of
Infectious Diseases, 5(2).
Qualitative Component
The qualitative aspect of this mixed-methods study explored perceived barriers to
treatment-seeking and adherence for TB in an Armenian population living within the
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United States. While several systematic reviews have been conducted on qualitative
studies addressing barriers and facilitators to TB treatment adherence, literature specific
to Armenians living in the United States and their native country is severely lacking.
Barriers to treatment-seeking and adherence in other populations, particularly
immigrants, will be discussed in the next section, quantitative components.
A systematic review of current qualitative research investigating patient
adherence to TB treatment was conducted by Munro et al. (2007) in order get a
comprehensive understanding of the dynamics relating to barriers to and drivers of TB
treatment adherence. Of the over 7800 citations screened for, 44 were analyzed based on
a set of established criteria. Reported factors by patients, caregivers, and health care
providers were considered. Key factors and their interactions were broken down as
structural (e.g., poverty and gender discrimination), social, health service, and personal
factors. The investigators were not able to substantially identify a single factor effecting
treatment adherence, but rather interactions thereof where it was recommended that new
improved approaches should be patient centered with all influential factors being taken
into account (Munro et al., 2007). Such an approach falls in line with the theoretical
framework of the study, SEM, which is a dynamic model.
A second systematic review of qualitative research investigating the effectiveness
of DOTS and TB management was conducted by Noyes and Popay (2007). A total of 58
studies were reviewed to address two main questions: (1) What does qualitative research
tell us about the facilitators and barriers to accessing and complying with TB treatment?
and (2) What does qualitative research tell us about the diverse results and effect sizes of
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the randomized control trials included in the Cochrane Review? Overall, five themes
were established: (a) socio-economic and material resources; (b) explanatory and
knowledge systems; (c) stigma and public discourse; (d) sanctions, incentives, and
support; and (e) social organizations and relationships (Noyes & Popay, 2007).
Furthermore, DOTS was found to be no more effective for ensuring treatment adherence
than self-supervised drug administration which also suggests that more personalized
treatment delivery systems need to be implemented.
In a study conducted by Tupasi et al. (2016), factors associated with loss to
follow-up during MDR-TB treatment in a population in the Philippines were explored. In
the case-control study of 273 adult patients, a five-level SEM model was used. It was
found that two individual factors (alcohol abuse and general TB knowledge), two factors
related to the healthcare setting (trust and support from staff, lack of assistance), and 1
factor relating to adverse reactions from treatment, particularly vomiting, were the most
significant (Tupasi et al., 2016).
TB is debilitating to Armenia as a whole. In 2006, Breitscheidel, Stamenitis, and
Bosch (2010) conducted an economic impact analysis of adult TB on the Armenian
government. Based on yearly treatment costs of $359 for smear positive and $239 for
smear negative individuals, the overall cost estimate for TB control in adults was $1.41
million (USD). For a developing country like Armenia, this is prohibitively high resulting
in insufficient resources to adequately treat and manage the disease and possibly
contributing to the worsening of the epidemic in this country.
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In a study looking into reasons for delayed TB treatment in Armenia, Schneider et
al. (2010) interviewed 240 TB patients in two Armenian TB reference hospitals where
questions regarding symptom recognition, time to seek medical attention after system
onset, outcomes following their first medical visit, and when treatment was initiated
following diagnosis. Significant factors associated with delayed medical attention
included weight loss and fatigue, inability to recognize the symptoms as being TB, and
inadequate diagnosis and/or referral after the first visit to the doctor (Schneider et al.,
2010). Such findings suggest that enhanced knowledge regarding recognizing signs and
symptoms of TB, along with improved medical care and staff would dramatically
improve disease outcomes in Armenia.
In a 2008 report by Grigoryan et al. (2008) on behalf of the Center for Health
Services Research and Development, American University of Armenia, a full assessment
of the TB in Armenia was conducted. The assessment involved the investigation of the
extent of disease burden, highly susceptible populations within the country, disease
perceptions, diagnostic and treatment challenges, and methods of disease management
improvement. The report found that highly susceptible populations included the homeless
and the poor, migrant populations (particularly refugees), HIV co-infected, the
incarcerated (current and former), orphans, those living in hospices and psychiatry
hospitals, those with medical co-morbidities (e.g., pulmonary disease, diabetes, immunocompromised), those in close contact with TB infected individuals (e.g., school workers,
municipal workers, health care, and public transportation), and drug users. Knowledge
and attitudes regarding TB was very telling. In one survey, 91% could identify TB but
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only half of those interviewed knew its mode of transmission. In another survey, the vast
majority did not realize that TB was a public health problem, could not identify
symptoms, and believed that they and their loved ones were not at risk. Social stigma is
also high, where roughly 20% keep their family’s TB status a secret. Furthermore, TB
patients were ill-informed about the duration of treatment and the consequences
regarding non-compliance or interrupted treatment (Grigoryan et al., 2008). All of these
themes, in conjunction with an inadequate and burdened national TB control program,
severely impact national TB management.
More specifically, Truzyan et al. (2015) looked at factors associated with TB
incidence in Armenian migrants, who have shown a significant rise since the fall of the
Soviet Union. Of the 95 migratory adults surveyed, 28.3% of respondents had MDR TB
and 5.3% were co-infected with TB. Because many of the respondents were abroad when
first diagnosed, time to treatment initiation and loss to follow-up upon returning to
Armenia was significantly higher (Truzyan et al., 2015). Due to the increased potential
for this group to spread the disease, as well as receive incomplete or inadequate
treatment, the need for a global reporting and tracking system is clearly apparent and
urged for by the researchers.
As can be seen from the few studies done on TB in Armenia, many of the
inadequacies and barriers to treatment are associated with the lack of resources and
funding allocated to the disease and the national health care system. While the Armenian
National Tuberculosis Control Program has made great strides, much more needs to be
done. However, studies regarding Armenians residing in their United States and their
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perceptions regarding TB and access to health care could not be found in the literature.
Therefore, this study can address this gap.
Quantitative Component
A thorough understanding of barriers to treatment adherence is vital for complete
disease management and control, regardless of the country afflicted. Reported psychiatric
and psychosocial factors effecting treatment adherence include poverty, disease coinfection (e.g., cardiovascular, HIV, hepatitis), social stigma, unsupportive social and
work environments, disbelief in the health facility and staff, helplessness, hopelessness,
and depression (Fry et al., 2005; Kandula et al., 2004; Naidoo et al., 2009). Molecular
factors also play a role, where genetic variation in both the host and the pathogen are
highly influential in the efficacy of disease transmission (Mathema et al., 2006). All
factors must be taken into account in order to achieve success. Individual or populationwide dynamics should be incorporated into a standardized basic model to see an impact
on disease incidence. Therefore, a multifaceted approach will need to be implemented in
order to achieve successful disease management and patient care.
The quantitative aspect of this mixed-method study sought to explore whether
there are differences in barriers to treatment-seeking and adherence for TB in Armenian
versus non-Armenian populations living in LA County and which factors (physical,
cultural, psychosocial, behavioral) have the greatest influence. Here, the dependent
variable, knowledge regarding TB treatment-seeking and treatment-adherence will be
explored in relation to the independent variables, barriers or factors relating to TB
treatment seeking and treatment adherence. As previously discussed, perceived barriers to
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treatment in Armenians have been minimally explored in their native country but not in
the United States. However, barriers to treatment in other populations, both in the United
States and their native country, have been reported and will be discussed in order to
ground the quantitative portion of the study.
TB burden has been shown to a have a strong correlation with socio-economics:
as socio-economics decline, TB burden increases. This is true within developed and
developing countries, with the poorest countries having an even greater risk. In a study by
Holtgrave and Crosby (2004), poverty, income inequality, and social capital had
significant correlations with TB case rates in the United States. The CDC revealed similar
findings in relation to TB, HIV, and hepatitis, and sexually transmitted diseases in an
effort to improve interventions and bring these diseases to the forefront of public policy.
Furthermore, TB rates among Hispanics and black populations is eight to nine times than
that of white populations (Sharpe, Harrison, & Dean, 2010). Similarly, as previously
mentioned, immigrant populations are major contributors to increased TB incidence in
the United States (CDC, 2012b; CDC, 2012d) and tend to fall within lower
socioeconomic populations in the United States (Ho, 2004). Aside from monetary
resources, social deprivation amongst many of the at risk populations (homeless,
incarcerated, some immigrant populations) has been shown. However, the causal links
between poverty, low socio-economics, and TB risk have not been pinpointed with
certainty (Lönnroth, Jaramillo, Williams, Dye, & Raviglione, 2009). As sequencing
technologies continue to evolve, more molecular factors and genetic variations in the host
and the pathogen may fill this sociobiological gap.
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For studies investigating psychological factors for TB treatment non-adherence,
self-reporting of helplessness, anxiety, depression, social support, and quality of life were
of primary concern. According to Carney and Freedland (2000, p. 200), depression has
been found to have a profound impact on treatment adherence for many illnesses and
therefore, such explorations are quite worthwhile and necessary. Severity of depression
has been found to be related to duration of illness, disease severity, and response to
therapy. Furthermore, it was found that in the presence of a great social support system
(mainly comprised of family and friends), depressive symptoms were found to be
decreased and/or relatively mild (Guo, Marra, & Marra, 2009; Naidoo et al., 2009;
Naidoo & Mwaba, 2010). Some of the main causes of depression in TB patients which
result in treatment non-adherence include altered social relationships, social stigma,
financial burden and loss of income, lack of social support, and persistent cough and
severity of symptoms (Issa, Yussuf, & Kuranga, 2009; Naidoo et al., 2009; Naidoo &
Mwaba, 2010; Sulehri et al., 2010). Depression has also been reported in family members
of those afflicted with the disease, which impacts social support for the patient (Ige &
Lasebikan, 2011).
Perceived social stigma in particular, has been shown to have a significant effect
on treatment initiation and adherence. Many investigators have reported that perceived
stigma results in early defaulting on treatment (Liefooghe & Muynck, 2001; Munro et al.,
2007; Naidoo et al., 2009; Naidoo & Mwaba, 2010). This may be further exacerbated by
HIV co-infection where further stigma may be associated with the disease. Such feelings
may be felt not only in the community but in the workplace and therefore feelings of
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depression and the lack of desire to continue working may take place. As a consequence,
it becomes imperative to educate the general public and those within the inner circle of
the patient to improve general understanding about the disease and promote treatment
adherence.
Summary and Conclusions
The preceding literature review provides a detailed representation of TB
epidemiology, current problems relating to TB diagnosis, treatment, and patient
management, vulnerable populations, and specific problems pertaining to the disease in
Armenian populations. The extensive discussion relating to these topics reveals the
dynamics surrounding the disease and how such interactions are central themes relating
to the problem being investigated: barriers to treatment seeking and treatment adherence
in a specific population, Armenians living in LA County in the United States. Such an
understanding has significant public health implications for effective treatment
management in this vulnerable population.
The theoretical framework and foundation explored further support the need for a
dynamic approach for effective disease management. The social ecological model uses a
multi-tiered approach for intervention where personal, social, and environmental
influences are utilized. These play in nicely with current reported barriers to TB treatment
seeking and adherence behaviors, which include psychological, psychosocial, physical,
biological, and cultural factors. The latter becomes a central element to this study, where
ethnography will serve as the theoretical foundation. Armenians are a proud group of
people, rich in family ties, influences, and ancestral adages. An understanding of TB
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knowledge and the interplay of cultural influences in the Armenian community will
complement current understandings of perceived TB treatment barriers reported for other
susceptible populations and groups.
The body of knowledge regarding TB epidemiology is vast and continues to grow
due to the enormity and severity of the disease at a global level. A smaller subset of TB
studies explores perceived barriers to treatment-seeking and adherence relative to
susceptible populations. However, a serious gap exists in the body of knowledge relating
to the Armenian community, both living in the United States and in Armenia. To the best
of my knowledge, there are no studies of Armenians living in the United States with
respect to TB or any other infectious disease behaviors or interventions. TB studies of
Armenians living in Armenia exist, but are limited. Those addressing perceived barriers
to treatment and knowledge are even narrower in scope.
In Chapter 3, the study design will be discussed, along with methodologies that
will be used to effectively address such gaps. Chapter 3 includes the methodology
utilized in this study to investigate the barriers to treatment-seeking and adherence in
Armenian versus non-Armenian populations. Included in this chapter will also be a
description of research design and approach, an understanding of the sample population
with justification of the sample size used, diagnostic measures and instruments used to
confirm disease prevalence and coding for barriers to TB treatment.
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Chapter 3: Research Methods
Introduction
As identified in the literature review, there is a gap in knowledge about the
perceived barriers to TB treatment-seeking and adherence of Armenians living in the
United States— a susceptible population. Therefore, a mixed-methods study was
conducted and focused on Armenians living in LA County. This chapter details the
qualitative and quantitative methodological approaches that were used to investigate the
TB knowledge, TB treatment-seeking and TB-adherence behaviors of Armenians versus
non-Armenians living in LA County. This chapter will include specifics on participant
selection and recruitment, the research setting, instrumentation, the pilot study, and data
analysis.
Setting
Several settings were employed for this study until the proper sample size was
met for each study. This was highly contingent on the success of recruitment for any
given setting. All recruiting was done in LA County, with emphasis on SPA-2.
Candidates were invited via social media and flyers, initially targeting local churches,
church groups, and community centers located within the county. Quantitative surveys
were administered online. More details on sampling and recruitment procedures are
provided in the next sections.
Research Design and Rationale
The goal of this mixed-methods study was to explore the differences in factors
relating to TB knowledge, such as (a) physical, psychosocial, cultural, or behavioral; (b)
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treatment-seeking and adherence among Armenians and non-Armenian living in LA
County; and (c) how such differences may impact the reduction of TB incidence in this
susceptible population. The purpose of this concurrent mixed-methods study was to
address the following research questions and hypotheses:
1. What are the perceived barriers to treatment seeking and adherence for
tuberculosis in an Armenian population living within the United States?
2. Is there a difference in barriers to treatment seeking and adherence for
tuberculosis in Armenian versus non-Armenian populations living in Los Angeles
County and which factors (e.g., physical, cultural, psychosocial, behavioral) have
the greatest influence?
HA2: There are differences in factors relating to treatment seeking and
adherence for tuberculosis in Armenian versus non-Armenian populations
in Los Angeles County.
H02: There are no differences in factors relating to treatment seeking and
adherence for tuberculosis in Armenian versus non-Armenian populations
in Los Angeles County.
Ethnography was one aspect of this study. Ethnography involves full immersion
in the culture under study in order to get a clear picture of daily life events, family
dynamics, and social interactions to enhance the observer’s ability to describe such
events and perceptions in detail (Robson, 2011, p. 142). Due to the extensiveness of
ethnography studies, they typically take a long time to conduct (Robson, 2011, p. 143);
however, having had significant Armenian influences throughout my life, these
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experiences were leveraged not only for expediently accessing the population but also
relating to participants. Further immersion on my part as the researcher involved the
ability to converse with participants in their native language, if need be. Therefore,
Armenian language courses were pursued in conjunction with assistance from Armenian
speaking family and friends. This was critical when preparing the questionnaire,
pretesting the questionnaire, and conducting final interviews of participants.
The mixed-methods study is a convergent parallel design. This design is an
intuitive and efficient approach whereby two different methods are utilized to obtain
triangulated results about a singular topic (Creswell & Plano Clark, 2011, pp. 77–78). In
this study qualitative and quantitative data were collected concurrently, analyzed, and
then merged during interpretation of the data (Figure 3). The rationale for combining both
quantitative and qualitative data is to better understand this research problem by
converging numeric trends and detailed data in an effort to reduce morbidity and
mortality associated with TB incidence and prevalence in Armenians. Such an approach
is common when the researcher is interested in triangulating methods by making direct
comparisons and contrasts between quantitative statistical results with qualitative
findings for validation purposes (Creswell & Plano Clark, 2011, p. 77). Furthermore, a
more complete understanding of the ethnographic influences may be achieved with such
an approach.
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Mixed-methods Convergent Parallel Design
Qualitative

Quantitative

Data Collection: Indepth interviews
• Data analysis: coding,
themes, relationships

Data collection: Survey
• Data analysis:
Univariate, bivariate
(χ2), multivariate

Merge results
• Interpret
• Relate to research
questions
Figure 3. Basic schematic for this mixed-methods convergent parallel
design study. Adapted from Designing and Conducting Mixed
Methods Research (p. 118), by J. Creswell and V. Plano Clark, 2011,
Los Angeles, CA: SAGE Publications, Inc.. Copyright 2011.
The qualitative aspect entailed conducting in-depth interviews of Armenians and
non-Armenians living in LA County to understand general perceptions about TB, along
with perceived barriers to TB treatment and treatment adherence. Ethnography was
emphasized here where shared beliefs, behaviors, and knowledge relating to TB
treatment-seeking and adherence among Armenians and non-Armenians were explored.
Using SEM as the foundation for the theoretical framework and belief or behavioral
patterns of the culture-sharing Armenian group in Glendale and surrounding areas,
appropriate interviews and questionnaires were administered for data collection. The
quantitative aspect of this study used a survey to explore whether such barriers to
treatment-seeking and adherence differ in Armenian versus non-Armenian individuals
residing in LA County, with potential implications for reducing disease incidence. Here,
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an association between the dependent variable, knowledge regarding TB treatmentseeking and treatment adherence, and the independent variables, barriers or factors
relating to TB treatment-seeking and adherence was explored. Such factors included
demographics (Armenian versus non-Armenian), socioeconomic, cultural, behavioral,
and/or individual beliefs. Furthermore, differences in such perceived barriers and
characteristics from other non-Armenian populations have been assessed.
In concurrent mixed-methods studies data collected from the qualitative study and
quantitative study are analyzed separately and then merged. The merged results from data
analysis are then related back to the research questions (Creswell & Plano Clark, 2011, p.
221). Data analysis strategies will be described in detail later in this chapter.
Role of the Researcher
In ethnography, researcher involvement can vary depending upon the level of
immersion desired. Generally, both observation and participation within the group’s
natural setting is required (Robson, 2011, p. 144); therefore, my role was an observerparticipant with more emphasis on being a participant particularly during the qualitative
portion of the study where in-depth interviews were conducted.
Personal and/or professional relationships were avoided. For those in the local
Armenian community in particular, there was the possibility that the researcher might be
familiar with the participant; however, those who have been in close contact with the
researcher throughout the years were strictly avoided in order to prevent bias or ethical
dilemmas.
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Methodology
Participant Selection
The participants involved with this study were Armenians and non-Armenians
living in LA County. The goal of the study is not to make generalizations but to get an in
depth and comprehensive understanding of potential treatment-seeking and adherence
behaviors and factors in Armenians versus non-Armenians living in LA County. For the
qualitative portion of the study, sampling was purposeful and non-probabilistic where
individuals were selected based upon proximity, availability, and ethnicity, following
Walden’s IRB approval (number 04-24-14-0230517). With respect to proximity,
individuals had to reside in LA County. Furthermore, ethnicity designation is an
important selection criterion where both Armenians and non-Armenians living in the area
are necessary. Aside from ethnicity, efforts were made to match participants closely
based upon other characteristics such as gender, age group, and zip code or city of
residence.
The primary method of purposive sampling involved snowball sampling. This
approach may be implemented when one or more individual from the population of
interest is identified and once interviewed, they are asked to identify other potential
members of the population (Robson, 2011, p. 275). Primary access was gained through
local Armenian churches, church groups, community centers and businesses in LA
County (primarily SPA-2). A similar approach was used for selecting non-Armenian
participants.
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For the quantitative element, both Armenian and non-Armenian participants were
selected based upon convenience sampling. Here, the closest and most convenient
persons were recruited in a continual manner until the appropriate sample size was
reached (Robson, 2011, p. 275). Ethnicity was the principal factor for recruiting potential
participants: Armenian or non-Armenian. LA County has a diverse racial make-up where
71.6% are White, 9.3% Black, 14.5% Asian, 1.5% American Indian, 0.4% Native
Hawaiian/Pacific Islander, and 2.8% multiple races. Of the White population, 48.2% are
classified as Hispanic or Latino and 27.3% as White alone, including Armenians (U.S.
Department of Commerce, 2013). Therefore, racial breakdown was selected for with
further stratification of “White” to differentiate Armenians from non-Armenians. For the
data analysis, further stratification of race may be required to determine if there are
significant differences among specific races, such Armenians versus Hispanics.
For both studies, ethnicity was the primary selection criterion, although
participants had to speak and read English or Armenian fluently. Participants were not
excluded based on gender and were adults, and therefore ≥ 18 years of age. Current TB
positive patients and those with latent TB were excluded; however, patients who had
undergone treatment and were TB negative were not discouraged from participating. For
data analysis, stratification based upon previous TB history may be required. Participants
were required to live in LA County, which was verified with proper identification and
compared to a list of zip codes or city names in LA County (County of Los Angeles,
2011). Zip codes within SPA-2 (County of Los Angeles Public Health, n.d.-b), which
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includes the city of Glendale, were preferred. Participants were pre-screened to ensure
that these criteria were met.
To facilitate recruitment for both studies, invitations were provided via social
media, flyers, or in the case of snowball sampling, were given to participants following
participation to explain the study to potential future participants. For social media, a
Facebook page was set-up specifically for the studies. Linked-In and Reddit (Reddit.com)
were also utilized, with a link to the Facebook site provided. For other recruitment
approaches utilizing flyers, the invitation was posted in public areas in the region of
interest, upon permission from the proprietor or from other participants in the case of
snowball sampling. For continuity, the Facebook page and flyer were similar in
appearance and content (see Appendices H, I, J, and K). The researcher could be
contacted via personal e-mail or through a personalized Quick Response (QR) code that
was scannable with a smart device, such as a cell phone or tablet.
For the qualitative part of the study, 10 Armenians and 8 non-Armenians
participated in the in-depth interviews addressing TB knowledge and perceived barriers
to treatmen- seeking and treatment adherence. With qualitative studies, there appears to
be more ambiguity when determining appropriate sample size. According to Rudestam
and Newton (2007, p. 107), 20 to 30 participants may be regarded as a sufficient sample
size, though others whom are representatives of grounded theory believe 5 to 6
participants are sufficient. An important factor for determining an appropriate sample size
in qualitative studies is saturation in order to fully develop a model or concept (Creswell,
2012, pp. 88–89). Here saturation is desirable where all possible answers or trends have
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been revealed and there is no added benefit in interviewing additional participants
(Robson, 2011, p. 148). This was taken into account when conducting interviews for the
qualitative study, though original proposed numbers were found to be suitable. Due to the
implementation of a convergent parallel design for this study, those who participated in
the qualitative study were not eligible to participate in the quantitative study. Following
the completion of the qualitative interview process, participants were given a $10 Target
gift card to extend appreciation for their involvement in the study.
For the quantitative component, the recruitment of 200 participants was proposed:
100 Armenians and 100 non-Armenians living in LA County. Participants were recruited
using social media and flyers, as described previously. Surveys were administered online
using the online survey tool, SurveyGizmo (www.surveygizmo.com).
Calculation of sample size was done a priori using correlations reported in the
literature regarding reported barriers to treatment in various populations and social
determinants effecting TB incidence in the United States. In a study by Holtgrave and
Crosby (2004), correlations between societal predictor variables and TB cases were
calculated using Pearson’s correlation coefficient (r). From this, coefficients of
determination (r2) were calculated, which were used to determine effect size for this
study. Coefficients ranged from 0.132 to 0.485, depending upon the variable. No such
information was available in the literature for Armenians living in Armenia or in the
United States. Therefore, using G* Power 3 calculator software (http://www.psycho.uniduesseldorf.de/abteilungen/aap/gpower3/) and Exact test parameters of bivariate normal
mode and an alpha level of 0.05, effect sizes range from 0.363 to 0.696, with resulting
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sample sizes of 92 and 20, respectively. Since information on this population is less
defined in the literature, an effect size of 0.363 was used and thus, roughly 100
Armenians and 100 non-Armenians were desired for surveying.
Instrumentation: Qualitative
The qualitative study involved in-depth interviews with Armenians and nonArmenians to get a thorough understanding of TB knowledge and perceptions relating to
the disease and treatment. Since this study was relatively unique, the interview guide with
open-ended questions was generated by the researcher; however, several pre-tested
questionnaires were used to generate some of the reference questions (Bakalian, 2011,
pp. 476–494; Jakubowiak et al., 2008; Xu et al., 2009). Interviews were tape recorded,
with permission from the participants, and were referenced when any questions or
ambiguities in response scripts arose.
Data triangulation was exercised to establish validity. Here, more than one
method of data collection was utilized (Creswell & Plano Clark, 2011, pp. 209–210;
Robson, 2011, p. 158) where transcripts were cross-checked with interview recordings.
Furthermore, the dissertation supervisor (V.M.) examined accuracy of transcription,
coding, and resulting common themes and conclusions. Proper coding and subsequent
interpretation is important for integrating themes with quantitative study results.
Questionnaires were administered in English and Armenian, with pretesting serving as a
means to validate the translation of the questions. Furthermore, someone fluent in
Armenian was available to administer or clarify questions to native Armenian speaking
participants.
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For the culturally relevant questions pertaining to Armenians, Bakalian (2011)
provided many pertinent questions relating to the study topic. In this study, the author
was interested in learning about challenges with assimilation faced by Native Armenians
as they immigrated to the United States. The questionnaire was mailed to Armenians
living in the New York and New Jersey area as part of the author’s dissertation at
Columbia University in the field of Sociology. Furthermore, in a study by Xu et al.
(2009), a mixed-methods approach was used for studying TB treatment adherence and
barriers to adherence in China. Insight from healthcare workers was also solicited, which
was a consideration for this study. Some examples of the open-ended questions in the
interview guide are the following (See Appendix B for Armenian translation):
Basic background information – Armenian participants
1. Did you emigrate from Armenia?
a. How long have you lived in the United States?
b. In what city are you currently residing?
2. Do you read/write Armenian? How well?
3. Is Armenian spoke in your household? If so, how often?
4. Do you read Armenian literature, watch Armenian TV programs (e.g.,
Armenian Teletime), or listen to Armenian radio?
a. If yes, which ones?
b. How often?
5. Do you patronize businesses or seek professional assistance (e.g., medical
doctors) because they are Armenian?
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6. Are you involved with community activities or organizations (e.g.,
Armenian Church, Massis Guild, Ararat Home)? Which ones?
7. Do you have kapoot ach (blue eye) in your residence?
Basic background information – non-Armenian participants
1. Did you emigrate from another country?
a. If yes, which country?
b. How long have you lived in the United States?
c. In what city are you currently residing?
2. Do you read/write in another language? Which one?
3. Is English the primary language spoken in your household? If no, what
other language is spoken?
4. Are you involved with community activities or organizations? Which
ones?
General Background questions - all
1. What year were you born?
2. What is your marital status?
3. Please describe your residence type. Do you own or rent?
4. How many people are living in your household?
a. Please describe relation to you.
b. Please describe gender and ages of each.
5. What is your highest level of education?
6. What is your occupation?
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7. What is your total annual household income (pre-tax)?
8. Do you have health insurance?
9. How frequently do you visit a local physician annually? Do you trust
your local physician?
10. When either you or family/friends are diagnosed with any disease, do you
seek spiritual guidance?
11. When you are feeling sick, do you use home remedies such as massages,
herbs, oils, drink herbal or spiced teas? Which ones specifically?
a. If yes, do you practice this prior to seeking help from a physician?
b. Upon visiting a physician, do you continue the use of home remedies
while under a physician’s care?
TB specific questions - all
1. Are you familiar with the disease, tuberculosis (TB)? If yes, please
describe what you know about it, including modes of transmission.
2. Is TB infectious to others? Please describe.
3. Have you heard about recent reports of tuberculosis cases in the news?
a. In the United States?
b. In other countries? Which ones?
4. Is TB a treatable disease?
a. What do you know about the treatment?
b. Are any of these factors a deterrent for seeking or adhering to
treatment? Which ones?
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5. If TB is mentioned by family, friends, or news reports, what are your
initial reactions and feelings?
6. If you re diagnosed with TB in the future (or have been diagnosed in the
past), what will be/have been your feelings towards this event?
7. If someone in your family, close friends, or colleague mention that he/she
has TB, what will be your feelings towards this event?
8. Has anyone in your family been diagnosed with TB?
a. If yes, did your behavior toward him/her change?
b. Describe how you felt when you learned of the diagnosis.
9. Are you aware of TB treatment facilities in Los Angeles County and the
services provided?
a. If no, if information was made available, (perhaps in Armenian for
Armenians only), would you be more inclined to read about the
disease?
b. Would you inform others in your community?
10. Are you aware of any social or community support groups for dealing
with the disease? If yes, please describe.
Instrumentation: Quantitative
Pilot Study
In order to determine comprehensibility and appropriateness of the quantitative
survey, a pilot study was conducted. According to Creswell (2012, p. 165), pilot testing is
advisable for refining questions and research instruments, assess bias, and adapt research
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procedures. For this study, the preliminary quantitative research instrument was
distributed to a panel of experts with qualifying credentials (e.g., PhD for at least five
years in academia or research within the scientific community). The instrument was
administered in paper form and through the online forum, SurveyGizmo, in order to also
assess the test-taking environment. Revisions to the instrument were made according to
recommendations and feedback by the panel. Subsequently, a small sample (15 to 20
people) was selected to pilot test the revised survey. Participants for the pilot study were
both Armenian and non-Armenians living in LA County and were recruited in the same
fashion as the main study (flyers, consent forms etc.). This was also conducted in the
same online test-taking environment as the officially launched study.
Survey
For the quantitative portion of this mixed-methods study, a pre-tested survey
questionnaire was administered to roughly 200 participants, approximately100 Armenian
and 100 non-Armenian, to further understand TB knowledge in the two populations and
to determine if there are differences among the two groups. Questions were similarly
phrased as in the qualitative study; however, questions were closed-ended and options
were provided in more of a Likert scale format to facilitate quantitation and data analysis.
Some questions allowed for the participant to fill-in a response as well as select multiple
options.
A key threat to validity and reliability for quantitative studies involves
instrumentation, which in this case was the survey questionnaire. An original
questionnaire was generated in order to ensure cultural sensitivity and relevance to the
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Armenian community. This presented some challenges because, as an original
questionnaire, assurances regarding its validity and cohesiveness may be lacking.
Therefore, pretesting was required to ensure questionnaire appeal and ease of
comprehension. To remove some ambiguity, the questionnaire was provided in English
and Armenian. Pretesting also ensured that all translations were comprehensible and
accurate.
Questions included in the survey questionnaire were (See Appendix C for
Armenian translation):
Basic background information
1. How old are you?
a. 18-20, b. 21-30 c. 31-40, d. 41-50, e. 51-60, f. 61-70, g. > 70 years old
2. What is your gender?
a. Male b. Female
3. What is your race?
a. White, non-Hispanic or Latino, b. White, Armenian, c. White, Hispanic or
Latino, d. Black / African American, e. Asian, f. American Indian /
Alaskan native, g. Native Hawaiian or Pacific Islander, h. two or more
races, Armenian i. two or more races, non-Armenian
4. What is your ethnicity?
a. Non-Hispanic, Latino, or Spanish origin, b. Mexican, Mexican-American,
Chicano, c. Puerto Rican, d. Cuban, e. other Hispanic, Latino, or Spanish
origin (e.g., Argentinian, Columbian, Dominican, Salvadoran)
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5. What is your country of origin (fill in)? ______________
6. How many years have you been living in United States?
a. a. less than 1 year b. 1-5 years c. 6-10 years d. 11-20 years e. > 20 years
7. What city do you currently reside in?
a. Glendale, b. Pasadena/South Pasadena, c. Burbank, d. San Fernando, e.
Santa Monica/West Los Angeles, f. Downey/Montebello/South Gate, g.
other _______________
8. What is your marital status?
a. Single, never married, b. married, c. divorced, d. widowed, e. separated
9. How many people are living in your household (excluding yourself)?
a. 0, b. 1 c. 2-4, c. 5-6, d. > 6
10. Describe their relationship to you? (select all that apply)
a. Spouse or partner, b. child, c. sibling, d. elderly parents or grandparents, e.
other _______________
11. Is English the primary language spoken in your household? a. yes b. no
12. What other languages are spoken in your household?
a. Armenian, b. Spanish, c. none, d. other______________
13. What is your highest level of education?
a. High school, b. some college, c. bachelor’s degree, d. graduate /
professional degree
14. What is your occupation?
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a. Unemployed, b. retired, c. homemaker, d. student, e. professional (doctor,
lawyer, teacher), f. manual laborer (skilled or unskilled worker)
15. What is your total annual household income (pre-tax)?
a. 0-$25,000, b. $25,001-$40,000, c. $40,001-$60,000, d. $60,001-$80,000,
e. $80,001-$100,000 f. > $100,000
16. Do you have health insurance? a. yes, b. no
17. Do you trust your primary care physician? a. yes, b. no, c. I don’t have one
18. Do you seek spiritual guidance upon diagnosis of any disease, either for you
or family/friends? a. yes, b. no
19. When feeling sick, do you use home remedies (e.g., massages, herbs, oils,
drink herbal or spiced teas)? A. yes, b. no
TB specific questions
1. Have you heard of the disease tuberculosis (TB)? a. yes, b. no
2. How have you heard about TB? (check all that apply)
a. TV, b. Internet, c. family or friends, d. newspaper/magazine e.
other________
3. Do you believe that TB is a modern day health problem in the US? a. yes, b.
no
4. Do you believe that TB is a modern day health problem internationally?
a. yes, b. no
5. How is TB transmitted?
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a. Coughing, sneezing, b. touching, c. sexual contact, d. food/water
ingestion, e. smoking, f. imbalance of hot and cold, g. do not know
6. What is the most common symptom of TB?
a. Coughing, b. sneezing, c. loss of appetite, d. tiredness/fatigue, e. bleeding,
e. do not know
7. Are you aware of treatment available for treating TB? a. yes, b. no
8. How long is the treatment regimen?
a. 3 days, b. 1 week, c. 1 month, d. > 6 months, e. do not know
9. Is TB treatment 100% effective? a. yes, b. no, c. do not know
10. Is TB a curable disease? a. yes, b. no, c. do not know
11. If TB is mentioned by family, friends, or news reports, what are your initial
reactions and feelings?
a. Frightened, b. informed, c. indifferent, d. helplessness
12. Have you or anyone in your family been diagnosed with TB? a. yes, b. no
13. If yes, how did you feel? (select any that apply)
a. Frightened, b. informed, c. indifferent, d. helpless, e. depressed
14. What factors do you associate with TB? (select any that apply)
a. Poverty, b. foreign-born, c. HIV status, d. drug history, e. low social class,
f. sexual orientation, g. mental illness, h. religion, i. a common disease, k.
a curable disease, l. smoking, m. imbalance of hot and cold, n.
incarceration
15. If someone has TB, you think that (select any that apply):
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a. he/she probably did something wrong, for example use of drugs, b. it’s a
punishment given by the God, c. he/she has the disease because of his/her racial

Disagree

No Opinion

Agree

Strongly
Agree

If you had TB, would you:

16.

Strongly
disagree

background, d. it could happen to anyone

1

2

3

4

5

Trust doctors to cure it?

a.
b.

Be compliant with doctors’ instructions
regarding treatment?

c.

Seek treatment outside the hospital/
private practice setting

17. If you would seek treatment outside of a hospital/ private practice setting,
where would you go? (select any that apply)
a. Chiropractor, b. Acupuncturist, c. Homeopathic doctor/nutritionist, d.
Religious/ church leader, e. massage therapist, f. home remedies (herbs,
oils, teas), g. I wouldn’t.
18. Are you aware of TB treatment facilities in Los Angeles County and the
services provided? a. yes, b. no
19. If no, if information was made readily available, would you be more inclined
to read about the disease and inform others in your community? a. yes, b. no
20. Are you aware of social support groups in your community for dealing with
the disease? a. yes b. no
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Recruitment, Participation, and Data Collection
All participants were recruited using social media and flyers in public places such
as local churches, church groups, community centers and businesses located within LA
County. Participant recruitment for the qualitative study also involved snowball
sampling, as described earlier, in order to gain access to Armenians and non-Armenian
living in LA County, primarily SPA-2. The project goals were outlined and informed
consent was obtained in order to move forward with the in-depth interviews as well as
with the completion of the surveys. Furthermore, participants were alerted to the fact that
a follow-up may be required if there are ambiguities in responses or if something required
clarification. An Armenian speaker was present for Armenian participants to ensure that
all intentions and goals were understood, and also provided a signed confidentiality
agreement in order to be included in the study.
For those who responded positively to the invitation, an email and phone number
of the researcher was made available to all interested parties. A separate email and phone
number was set-up by the researcher to maintain professionalism and exclusivity to the
study. For those completing the quantitative survey online, the letter of consent
(Appendices D, E, F, and G) was checked to reflect participant willingness to agree to
study terms and participate. They were available in English or Armenian, depending upon
participant preference. Upon completion, a thank you was generated. A $10 Target gift
card was also provided as compensation for those who participated in the qualitative
component of the study.

83
All data have been stored electronically, with backups on a separate password
protected computer. Furthermore, recordings for the qualitative interviews were copied
and serve as a backup in case the original becomes compromised from overuse or
researcher error during transcription.
Data Analysis
In the study, perceived barriers and factors were explored using in-depth
interviews and surveys with Armenians and non-Armenians in the community. For the
qualitative component, data and coding were divided based upon key words or phrases
for each question, with the use of Microsoft Excel and Word software. Also, these data
were analyzed thematically. Microsoft Word can be used for “coding and retrieving,
semi-automated coding and inspection, creating hierarchies of code categories via
indexing, global editing of theme codes, coding of ‘face sheet’ data, exploring
relationships between face-sheet codes and conceptual codes, quantifying the frequency
of code instances, and annotating text” (LaPelle, 2004). Further, thematic analysis was
selected since it is a widely used approach for detecting, analyzing and reporting themes
within qualitative data (Braun & Clarke, 2006). The six phases of analysis were the
following: familiarizing with the data, generating initial codes, searching for themes,
reviewing themes, defining and naming themes and finally producing a scholarly report
of the analysis (Braun & Clarke, 2006).
For the quantitative component, the goal is to explore whether there are
differences in barriers to treatment-seeking and adherence for TB in Armenian versus
non-Armenian populations living in LA County and which factors (e.g., physical,
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cultural, psychosocial, behavioral) have the greatest influence (Table 1). First, all data was
entered into Statistical Program for Social Sciences (SPSS; IBM Corporation, version
21). Then, since all variables of the study were categorical, frequencies were calculated
and reported. Second, bivariate analysis (chi-square test) was used to test the strength of
associations between independent (barriers or factors relating to TB treatment seeking
and adherence, such as ethnicity, demographics, cultural beliefs etc.) and dependent
variables (knowledge regarding TB treatment seeking and treatment adherence). Finally,
the estimates of the relative risks of the dependent variable were reported by calculating
the odds ratios (ORs) and the corresponding 95% confidence intervals (CIs), using
multinomial logistic regression analysis (for more details on the statistical procedures, see
Table 2). The dependent variable was knowledge regarding TB treatment seeking and

treatment adherence and predictors were all the aforementioned independent variables.
Significant confounders, as well as interactions were retained in the models. Deviance
residuals were calculated to evaluate the model's goodness-of-fit. All reported probability
values (p-values) were compared to a significance level of 5%.
In order to integrate the data from the qualitative and quantitative studies, the data
were analyzed separately and then merged. The merged results from data analysis were
then related back to the research questions.
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Table 1
Variables, Research Questions, and Items on Surveys
Variable
Research Question
1. What are the perceived 1. Ethnicity/race
(IV)
barriers to treatment
seeking and adherence for 2. Cultural beliefs
(IV)
Tuberculosis in an
3. Demographics
Armenian population
(IV)
living within the United
4. Religion (IV)
States?
5. Knowledge (DV)
1. Ethnicity/race
2. Is there a difference in
(IV)
barriers to treatment
seeking and adherence for 2. Cultural beliefs
Tuberculosis in Armenian (IV)
versus non-Armenian
3. Demographic (IV)
populations living in LA
County and which factors 4. Religion (IV)
(e.g., physical, cultural,
psychosocial, behavioral)
5. Knowledge (DV)
have the greatest
influence?

Item number(s) in Survey
“TB Specific” #14, 15
“TB Specific” #14, 15
“TB Specific” #14, 15
“TB Specific” #15, 17
“TB Specific” # 1-13, 16, 18,19
“Basic background information” # 3, 4;
“TB Specific” #14, 15
“Basic background information” #17, 19;
“TB Specific” #5, 14, 15
“Basic background information” # 1, 2, 515, “TB Specific” #14, 15
“Basic background information” # 16, 18;
“TB Specific” #15, 17
“TB Specific” # 1-13, 16, 18, 19

Note. IV = independent variable; DV = dependent variable
Table 2
Statistical Procedures Per Research Question and Hypothesis
Hypothesis (Ha)
Variables
Research Question
RQ2: Is there a difference
in barriers to treatment
seeking and adherence for
TB in Armenian versus nonArmenian populations
living in LA County and
which factors (e.g., physical,
cultural, psychosocial,
behavioral) have the
greatest influence?

There are
differences in
factors relating to
treatment seeking
and adherence for
TB in Armenian
versus nonArmenian
populations in LA
County

Statistical Procedure/
Analysis
1. Univariate: Frequency

IV:
barriers /
factors
DV: TB
2. Bivariate: Chi-square test
knowledge (χ2)
3. Multivariate:
Multinomial Logistic
Regression (Odds Ratios
(ORs) and Confidence
Intervals (CIs))

Threats to Validity
When a study is tailored to a specific population, threats to external validity occur
through generalizability (McKenzie, Neiger, & Thackeray, 2009, p. 369). With this
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particular study, the focus was on Armenians residing in LA County. LA County is
home to the second largest population of Armenians in the country and world (Hayk the
Ubiquitous Armenian, 2012), and therefore it is believed that it the study involves a
representative pool. However, the social and economic factors impacting the study may
not be generalizable to Armenians living in other parts of the world. Furthermore,
cultural elements will be specific only to Armenians, and possibly those living the former
Soviet Union, and may therefore lack generalizability to other populations. However, the
goal of this study was to address the gap in developing suitable public health intervention
TB programs specific for this at-risk population.
Sampling validity is also a potential concern. Here, the concern is whether the
target population is adequately sampled by the instrument being used to measure or
address the question. This is a problem when investigators construct and employ
instruments for the first time (Frankfort-Nachmias & Nachmias, 2008, p. 150). Due to the
specificity of this study design as it relates to a specific population, sampling validity
may have become a threat. However, pilot testing was conducted ahead of time to ensure
that the questionnaires were adequately measuring what they were intended to measure.
Trustworthiness
This mixed-methods study addresses the issue of credibility through the use of
triangulation and peer review. Triangulation, the use of multiple methods of data
collection to test hypotheses and measure variables (in this case qualitative and
quantitative data, using convergent parallel design), is a useful strategy for limiting the
validity of scope and minimizing specificity relating to a particular method of data
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collection (Frankfort-Nachmias & Nachmias, 2008, p. 189). In this study, both in-depth
interviews and questionnaire surveys were utilized. The in-depth interviews allowed for
observation of participant as well as verbal content to each question. At the end of both
studies, analyzed data were merged. If the findings obtained from the two collection
methods concur, then the validity of findings are increased (Frankfort-Nachmias &
Nachmias, 2008, pp. 189–190). Triangulation further established dependability of the
study. Furthermore, the dissertation supervisor (V.M.) was incorporated to serve as a
peer-reviewer to ensure proper interpretation of responses and results. This also serves as
a means to improve dependability of the findings.
Transferability is similar to generalizability in that it can threat the validity of a
study if the population is too limited. Again, one component of this study was an
ethnography focusing on Armenians living in LA County. Should other researchers
attempt to replicate these finding, alterations may need to be made to accommodate
specific attributes of the population being studied.
Ethical Considerations
This study was conducted in accordance with guidelines established by Walden
University’s IRB, approval number 04-24-14-0230517. All necessary IRB documentation
is shown in Appendix A, which addresses access to participants, appropriate treatment of
participants, and institutional permissions.
With research involving human subjects, ethics must always be considered and
addressed in order to protect participant’s basic human rights. Robson (2011, p. 200) has
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highlighted ten questionable practices in social research that will be avoided and
addressed in this study (Table 3).
Table 3
Ten Questionable Practices in Social Research
1 Involving people without their knowledge or consent
2 Coercing them to participate
3 Withholding information about the true nature of the research
4 Otherwise deceiving the participant
5 Inducing them to commit acts that may diminish self-esteem
6 Violating rights of self-determination
7 Exposing participants to physical or mental stress
8 Invading their privacy
9 Withholding benefits from some participants
10 Not treating participants fairly, or with consideration, or with respect

When recruiting and enrolling participants, the project was explained clearly both
verbally and in writing. For Armenian participants, an Armenian translator was made
available during the qualitative component. All questionnaires were made available in
Armenian. Upon acceptance, participants were required to read and sign the letter of
consent form (Appendices D and E), reflecting their understanding of the project and
their involvement. Confidentiality was ensured for the qualitative component; whereas
anonymity and confidentiality was ensured for the quantitative component. Each
participant was given a randomized code, which were used throughout the entire process,
including data analysis. The peer-reviewer was not privy to any participant’s name or
information.
Data, including coding logs, were stored in a locked file cabinet, off-premises
from the researcher for 5 years. Subsequent to this, all data, including transcripts and
coding logs, will be destroyed.
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Summary
This concurrent mixed-methods study is designed to address the gap that exists in
the body of knowledge regarding perceived barriers to TB treatment-seeking and
adherence relative to a susceptible population, Armenians living in the United States,
namely LA County, and in Armenia. This was achieved through in-depth interviews and
surveys designed to assess TB knowledge and treatment-seeking and adherence behaviors
in Armenian versus non-Armenians living in LA County, using the convergent parallel
design. Measures to ensure internal and external validity in the study, along with ethical
concerns, were also addressed. Data analysis and interpretation of the two studies were
conducted and then merged.
Chapter 4 will detail the results and findings from the two components of the
study.
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Chapter 4: Results
Introduction
The purpose of this mixed-methods study was to explore factors (physical,
psychosocial, cultural, or behavioral) relating to TB knowledge, treatment-seeking and
adherence among Armenians living in LA County and compare them to non-Armenian
living in LA County. Such differences may impact the reduction of TB incidence in the
highly susceptible Armenian population. To understand the general perceptions about
TB, along with perceived barriers to TB treatment and treatment adherence in both
groups, the qualitative component of this study used in-depth interviews of both
Armenians and non-Armenians living in LA County. A survey was used with the
quantitative component to explore whether such barriers to treatment-seeking and
adherence differ between Armenians and non-Armenians living in LA County, which
have implications for reduction in the incidence of disease. Both survey instruments were
original and required pretesting or pilot testing prior to administration.
Research question 1 (RQ1) was a descriptive inquiry whereas Research question 2
(RQ2) was inferential in nature:
RQ1. What are the perceived barriers to treatment seeking and adherence for
tuberculosis in an Armenian population living within the United States?
RQ2. Is there a difference in barriers to treatment seeking and adherence for
tuberculosis in Armenian versus non-Armenian populations living in Los Angeles
County and which factors (e.g., physical, cultural, psychosocial, behavioral) have
the greatest influence?
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HA2: There are differences in factors relating to treatment seeking and
adherence for tuberculosis in Armenian versus non-Armenian populations
in Los Angeles County.
H02: There are no differences in factors relating to treatment seeking and
adherence for tuberculosis in Armenian versus non-Armenian populations
in Los Angeles County.
This chapter details the data collection methods and data analyses from both the
qualitative and quantitative components. For the qualitative element, responses were
tabulated using Excel and common themes extracted and organized Word. For the
quantitative element, SPSS, version 21, software was used to conduct univariate,
bivariate, and multivariate analyses of the data. The findings from both study components
were further triangulated and themes merged and related back to the research questions.
Pilot Study
A pilot study was conducted for the quantitative survey to ensure
comprehensiveness, appropriateness, and lack of bias of the questions, invitation, and
testing forum. The preliminary quantitative research instrument was distributed in paper
form and through the online forum to a panel of experts with qualifying credentials (e.g.,
PhD for at least five years in academia or research within the scientific community).
Once feedback was provided by the expert panel, minor revisions were made to the
survey instrument which included minor wording of question to remove ambiguities.
Subsequently, a small sampling of 35 people comprised of 17 Armenians and 18 nonArmenians living in LA County were recruited in the same fashion as the main study
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(flyers, consent forms etc.). Of the 35 recruited participants, 23 completed either the
paper version, online version, or both. All participants were asked to keep track of time to
completion and the invitation was adjusted to reflect the average time. Criticisms relating
to the questions as originally proposed or the test taking environment were minimal.
Some changes that were made included allowing participants to specify/ fill-in responses
for the “other” option for background question SQ7 and tuberculosis-specific questions
SQ2 and SQ13. This helped in further clarifying and stratifying answers for data analysis.
Upon incorporating the suggested changes, the official study was launched in the online
forum, SurveyGizmo.
Setting
For both the qualitative and quantitative component, Armenian translated
questionnaires and surveys were made available to Armenian participants. Furthermore,
an Armenian translator was available for all Armenian participant interviews. Initial
questionnaire and survey questions were translated by a fluent Armenian speaker, whom
is also employed as an English-Armenian translator. The questionnaires and surveys were
translated into Western Armenian, as opposed to Eastern Armenian, because the primary
dialect spoken in LA County is Western Armenian. While the two dialects have many
similarities, any participants whom were more familiar with Eastern may have
encountered minimal confusion. All of the translations were then back-translated to
verify validity and accuracy of the questions by an unrelated Armenian speaker, whom is
fluent in both Eastern and Western dialects. This individual also served as the translator
for the face-to-face interviews. As recommended by Walden’s IRB committee, a
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confidentiality agreement and NIH Human Subjects training were completed by the
translator.
Demographics
For both the qualitative and quantitative study, participants living in LA County
were recruited and classified as either Armenian or non-Armenian. A participant was
classified as Armenian if they were born in Armenia, emigrated from Armenia, were two
or more races (one of which being Armenian), and/or were born in the United States and
speak Armenian in their household. All such information was extracted from various
questions on both surveys and questionnaires. Furthermore, participants were required to
live in LA County and be at least 18 years of age. Several participants from the
quantitative study were removed post-participation due to the lack of fulfillment of these
requirements.
Data Collection
Qualitative Component
For the qualitative study, the goal was to recruit 15-25 participants over 18 years
of age living in LA County, with relative equal distribution between classifications of
Armenian and non-Armenian. Ultimately, 10 Armenians and 8 non-Armenians met the
specified criteria and were interviewed face-to-face. Table 4 summarizes the overall
demographics of the Armenian and non-Armenian participants. The Armenian contingent
has spent fewer years living in the United States than the non-Armenian group, though
the age distribution is relatively the same among groups. This suggests that the
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Armenians are likely more first and second generation where cultural traditions may be
more influential.
Table 4
Characteristics of Individuals Interviewed about Tuberculosis Knowledge and
Perceptions (n = 18)
Characteristics

Classification
Gender
Male
Female
Age
18-30
31-40
41-50
51-60
>60
Country of Origin
Iran
Iraq
Lebanon
Mexico
Romania
United States
Years in United States
≤ 20 years
> 20 years
City Residing In LA County
Altadena / Pasadena
Glendale
Granada Hills
Rancho Cucamonga
Marital Status
Single, never married
Married
Divorced

No. of
Individuals,
Armenians
(%)
10

No. of
Individuals,
Non-Armenian
(%)
8

2 (20)
8 (80)

3 (37.5)
5 (62.5)

3 (30)
0
1 (10)
3 (30)
3 (30)

1 (12.5)
2 (25)
2 (25)
0
3 (37.5)

5 (50)
3 (30)
1 (10)
0
0
1 (10)

1 (12.5)
0
0
1 (12.5)
1 (12.5)
5 (62.5)

6 (60)
4 (40)

1 (12.5)
7 (87.5)

2 (20)
8 (80)
0
0

5 (62.5)
1 (12.5)
1 (12.5)
1 (12.5)

3 (30)
3 (30)
1 (10)

1 (12.5)
5 (62.5)
2 (25)
(table continues)
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Widowed
Separated
Residence Type
Apartment, rent
Condominium, own
House, own
House, rent
Number of People in Household (excluding self)
0
1
2-4
5-6
Primary Language Spoken in Household
Armenian
English
Spanish
Other
Educational Level
High School
Some College
Bachelor’s Degree
Graduate/Professional Degree
Occupation
Unemployed
Retired
Homemaker
Student
Professional
Manual Laborer
Annual Household Income
$0-$40,000
$40,001-$100,000
>$100,000
Health Insurance
Yes
No
Trust Primary Care Physician
Yes
No
Don’t have one
Annual visits to Physician
0-1
2-4

3 (30)
0

0
0

0
1 (10)
6 (60)
3 (30)

1 (12.5)
0
5 (62.5)
2 (25)

2 (20)
0
6 (60)
2 (20)

1 (12.5)
1 (12.5)
5 (62.5)
1 (12.5)

10 (100)
0
0
0

0
5 (62.5)
2 (25)
1 (12.5)

2 (20)
0
6 (60)
2 (20)

3 (37.5)
0
4 (50)
1 (12.5)

0
1 (10)
3 (30)
1 (10)
5 (50)
0

0
3 (37.5)
0
0
4 (50)
1 (12.5)

6 (60)
3 (30)
1 (10)

1 (12.5)
4 (50)
3 (37.5)

7 (70)
3 (30)

7 (87.5)
1 (12.5)

7 (70)
2 (20)
1 (10)

7 (87.5)
1 (12.5)
0

7 (70)
1 (10)

2 (25)
5 (62.5)
(table continues)
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5-6
>6
Use Home Remedies
Yes
No
Seek Spiritual Guidance
Yes
No

1 (10)
1 (10)

1 (12.5)
0

10 (100)
0

8 (100)
0

6 (60)
4 (40)

4 (50)
4 (50)

Recruitment for the qualitative component was purposive and relied primarily on
snowball sampling, as proposed. Overall, recruitment spanned over a period of two
months, from February through the end of March of 2015. Many of the face-to-face
interviews were conducted at the participant’s residence or a friend’s residence. This may
have contributed to the participant’s willingness to consent and conduct the interviews
and therefore be open with their responses due to their increased comfort level. All
interviews were recorded, with prior knowledge and consent by the interviewee. On
average, each interview took ten minutes. Following the recorded interview, time was
taken to explain tuberculosis, its history, and relevance to today in more detail. All
participants appeared quite interested and appreciated this extra effort in order to
understand that TB remains a public health threat, particularly among the Armenian
community living locally and in their native country.
Quantitative Component
For the quantitative study, it was proposed to recruit 200 participants over 18
years of age living in LA County, half of which were Armenian and half non-Armenian.
Overall, a total of 130 participants completed the survey; however, three were removed
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from the study due to residing outside of LA County. This resulted in a final tally of 72
non-Armenians (56.7%) and 55 Armenians (43.3%) qualified participants. The resulting
post-hoc power analysis was satisfactory > 0.90. This was determined using G* Power 3
calculator software (version 3.1.4) and logistic regression test, an alpha level of 0.05, and
an odds ratio of 0.347 (for “TB route of Transmission” as the dependent variable, with
the weakest obtained significant p value, 0.05) as determined below in data analysis
(Table 12).
Table 5 provides a summary of the demographics pertaining to both participant
populations. More females participated in the survey than males (62.2% vs 37.8%), with
the majority of participants living in the United States more than 20 years (89%). The
latter observation is a more skewed than in the qualitative study where the populations
were more even evenly distributed, with the Armenians having spent less time in the
United States (< 20 years). Furthermore, 67.7% of participants were classified as
professional (e.g., doctor, lawyer, teacher) and 50.4% have an annual household income
> $100,000, potentially impacting socioeconomic implications. While the majority of
respondents trust their primary care physician (86.6%), 66.1% also rely on home
remedies for personal medicinal therapy and 70.9% do not seek spiritual guidance upon
receiving diagnosis of a disease for themselves or close family/friends.
Table 5
Descriptive Statistics – Demographic Variables (n = 127)
Demographic
Classification
Armenian
Non-Armenian

Frequency (ƒ)
127
55
72

Percent (%)
43.3
56.7
(table continues)
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Gender
Male
Female
Age
18-30
31-40
41-50
>50
Race
White, Non-Hispanic/Latino
White, Armenian
White, Hispanic/Latino
Black, African American
Asian
2 or more, Armenian
2 or more, non-Armenian
Ethnicity
Non-Hispanic, Latino, or Spanish Origin
Mexican, Mexican American, Chicano
Cuban
Other Hispanic, Latino, or Spanish Origin (e.g.,
Argentinian, Columbian, Salvadoran,
Dominican)
Country of Origin
Armenia
Canada
Egypt
El Salvador
European Countries
Hong Kong
Iran
Japan
Lebanon
Mexico
Philippines
Turkey
United States
Years in United States
≤ 20 years
> 20 years
City Residing In (LA County)
Glendale
Pasadena/South Pasadena

48
79

37.8
62.2

32
49
28
18

25.2
38.6
22.0
14.2

55
37
10
1
8
12
4

43.3
29.1
7.9
0.8
6.3
9.4
3.1

109
9
1
8

85.8
7.1
0.8
6.3

4
1
1
1
2
1
3
1
9
1
2
1
100

3.1
0.8
0.8
0.8
1.6
0.8
2.4
0.8
7.1
0.8
1.6
0.8
78.7

140
113

11.0
89.0

9
31

7.1
24.4
(table continues)
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Burbank
San Fernando
Santa Monica/ West Los Angeles
Downey / Montebello / South Gate
Other
Alhambra
Altadena
Azusa
Canoga Park
Cerritos
Claremont
Glendora
Hollywood
La Crescenta
La Habra
La Verne
Long Beach
Los Angeles
Monrovia
North East LA
Northridge
Norwalk
Pomona
Porter Ranch
Reseda
San Dimas
San Gabriel
Santa Clarita
Shadow Hills
South Bay
Sun Valley
Sunland
Tujunga
Upland
Venice
Winnetka
Marital Status
Single, never married
Married
Divorced
Widowed
Separated
Number of People in Household (excluding self)

5
2
8
4
68
4
3
1
1
2
5
3
2
1
1
1
5
10
1
1
4
1
4
3
1
2
1
1
1
1
1
2
2
1
1
1

3.9
1.6
6.3
3.1
53.5
3.1
2.4
0.8
0.8
1.6
3.9
2.4
1.6
0.8
0.8
0.8
3.9
7.8
0.8
0.8
3.1
0.8
3.1
2.4
0.8
1.6
0.8
0.8
0.8
0.8
0.8
1.6
1.6
0.8
0.8
0.8

53
67
4
1
2

41.7
52.8
3.1
0.8
1.6
(table continues)

100
0
1
2-4
5-6
>6
Household Relation
Spouse/ Partner
Spouse/Partner, Child
Spouse/Partner, Child, Elderly parent/
grandparent
Spouse/Partner, Child, Other
Spouse/Partner, Elderly parent/ grandparent,
other
Spouse/Partner, other
Child
Child, Elderly parent/grandparent
Sibling
Sibling, Elderly Parent / grandparent
Elderly Parent / grandparent
Other
Friend
Housemate / Roommate
Niece
Whole family
English Primary Spoken Household Language
Yes
No
Primary Household Language (non-English)
Armenian
Spanish
None
Other
Arabic
Armenian, Russian
German
Korean
Mandarin
Russian, Turkish
Turkish, Arabic
Educational Level
High School
Some College
Bachelor’s Degree

15
25
81
5
1

11.8
19.7
63.8
3.9
0.8

37
39
1

29.1
30.7
0.8

1
2

0.8
1.6

1
6
1
3
11
5
5
3
4
1
1

0.8
4.7
0.8
2.4
8.7
3.9
3.9
2.4
3.1
0.8
0.8

106
21

83.5
16.5

40
8
72
7
1
1
1
1
1
1
1

31.5
6.3
56.7
5.5
0.8
0.8
0.8
0.8
0.8
0.8
0.8

7
26
46

5.5
20.5
36.2
(table continues)
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Graduate/Professional Degree
Occupation
Unemployed
Retired
Homemaker
Student
Professional (e.g., lawyer, doctor, teacher)
Manual Laborer
Annual Household Income
$0-$40,000
$40,001-$100,000
>$100,000
Health Insurance
Yes
No
Trust Primary Care Physician
Yes
No
Don’t have one
Seek Spiritual Guidance
Yes
No
Use Home Remedies (herbs, teas, etc.)
Yes
No

48

37.8

4
4
9
18
86
6

3.1
3.1
7.1
14.2
67.7
4.7

21
42
64

16.5
33.1
50.4

120
7

94.5
5.5

110
3
14

86.6
2.4
11.0

37
90

29.1
70.9

84
43

66.1
33.9

The survey was administered online through SurveyGizmo over the span of 8
months, from July 2014 to February 2015. Recruitment was again purposive where
snowball sampling was the primary mode, relying on social media and paper flyers
distributed in local businesses in the community to initiate awareness regarding the study.
Recruitment proved to be challenging overall, which is likely due to the vastness of LA
County despite extensive efforts by the investigator using the aforementioned avenues.
Recruitment of the Armenian population proved to be particularly challenging as
compared to non-Armenians despite the flyers and survey being made available in
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Armenian. An additional fourteen participants, the majority being Armenian, failed to
complete the survey and were thus eliminated from the participant response pool and
subsequent data analysis. Here, all of the questions relating to demographics were
completed with attrition occurring once tuberculosis-related questions were encountered.
Data Analysis
Qualitative Component
During each of the face-to-face interviews, a paper interview guide (Chapter 3
and Appendix B) was used for each individual to direct the flow of the interview
questions and allow for note-taking, while everything was being voice recorded. This was
also the case for those requiring the Armenian translator. Once all of the face-to-face
interviews were completed, the recorded interviews were played repeatedly until every
word was transcribed verbatim. The researcher also met with the Armenian translator on
a separate occasion to transcribe all of the Armenian respondents verbatim. Copies of the
written transcripts were de-identified and provided to the peer reviewer.
To facilitate finding themes, the responses to each question by each respondent
were tabulated in an Excel spreadsheet. From there common themes and subthemes were
identified and coded in Microsoft Word. Key themes and sub-themes relating to disease
transmission and infectivity, incidence (national and international), treatment, and feeling
and reactions to the disease were identified and tabulated for each population, see Tables
6 and 7 (Armenian and non-Armenian, respectively).
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Quantitative Component
The quantitative survey was administered using SurveyGizmo which facilitated
data analysis as all question results can be exported directly to Excel or SPSS. Also,
outside of SurveyGizmo, a codebook was generated based on responses for each question
(Appendix L). Some glitches relating to coding when exporting directly from
SurveyGizmo to SPSS were discovered, so Excel was used as an intermediary. Once all
of the responses from completed surveys were exported into Excel, they were first
checked for qualifications (resident of LA County and 18 years or older). Three
participants were disqualified based on these criteria. The responses were then coded
using the codebook for each question and respondent using extensive “if-then” statements
in Excel. All of the coded data were then input into SPSS to check for errors. Any
missing values were designated as “999”. These coded data were cross checked by the
peer-reviewer to ensure that no errors were present and that data analysis could proceed.
Results
Qualitative Component
Following the face-to-face interviews, the oral responses from the 10 Armenian
(A) and 8 non-Armenian (NA) participants were transcribed verbatim. Two of the
Armenian participants required the translator to be present during the interview and the
translator subsequently assisted in translating the responses for the researcher.
Furthermore, one of the Armenian participants (A10) had limited English skills,
unbeknownst to the researcher. The translator was not present at the time of the
interview; however, a family member was able to provide some assistance. Therefore,

104
information gathered from this respondent was limited. Following this, all responses were
tabulated using Microsoft Excel. Themes and subthemes for each population were then
analyzed in more detail using Microsoft Word (LaPelle, 2004).
RQ2 addresses factors relating to TB knowledge and perceptions (e.g., physical,
cultural, psychosocial, behavioral) in Armenians and non-Armenians living in LA
County, and to determine differences among the populations. TB-related responses were
broken down and grouped based on disease knowledge and awareness, and disease
perceptions. Knowledge- and awareness-based questions explored mode of transmission,
incidence, ability to treat, and familiarity with treatment facilities and support programs.
Perception-based questions explored personal reactions to hearing about the disease,
either on the news, by a close family member or friend, or if they were to hypothetically
personally contract the disease.
As can be seen in Tables 6 and 7, there are some similarities and differences in
responses between the two populations. Both populations had general vague knowledge
as to how TB is transmitted, its molecular properties, degree of infectivity, and national
and international incidence. Both also felt like there “should be” a treatment available but
didn’t have any details on regimen; however, only the Armenian population
acknowledged the availability of a vaccine. When it came to perceptions and feelings
about the disease, the Armenian population expressed more empathy, an overt
willingness to help someone with the disease, desire to seek treatment or urge others to
seek treatment, and seek spiritual guidance and outside education for themselves or
others. When asked, all of the Armenian respondents had kapoot ach (blue eye) in their
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homes, with A9 responding “Yes, it’s all around. It’s something an Armenian family has
to have!” The non-Armenian population appeared more trepid, less willing to help others
and urge them to seek treatment, and less open to seek spiritual guidance; however, they
were very willing to educate themselves about the disease.
Table 6
Thematic Analysis of Tuberculosis Knowledge and Perceptions by 10 Armenian Adults
Theme /
category
TB Mode of
transmission

Subcategory

Variable
routes of
transmission

Awareness of
infectivity

TB incidence

Unfamiliar
with reports

TB treatable

Ignorance if
curable

Ignorance of
treatment
Vaccine
availability
Reaction if
Empathetic
TB
mentioned or initial
contracted by reaction
others

Selected Extract(s)
“Not so familiar with TB, think it’s airborne.” (A2)
“Transmits, I think it’s a virus. Transmitted through
bodily fluids.” (A6)
“Transferred through mouth, cough, and close relations
or contact.” (A7)
“Contagious, in my time growing up TB patients weren’t
allowed to stay inside at home. They were taken outside
because very contagious or go to private hospital and
stay there for years.” (A4)
“Couple of incidence in the U.S. I didn’t follow-up but
heard of that there were such things in different states.”
(A1)
“No, just Ebola!” (A9)
“Should be treatable because it is bacterial. Like every
other disease, depends upon level of how far you are and
how damaged.” (A3)
“For preliminary stages, yes, otherwise no.” (A5)
“I think there is a medicine or pill for it. When I got my
skin test, I was told not to go into the sun but I did
anyway and it changed color. Therefore, I was given a
prescription for medicine but never took it.” (A8)
“There was an outbreak a long time ago and they
couldn’t control it. They found vaccine for it, I think
there is a vaccine for it.” (A6)
“Going to be sad because person will endure a lot.” (A4)
“Sad because it is a dangerous disease and try to prevent
getting contaminated by using masks.” (A5)
“Initially feel that they could be going through a lot of
stress and pain, but would want to comfort them even
though that is not really my personality.” (A6)
(table continues)
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Overt
willingness
to help
Spiritually
influenced
Pro-active in
providing
advice for
seeking
treatment
Desire to
improve
disease
knowledge

“Go visit and help. I’m not afraid of getting sick.” (A3)
“I would try to help the person and support them and be
there for them and comfort them.” (A8)
“Going to be careful around person and pray for them.”
(A4)
“I would feel sorry for them and make them seek
treatment.” (A1)

“I would be curious as to how I could get it (e.g., from a
person coughing). How is it transmitted? I would read
about it more and inform myself.” (A8)

“I would be immediately angered but family would help
Varied Initial me relax but I would still think about it.” (A6)
reactions
“If I knew it was deadly, I would try hard to not let it kill
me.” (A9)
“I would stay away from everybody as soon as possible
Eager to seek and start treatment as soon as possible.” (A1)
“I would stay away from everybody and get complete
treatment
treatment before going back into society.” (A5)
“I would try to gain as much knowledge about the
Seek outside disease, read day and night in order to break it down and
knowledge or analyze it more as a physician. Secondly, try to use
spiritual
personal logic gained to see if maybe herbal medicine
guidance
will help or maybe change environmental for a limited
time.” (A3)
“Aware of groups for drugs and all that, but not for TB
Awareness of
unfortunately.” (A1)
TB treatment
Completely
“Not specifically for TB but aware of clinics that offer
facilities or
unaware
but can’t tell for certain if only TB but assuming that
support
there a lot clinics available for diagnosing or testing.”
groups in LA
(A3)
County
Majority
interested in “No, not interested unless it becomes personal and am
TB
information
able to help them but would not seek in general.” (A3)
information
and
“Yes, would love to hear more to know what’s going on
seeking
informing
and happening with the disease.” (A4)
others
Reaction if
diagnosed
with TB
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Table 7
Thematic Analysis of Tuberculosis Knowledge and Perceptions by 8 Non-Armenian
adults
Theme /
category

TB Mode of
transmission

Subcategory

Variable routes
of transmission

Awareness of
infectivity

TB incidence

Unfamiliar with
reports

TB treatable

Ignorance if
curable

Ignorance of
treatment
Vaccine
availability
Reaction if
TB
Trepid initial
mentioned or
reaction
contracted by
others
Covert
willingness to
help

Selected Extract(s)
“TB is a blood disease or immune disease. Maybe
sexually transmitted”. (NA1)
“Disease that starts in the lungs, transmitted by viral,
air, coughing. Transmitted using things that were in
contacted with person that carries the disease, like
drinking from same cup.” (NA5)
“I don’t really know much about it. I’m assuming it is
transmitted through moisture, saliva, sneezing, and
maybe blood transfusions.” (NA7)
“My understanding that it was a communicable
disease and they had sanitariums for it.” (NA4)
“Highly infectious. I have to be tested regularly as a
public servant who works with children.” (NA6)
“Don’t recall in the past few years, but measles has.
There’s more incidence of cancer than TB.” (NA6)
“It’s prevalent in poor countries that don’t have
resources.” (NA7)
“My assumption is that it’s treatable (and treatment is
available) based on the fact that most diseases are, but
don’t know if is life-saving or just prolong death.”
(NA1)
“Once you get it and don’t get medical attention, it’s
very seldom that you thrive from it.” (NA3)
“Don’t know specifics about treatment.” (NA7)
“Treatable now but years ago it wasn’t.” (NA8)
Vaccine not mentioned by any NA participant.
“Afraid to come in contact with person.” (NA3)
“Concerned, if a family member. If in the news, then it
could start an epidemic, so I would be concerned.”
(NA5)
“It depends upon how close to me is in the
neighborhood, then would be leery about going
around and visiting or making contact.” (A3)
“I would probably stay clear and would suggest that
(table continues)
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Non-spiritually
influenced
Non-proactive
in emphasizing
treatment
seeking
activities
Desire to
improve disease
knowledge

Reaction if
diagnosed
with TB

Trepid Initial
reaction
Willing to seek
treatment
Seek outside
knowledge or
guidance

Awareness of
TB treatment
Completely
facilities or
unaware
support
groups in LA
County
TB
information
seeking

Concordant
interest in
information and
informing
others

they make everything possible so they don’t
contaminate other people.” (NA5)
There was no mention of praying for others or seeking
outside spiritual guidance by any NA participants.
There was no mention of advising others to seek
treatment upon mention of a diagnosis amongst NA
participants.
“I would start researching from many different sources
(e.g., colleges and doctors) and compile my own
thoughts.” (NA1)
“I would educate myself on what I can or cannot do
around them to know how the possibility of
transmission.” (NA7)
“I would be scared. Am I going to live? Could I give it
to my kids?” (NA1)
“I’ve never been diagnosed, but if I were I would be
shocked.” (NA5)
“I would definitely seek medical treatment.” (NA5)
“I wouldn’t be scared. It’s just like any other disease
and would go to doctor.” (NA8)
“I would immediately research to see exactly how
scared I would be and how transmissible it is.” (NA1)
“Not aware but feel like there is because there are
support groups for everything (e.g., drug abusers,
sexual abusers, cancer, death). Don’t know specifics
on location. Don’t know anyone who would seek it
out unless had the disease.” (N1)
“Used to have a sanitarium in the Foothills many years
ago (~50 years ago).” (N4)
“Yes, love educating self. Knowledge is power.”
(NA1).
“If it were brief and not a book, yes would want to
know if it was existing.” (NA4)

Some of the questions not relating to TB yielded similar responses in regards to
doctor trust, the use of home remedies, and spiritual guidance, with positive outlooks on
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most accounts (Tables 4 and 8). For both groups, the majority (> 80%) expressed great
trust in the ability of their doctor to effectively diagnose and treat any given disease;
however, a minority (≤ 20%) expressed a harsh distrust. Both groups had a similar
distribution of individuals who seek spiritual guidance upon receiving news of a disease
diagnosis for either themselves or close family/friends and those who don’t. Overall, all
participants opted for the use of home remedies, either prior to seeking a doctor’s
consultation and/or most continued taking the home remedy following prescription of
treatment by a doctor.
Table 8
Thematic Analysis of Non-tuberculosis Perceptions by 10 Armenian and 8 Non-Armenian Adults
Theme /
category

Doctor Trust

Subcategory

Positive
Outlook
Negative
Outlook

Spirituality

Highly
Spiritual

Non-Spiritual

Use home
remedies

Teas most
preferred
Alternative
remedies

Selected Extract(s)
A1: “I don’t have a particular one, but I should trust who I
get.”
NA1: “Yes, but all are prone to error and some tests don’t
find things, for example cancer, heart condition, etc. Once
see a physician, I trust them enough to ask for advice.”
A3: “Absolutely not!”
NA5: “No!”
A6: “Yes, the first thing I and my family does is seek
spiritual guidance.”
NA1: “I’m a spiritual person but not religious, I do selfprayer but wouldn’t physically seek it at a church or
mosque. I would seek the best doctors in the world first.”
A7: “No, goes to the doctor.”
NA7: “No, but some family might pray but not me
personally.”
A4: “Yes, mint tea and Turkish tea.”
NA3: “Yes, it depends upon what it is at the time. There are
certain herbs and teas that grow in yard (mint and mint
bark).”
A6: “My family and I give each other massages and I stay in
bed.”
A4: “Massages on occasion.”
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Quantitative Component
RQ1 identifies the perceived barriers to TB treatment-seeking and adherence
within the Armenian population surveyed in LA County. The independent variables (IV)
include ethnicity/race, cultural beliefs, demographics, and religion, with knowledge being
the dependent variable (DV). To address this, a univariate analysis was performed by
comparing frequencies of responses for each question for those participants classified as
Armenian. The responses were subsequently tabulated, including associating each
question to specific independent variables to facilitate data interpretation (Table 9).
Questions relating to TB knowledge reveal that 98.2% of Armenians have heard
of TB, with a singular source of knowledge coming from family and friends (27.8%) or
school (12.7%) or a combination of sources such as TV, Internet, family/friends, and
newspaper/magazines (11.1%). Armenian respondents believe it is a modern day health
problem in the U.S. (63.6%) and internationally (89.1%), with coughing and sneezing as
the primary mode of transmission (63.6%). While 54.5% believe there is a treatment
available for TB, the majority of respondents are unaware of the duration of treatment
regimen (61.8%), whether it is 100% effective (54.5%), or if the disease is curable
(30.9%). 94.5% of the Armenian participants have never been diagnosed or know
someone who has been diagnosed with TB and 41.8% feel informed at the mention of the
disease. Factors associated with TB were found to be vast, with 20.9% believing it is a
curable disease and 90.9% believing that contracting the disease could happen to anyone.
If contracted, 92.7% trust their physician to cure it (58.2% strongly agree and 34.5%
agree), 80% would comply with treatment recommendations (67.3% strongly agree and
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12.7% agree), and 50.9% would not seek treatment outside of a hospital setting (23.6%
strongly agree, 27.3% agree), though 76.4% also utilize home remedies.
Table 9
RQ1. What are the Perceived Barriers to Treatment-seeking and Adherence for
Tuberculosis in an Armenian Population Living within the United States? (n = 55)
Survey Question
1

2

3

Heard of Tuberculosis
Yes
No
How have you heard about TB?
TV
Internet
Family or friends
Newspaper/magazine
TV and Internet
TV and newspaper/magazine
Internet and family/friends
Internet and newspaper/magazine
Family/friends and other
Newspaper/magazine and other
TV, Internet, family/friends
Internet, family/friends,
newspaper/mag
Internet, family/friends, other
TV, Internet, family/friends,
newspaper/magazine
Other
Common Knowledge
Doctor
Health Center
Health Industry
Research
School
Required TB test
Work
Modern day health problem in the US?
Yes

Frequency
(ƒ)

Percent
(%)

54
1

98.2
1.8

5
2
15
0
1
1
1
1
4
1
5
1

9.3
3.7
27.8
0
1.9
1.9
1.9
1.9
7.4
1.9
9.3
1.9

1
6

1.9
11.1

10
1
2
1
1
1
7
1
1

18.5
1.8
3.6
1.8
1.8
1.8
12.7
1.8
1.8

35

63.6

Associated
Variable(s)
Knowledge

Knowledge

Knowledge
(table continues)
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4

5

6

7

8

9

10

11

12

No
Modern day problem internationally?
Yes
No
Mode of transmission
Coughing, sneezing
Touching
Sexual contact
Food/water ingestion
Smoking
Imbalance of hot and cold
Do not know
Most common symptom
Coughing
Sneezing
Loss of appetite
Tiredness/fatigue
Bleeding
Do not know
Treatment available?
Yes
No
Length of treatment
3 days
1 week
1 month
> 6 months
Do not know
Treatment 100% effective?
Yes
No
Do not know
A curable disease?
Yes
No
Do not know
Initial reactions and feelings when
mentioned by family, friends, or news?
Frightened
Informed
Indifferent
Helplessness
You or anyone in family diagnosed?

20

36.4

49
6

89.1
10.9

35
0
0
2
0
0
18

63.6
0
0
3.6
0
0
32.7

34
1
1
8
1
10

61.8
1.8
1.8
14.5
1.8
18.2

30
25

54.5
45.5

1
4
5
11
34

1.8
7.3
9.1
20.0
61.8

12
13
30

21.8
23.6
54.5

33
5
17

60
9.1
30.9

15
23
16
1

27.3
41.8
29.1
1.8

Knowledge

Knowledge

Knowledge

Knowledge

Knowledge

Knowledge

Knowledge

Knowledge

Knowledge
(table continues)
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13

14

Yes
No
If yes, how did you feel?
Frightened
Informed
Indifferent
Helpless
Depressed
Informed & Indifferent
Factors associated with TB:
Poverty
Foreign-born
HIV status
Drug history
Low social class
Sexual orientation
Mental illness
Religion
A common disease
A curable disease
Smoking
Imbalance of hot and cold
Incarceration
Poverty and low social class
Poverty and a common disease
Poverty and a curable disease
Poverty, foreign-born, and low social
class
Foreign-born and a curable disease
A common disease and a curable
disease
A common disease and smoking
Poverty, foreign-born, a curable
disease
Poverty, HIV status, and a curable
disease
Poverty, drug history, and
incarceration
Poverty, sexual orientation, religion,
incarceration
Foreign-born, low social class,
common disease, incarceration
A common disease, curable disease,

3
52

5.5
94.5

1
1
0
0
0
1

33.3
33.3
0
0
0
33.3

2
1
0
0
0
0
0
0
6
11
2
4
1
1
1
2
3

3.6
1.8
0
0
0
0
0
0
10.9
20.0
3.6
7.3
1.8
1.8
1.8
3.6
5.5

2
2

3.6
3.6

1
3

1.8
5.5

1

1.8

1

1.8

1

1.8

1

1.8

1

1.8

Knowledge

Ethnicity/
Race
Cultural
Belief
Demographics
Religion
Knowledge

(table continues)
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15

16a

16b

16c

and smoking
A curable disease, smoking, imbalance
of hot and cold
Poverty, foreign-born, curable disease,
incarceration
Poverty, foreign-born, low social
class, common disease, curable disease
Poverty, HIV status, drug history,
common disease, smoking
Poverty, drug history, smoking, and
imbalance of hot and cold
Poverty, foreign-born, low social
class, curable disease, and
incarceration
Poverty, foreign-born, low social
class, curable and common disease,
incarceration
If someone has TB, you think that:
Did something wrong (e.g., drug use)
A punishment given by the God
Due to racial background
It could happen to anyone
Did something wrong and it could
happen to anyone
Due to racial background and it could
happen to anyone
If you had TB, would you trust doctors
to cure it?
1. Strongly agree
2. Agree
3. No Opinion
4. Disagree
5. Strongly disagree
If you had TB, would you be compliant
with doctors’ instructions regarding
treatment?
1. Strongly agree
2. Agree
3. No Opinion
4. Disagree
5. Strongly disagree
If you had TB, would you seek
treatment outside a hospital/ private

1

1.8

1

1.8

1

1.8

1

1.8

1

1.8

1

1.8

1

1.8

0
1
2
50
1

0
1.8
3.6
90.9
1.8

1

1.8

32
19
4
0
0

58.2
34.5
7.3
0
0

37
7
6
2
3

67.3
12.7
10.9
3.6
5.5

Ethnicity/
Race
Cultural
Belief
Demographics
Religion

Cultural
Belief
Demographics
Religion

Cultural
Belief
Demographics
Religion

Cultural
Belief
(table continues)
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17

18a

18b

practice setting?
1. Strongly agree
2. Agree
3. No Opinion
4. Disagree
5. Strongly disagree
If seeking outside treatment, where
would you go?
Chiropractor
Acupuncturist
Homeopathic doctor/nutritionist
Religious/ church leader
Massage therapist
Home remedies (herbs, oils, teas)
I wouldn’t
Acupuncturist and homeopathic doctor
Homeopathic doctor and home
remedies
Chiropractor, religious leader, home
remedies
Acupuncturist, homeopathic doctor,
home remedies
Homeopathic doctor, religious leader,
home remedies
Chiropractor, Acupuncturist,
Homeopathic doctor, and massage
therapist
Chiropractor, Acupuncturist,
Homeopathic doctor, and home
remedies
Chiropractor, Acupuncturist,
Homeopathic doctor, massage
therapist, home remedies
Chiropractor, Acupuncturist,
Homeopathic doctor, religious leader,
massage therapist, home remedies
Aware of TB treatment facilities in LA
County and the services provided?
Yes
No
If no, if information was made readily
available, would you be more inclined
to read about the disease and inform

5
8
14
15
13

9.1
14.5
25.5
27.3
23.6

0
0
4
2
0
3
35
2
1

0
0
4.3
3.6
0
5.5
63.6
3.6
1.8

1

1.8

1

1.8

1

1.8

1

1.8

1

1.8

1

1.8

2

3.6

8
47

14.5
85.5

Demographics
Religion

Cultural
Belief
Religion

Demographics
Knowledge
Cultural
Belief
Knowledge
(table continues)
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others in your community?
Yes
No
19
Aware of community social support
groups for dealing with the disease?
Yes
No
Basic Background Information
18
Seek Spiritual Guidance
Yes
No
19
Use Home Remedies (herbs, teas, etc.)
Yes
No

32
15

68.1
31.9

5
50

9.1
90.9

24
31

43.6
56.4

42
13

76.4
23.6

Knowledge

Religion
Cultural
Belief

RQ2 identifies which factors (e.g. physical, cultural, psychosocial, behavioral), if
any, contribute to differences in knowledge (DV) relating to TB between Armenians and
non-Armenians living in LA County. To explore this, bivariate chi-square (χ2) analyses
were performed with classification of populations (Armenian or non-Armenian) servings
as the independent variable (IV). Table 10 summarizes all of the χ2 results, highlighting
significant factors (p <0.05) and the effect size associated with these variables.
Table 10
RQ2. Bivariate Analysis (n = 127)
Dependent
Variable
Heard of TB

Source of TB
Knowledge

Independent
Variable
Armeniannon
Armenian
Armeniannon
Armenian

χ2

p

Interpretation

1.319

ns

40.213

0.037

Arm/Non-Arm status
does not affect heard of
TB
There is a significant
difference in TB
knowledge source in
Arm (9.3% TV, 3.7%
Internet, 27.8%
family/friends, 0%

Effect Size
(Cramer’s V)
NA

0.565

(table continues)
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TB US
Problem

Armeniannon
Armenian
Armeniannon
Armenian
Armeniannon
Armenian

0.085

ns

0.048

ns

8.203

ns

TB
Symptoms

Armeniannon
Armenian

5.631

ns

TB
Treatment
Available

Armeniannon
Armenian

0.073

ns

TB
Treatment
Length

Armeniannon
Armenian

6.913

ns

TB
Treatment
Effectiveness

Armeniannon
Armenian

1.279

ns

TB Curable
Disease

Armeniannon
Armenian

0.883

ns

TB reactions

Armeniannon
Armenian

2.212

ns

Armeniannon
Armenian
TB Diagnosis Armenian-

0.392

ns

5.625

ns

TB
International
Problem
TB route of
Transmission

TB Diagnose
family/friend

printed media, 10%
other) as compared to
non-Arm (1.4%, 0%,
11.1%, 2.8% 13.9%,
resp)
Arm/Non-Arm status
NA
does not affect TB
national awareness
Arm/Non-Arm status
NA
does not affect TB
international awareness
Arm/Non-Arm status
NA
does not affect route of
TB transmission
knowledge
Arm/Non-Arm status
NA
does not affect route of
TB symptom
knowledge
Arm/Non-Arm status
NA
does not affect TB
treatment availability
knowledge
Arm/Non-Arm status
NA
does not affect TB
treatment duration
knowledge
Arm/Non-Arm status
NA
does not affect TB
treatment effectiveness
knowledge
Arm/Non-Arm status
NA
does not affect TB
disease status
knowledge
Arm/Non-Arm status
NA
does not affect
reactions to TB
diagnosis
Arm/Non-Arm status
NA
does not affect personal
TB diagnosis
Arm/Non-Arm status
NA
(table continues)
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Feelings

non
Armenian

Factors
Associated
with TB
Trust Doctor
to treat TB

Armeniannon
Armenian
Armeniannon
Armenian

52.321

ns

5.631

ns

Compliant
with doctors’
instructions
regarding
treatment
Seek
treatment
outside of
doctor’s care
Alternative
Treatment
types

Armeniannon
Armenian

11.630

0.020

Armeniannon
Armenian

1.549

ns

Armeniannon
Armenian

18.286

ns

Aware of LA
County TB
treatment
facility
Read about
TB, if
provided

Armeniannon
Armenian

0.278

ns

Armeniannon
Armenian

0.864

ns

Aware of
community
TB support
groups
Seek spiritual
guidance

Armeniannon
Armenian

0.369

ns

Armeniannon
Armenian

9.8883

0.002

Use Home
Remedies

Armeniannon
Armenian

4.526

0.033

does not affect feelings
toward TB positive
individual
Arm/Non-Arm status
NA
does not affect TB
factors knowledge
Arm/Non-Arm status
NA
does not affect trust in
physician’s ability to
treat TB
Non-Arm significantly
0.303
more compliant
(strongly agree/agree)
as compared to Arm
(97.2% vs. 80%)
Arm/Non-Arm status
NA
does not affect desire to
seek outside treatment
for TB
Arm/Non-Arm status
NA
does not affect
alternative treatment
sought
Arm/Non-Arm status
NA
does not affect LA
County TB treatment
facility awareness
Arm/Non-Arm status
NA
does not affect desire to
read about TB if
provided
Arm/Non-Arm status
NA
does not affect TB
community support
group awareness
Significantly more Arm
0.279
seek spiritual guidance
(43.6%) as compared to
non-Arm (18.1%)
Significantly more Arm
0.189
use home remedies
(76.4%) as compared to
non-Arm (58.3%)
(table continues)
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Trust
Primary
Physician
Have Health
Insurance

Armeniannon
Armenian
Armeniannon
Armenian

2.889

ns

0.578

ns

Gender

Armeniannon
Armenian
Armeniannon
Armenian

0.201

ns

7.970

0.005

Armeniannon
Armenian
Armeniannon
Armenian

1.405

ns

13.138

0.011

Armeniannon
Armenian

27.636

0.000

Level of
Education

Armeniannon
Armenian

12.755

0.005

Occupation

Armeniannon
Armenian

8.742

ns

Years in US

Marital
Status
Number of
People in
household
(excluding
self)
English
primary
language
spoken

Arm/Non-Arm status
does not affect trust of
primary care physician
Arm/Non-Arm status
does not affect health
care insurance
procurement
Arm/Non-Arm status is
not affected by gender

NA

Arms have
significantly fewer
years in US (80% ≥ 20
years) as compared to
non-Arm (95.8%)
Arm/Non-Arm status is
not affected by marital
status
Arm have significantly
more people per
household (83.6% ≥ 2)
as compared to nonArm (56.9%)
Arm have a
significantly lower
level of English as their
primary language
(63.6%) as compared to
non-Arm (98.6%)
Arm have a
significantly lower
level of education
(12.7% High school,
25.5% some college,
27.3% Bachelor’s,
34.5%
Graduate/Professional)
as compared to nonArm (0%, 16,7%,
43.1%, 40.3% resp)
Arm/Non-Arm status is
not affected by
occupation

0.251

NA

NA

NA

0.322

0.466

0.317

NA

(table continues)
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Annual
Household
Income

Armeniannon
Armenian

3.565

ns

Arm/Non-Arm status is
not affected by annual
household income

NA

The effect size was calculated using the 2-sided Pearson’s chi-square value where
p-values ≤ 0.05 were considered to be significant. Of those factors with significance, a
Cramer’s V scale was used to evaluate the strength of the effect size (d.f. ≥ 3): < ± 0.06,
small; ± 0.17 medium, and ≥ ± 0.29, large (Zaiontz, 2016). For this study, the effect size
was calculated using only those factors relating to TB-specific questions. Other factors
relating to background of the two populations also showed some significant differences
with strength (Table 10) and will be discussed later in Chapter 5.
As seen in Table 11, those factors with the greatest significance and strength
relate to how the two populations learned about the disease (“TBHearSource”) and how
compliant with a doctor’s instructions would they would be if diagnosed (“TBWhatifB”).
From these, the average Cramer’s value was calculated, resulting in an effect size of
0.434.
Table 11
Effect Size Determination: TB-Specific Questions (n = 127)
Variable
TBHearSource
TBWhatifB
Average

Pearson’s
0.037
0.020

Cramer’s V
0.565
large
0.303
large
0.434

For RQ2, multinomial logistic regression was used to explore interactions
between the nominal, multi-categorical dependent variables for any of the independent
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variables. The dependent variables explored were those with large effect sizes and
significant chi-square values (0.1 > p < 0.05) from the bivariate analysis, which included
“TBHearSource, TBWhatifB (compliance), and TBTransmit” (p = 0.084, Cramer’s V
0.254). These variables were tested against predictor factors relating to demographics,
religion, and cultural beliefs, focusing on those that were found to be significant in the
bivariate analysis (Table 10).
Table 12 summarizes the significant findings and predictors, where the full model
predicts significantly better than the null model. Overall, it was found that for the
dependent variable, Source of TB knowledge (TBHearSource), classification (Armenian
versus non-Armenian) and the use of home remedies were significant factors with the
latter having a number of combinations of factors that are good predictors. For the
dependent variable TB Route of Transmission (TBTransmit), classification and age were
found to be significant, with “coughing and sneezing” representing a good predictor (OR
0.347; CI 0.134-0.838). For the question addressing compliance (TBWhatifB),
classification, English spoken in household, and education were significant. However, in
some cases there were limitations in the models where there were singularities with some
of the predictor variables, suggesting they should be removed or merged (see notation a).
Proposed mitigations will be discussed further in Chapter 5.
Table 12
RQ2. Multivariate Analysis (n=127)
Dependent
Variable

Factor

p

Parameter Estimates
Predictor

Source of TB

Classification

< 0.05

p

Odds
Ratio

95% Confidence
Interval (CI)
Lower
Upper

a

(table continues)
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Knowledge
(TBHear
Source)

TB route of
Transmission

Compliance
if Diagnosed

(Armenian/
nonArmenian)
Use of Home
Remedies

Classification
(Armenian/
nonArmenian)
Age
Classification
(Armenian/

< 0.05

0.05

< 0.05
< 0.05

Family/friends
Internet +
Newspaper/
Magazine
Internet +
other
Family/friends
+ other
Newspaper/
Magazine +
other
TV + Internet
+ Newspaper/
Magazine
TV + Family/
friends +
Newspaper/
Magazine
Internet +
Family/friends
+ Newspaper/
Magazine
Internet +
Family/friends
+ other
Family/friends
+ Newspaper/
Magazine +
other
TV + Internet
+ Family/
friends + other
Internet +
Family/friends
+ Newspaper/
Magazine +
other
Coughing/
sneezing

< 0.05
0.00

14.25
3. 50e8

1.16
3. 50e8

174.80
3.50e8

0.00

3. 50e8

3.50e8

3.50e8

< 0.05

33.00

1.56

697.96

0.00

3. 50e8

3.50e8

3.50e8

0.00

3. 50e8

3.50e8

3. 50e8

0.00

3. 50e8

3.50e8

3.50e8

0.00

3.50e8

3.50e8

3.50e8

0.00

3.50e8

3.50e8

3.50e8

0.00

3.50e8

3.50e8

3.50e8

0.00

3.50e8

3.50e8

3.50e8

0.00

3.50e8

3.50e8

3.50e8

< 0.05

0.35

0.13

0.84

0.00

5.70e-9

1.09e-9

2.98e-8

a

Strongly
Agree

(table continues)
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with TB
(TBWhatifB)

nonArmenian)
Years in US

< 0.05

Strongly
Disagree
No Opinion
Strongly
Agree
Strongly
Disagree
No Opinion

0.00

3.64e-9

5.39e-10

2.27e-9

0.00
0.00

2. 50e-8
3.28e7

2. 50e-8
1.82e6

2.50e-8
5.91e8

0.00

6.97e7

3.38e6

1.44e9

0.00

4.64e8

2.09e7

1.03e10

b

English
< 0.05
spoken in
household
Education
< 0.05 a
a
Unexpected singularities in the Hessian matrix encountered, indicating that either some
predictor variables should be excluded or some categories should be merged
b
low logistic coefficients

Summary of RQ1 Results
RQ1 is a descriptive inquiry that investigates the perceived barriers to treatment
seeking and adherence for TB in an Armenian population living within the United States.
The quantitative study utilized a series of online survey questions addressing knowledge-,
cultural-, religious-, demographic-, and ethnicity-based inquiries (Table 9). Univariate
analyses of the 55 Armenian respondents revealed themes relating to all independent
variables. Some of the knowledge-based inquiries revealed that 98.2% of Armenians
have heard of TB, with a singular source of knowledge coming from family and friends
or school, or a combination of sources such as TV, Internet, family/friends, and
newspaper/magazines. Furthermore, Armenian respondents believe TB is a modern day
health problem both in the U.S. and internationally, with coughing and sneezing as the
primary mode of transmission. While just over 50% believe there is a treatment available,
the majority of respondents are unaware of the duration of treatment regimen, whether it
is 100% effective, or if the disease is curable. Almost all of the Armenian participants
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have never been diagnosed or know someone who has been diagnosed with TB, with less
than 50% feeling informed at the mention of the disease. Factors associated with TB were
found to be vast, with 20.9% believing it is a curable disease and 90.9% believing that
contracting the disease could happen to anyone. If contracted, 92.7% trust their physician
to cure it, 80% would comply with treatment recommendations, and just over half of
respondents would not seek treatment outside of a hospital setting, though 76.4% also use
home remedies.
Further support was achieved through the face-to-face interviews of 10 Armenian
participants in the qualitative study, with some ambiguities. Here knowledge of TB
existed but mode of transmission, incidence, and treatment characteristics (e.g., duration,
type, and effectiveness) was more uncertain. The majority of Armenians expressed great
trust in the ability of their doctor to effectively diagnose and treat any given disease;
however, a minority expressed a harsh distrust. All of the respondents also opted for the
use of home remedies, either prior to seeking a doctor’s consultation and/or most
continued taking the home remedy following prescription of treatment by a doctor. The
culturally-based inquiry regarding the presence of kapoot ach in their house revealed that
all of them had at least one, with one (A9) responding “Yes, it’s all around. It’s
something an Armenian family has to have!”
Summary of RQ2 Results
RQ2 is inferential and explores differences in barriers to treatment seeking and
adherence for Tuberculosis in Armenian versus non-Armenian populations living in LA
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County and determines which factors (e.g., physical, cultural, psychosocial, behavioral)
have the greatest influence? The alternative and null hypotheses are:
HA2: There are differences in factors relating to treatment seeking and adherence
for tuberculosis in Armenian versus non-Armenian populations in Los
Angeles County.
H02: There are no differences in factors relating to treatment seeking and
adherence for tuberculosis in Armenian versus non-Armenian populations in
Los Angeles County.
The quantitative element of the study involved surveying 55 Armenians and 72
non-Armenians residing in LA County. To determine significant differences, if any,
between the two populations in regards to barriers to treatment-seeking and adherence for
TB, bivariate chi-square (χ2) analyses were performed with classification of populations
(Armenian or non-Armenian) servings as the independent variable (IV) As can be seen
in Tables 10 and 11, significant factors (p <0.05) with medium to large effect sizes relate
to how the two populations learned about the disease (“TBHearSource”) and how
compliant with a doctor’s instructions would they would be if diagnosed (“TBWhatifB”).
From these, the average Cramer’s V value was calculated, resulting in an effect size of
0.434.
Multinomial logistic regression was then used to explore interactions between
these nominal, multi-categorical dependent variables for any of the independent
variables. “TBHearSource”, “TBWhatifB” (compliance), and “TBTransmit” (p = 0.084,
Cramer’s V 0.254) were tested against predictor factors relating to demographics,
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religion, and cultural beliefs, focusing on those that were found to be significant in the
bivariate analysis (Table 10). For the dependent variable, Source of TB knowledge
(TBHearSource), classification (Armenian versus non-Armenian) and the use of home
remedies were significant factors with the latter having a number of combinations of
factors that are good predictors. For the dependent variable TB Route of Transmission
(TBTransmit), classification and age were found to be significant, with “coughing and
sneezing” representing a good predictor (OR 0.347; CI 0.134 - 0.838). For the question
addressing compliance (TBWhatifB), classification, English spoken in household, and
education were significant. However, in some cases there were limitations in the models
where there were singularities with some of the predictor variables, suggesting they
should be removed or merged.
The qualitative component of the study where 10 Armenians and 8 nonArmenians were interviewed face-to-face, found some similarities and differences in
responses between the two populations. Both populations had general vague knowledge
relating to route of transmission, degree of infectivity, molecular properties, and
incidence. Both also felt like there “should be” a treatment available but didn’t have any
details on regimen; however, only the Armenian population acknowledged vaccine
availability. When it came to perceptions and feelings, the Armenian population
expressed more empathy, an overt willingness to help someone with the disease, desire to
seek treatment or urge others to seek treatment, and seek spiritual guidance and outside
education for themselves or others. The non-Armenian population appeared more trepid,
less willing to help others and urge them to seek treatment, and less open to seek spiritual
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guidance; however, they were very willing to educate themselves about the disease. Both
groups had a similar distribution of individuals who seek spiritual guidance upon
receiving news of a disease diagnosis for either themselves or close family/friends and
those who don’t. Overall, all participants opted for the use of home remedies, either prior
to seeking a doctor’s consultation and/or most continued taking the home remedy
following a physician’s prescription of treatment.
Trustworthiness
When conducting a mixed-methods study, there are many important aspects that
need to be considered to guarantee credibility and dependability. For this concurrent
mixed-methods study, data triangulation was utilized to address these concerns. By
utilizing multiple modes of data collection, e.g., observational from the face-to-face
interviews of the qualitative study and online survey research from the quantitative study,
specificity and validity concerns relating to a particular approach is minimized. For this
study, data from the qualitative study and quantitative study were collected in parallel,
analyzed separately, and then converged following data analysis. From this convergence,
it was found that the findings from both studies are primarily in agreement, with some
minor diverging trends. These are likely due to differences in survey environment (faceto-face versus remote and online), where the online participants appeared to be more
informed about the disease overall irrespective of classification.
To further address potential issues relating to credibility and dependability, peer
review was utilized as a mechanism for external checking the research process, remove
threats of bias, provide analytical direction, and confirm results. For these studies, the
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dissertation supervisor, V.M., served as the peer reviewer throughout the process by
looking over all of the results (pilot study and final studies) and confirming appropriate
implementation and analysis of all statistical tests used.
For an ethnography in particular, transferability or generalizability is a concern.
Not only did this study focus on a particular population, Armenians, but was even more
selective for those living in LA County. If other researchers attempt to replicate this
study, it is likely that alterations may need to be made to account for attributes specific to
the population being studied (e.g., demographics).
Data validity and reliability are serious concerns for any researcher. They can be
threatened by the instrumentation used to conduct the study, particularly when developed
by the researcher, as well as from data coding methods following data collection but prior
to analysis. For the quantitative portion of the study, pilot testing was conducted to
validate the instrumentation. The recommendations were incorporated into the final
survey prior to recruitment and implementation online. Furthermore, a codebook was
generated for each research question (Appendix L). This was approved by the peer
reviewer V.M. prior to data analysis. All of the responses from completed online surveys
were exported from SurveyGizmo into Excel, where the researcher manually coded all of
the responses based on the approved codebook. This was transferred into SPSS and
checked externally for errors by V.M.
Coding for qualitative studies may be more subjective which can offer challenges
relating to reliability. For the qualitative component of this study, written transcripts were
generated from the voice recordings. The data were then analyzed for key words and
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phrases that relate back to the research questions. For these key themes, sub-themes were
also formulated and indexed. These were cross-checked by the peer reviewer for errors.
Summary
The purpose of this mixed-methods study was to explore factors (physical,
psychosocial, cultural, or behavioral) relating to TB knowledge, treatment-seeking and
adherence in Armenians versus non-Armenian residing in LA County and whether
differences exist between the populations. Univariate (frequencies), bivariate (chisquare), and multivariate (multinomial logistic regression) statistical analyses were
implemented to determine factors and relationships. The qualitative component utilized
face-to-face interviews with coded and grouped responses to address concerns relating to
specificity and validity. Data from both study components were collected in parallel,
analyzed separately, and then converged post-analysis.
The null hypothesis (H0) for RQ2 is rejected in favor of the alternative hypothesis
(HA), “there are differences in factors relating to treatmen- seeking and adherence for TB
in Armenian versus non-Armenian populations in Los Angeles County”. The resulting
post-hoc power analysis was satisfactory > 0.90. Bivariate analysis determined that there
are two factors that are significantly different between Armenian and non-Armenian
populations: (a) the source of TB knowledge and (b) compliance with a doctor’s
instructions if a TB diagnosis is received. The multivariate analysis found factors that
were good predictors for each of these variables, though some limitations were found
with the model (further discussed in Chapter 5). Some factors with significance include
the use of home remedies (with many combinations of predictors), age, years residing in
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the United States, education, and English as the primary language in the household.
Analysis of the responses from the qualitative component revealed that both populations
were in general uninformed about TB (e.g., transmission, treatment, curability, and
incidence). The Armenian population appeared to be more willing to help others, while
using caution, if diagnosed and trust their physician for diagnosing and treating; whereas,
non-Armenians were less willing to help others and jeopardize their health and expressed
less trust in their physician’s ability to effectively treat the disease.
The results of the study will be summarized and interpreted further in Chapter 5.
Furthermore study limitations, as well as recommendations for future research, social
implications, the theoretical foundation (SEM), and conclusions of the study will be
discussed.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
TB continues to be a global public health problem and has been made a top
priority disease for control and eradication by the WHO and national health ministries
(WHO, 2015). Armenians, in particular, are a susceptible population due to high national
incidence of MDR-TB, inadequate health care, poor disease surveillance, poor disease
education, poverty, and emigration/immigration (Bakalian, 2011; Hayrapetyan, 2012;
Truzyan et al., 2015; Vink et al., 2005); however, very few epidemiological or prevention
studies have been dedicated to this group.
The purpose of this study was to explore differences in factors (physical,
psychosocial, cultural, or behavioral) relating to TB knowledge, treatment-seeking and
adherence in Armenians as compared to non-Armenians in LA County to determine
which factors have the greatest potential impact on reducing TB incidence in this
susceptible population. To do this, a mixed-methods study design was implemented using
concurrent quantitative components, an online survey, followed by qualitative face-toface interviews. Resulting data were analyzed separately and merged during the
interpretation phase of the study.
For the quantitative component, 55 Armenians residing in LA County were
surveyed through the online platform SurveyGizmo. Here, knowledge-, cultural-,
religious-, demographic-, and ethnicity-based inquiries were investigated. Among the
surveyed Armenian population, perceived barriers to treatment-seeking and adherence for
TB were explored and analyzed for (Table 9). Knowledge-based inquiries revealed that
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98.2% of Armenians have heard of TB, with knowledge coming from family and friends
or school, or a combination of sources such as TV, Internet, family/friends, and
newspaper/magazines. Furthermore, Armenian respondents believe TB is a global health
problem, with the primary mode of transmission being coughing and sneezing. Factors
associated with TB were found to be vast, with 20.9% believing it is a curable disease
and 90.9% believing that contracting the disease could happen to anyone. While just over
50% believe that treatment is available, the majority were unsure of treatment details
such as duration and effectiveness. Almost all of the Armenian participants have never
been diagnosed or know someone who has been diagnosed with TB, with less than 50%
feeling informed at the mention of the disease.
The qualitative component further supported the quantitative findings among the
Armenian population. Here, 10 Armenian participants were interviewed face-to-face.
Analysis of responses revealed awareness of TB; however, knowledge of the mode of
transmission, incidence, and treatment characteristics (e.g., duration, type, and
effectiveness) was absent. The culturally based inquiry on the presence of kapoot ach in
their residence revealed all of them had at least one.
Differences in barriers to treatment-seeking and adherence for TB in Armenian
and non-Armenian populations in LA County were identified using bivariate chi-square
(χ2) and multivariate multinomial logistic regression analyses of the online survey data.
When comparing data from the 55 Armenians and 72 non-Armenians surveyed,
significant factors with medium to large effect sizes were: (a) how the two populations
learned about the disease (“TBHearSource”) and (b) how compliant with a doctor’s
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instructions would they would be if diagnosed (“TBWhatifB”). Using Cramer’s V
calculations, the resulting effect size was 0.434 (see Tables 10 and 11). Multivariate
analyses of these factors, along with an additional factor of how TB is transmitted
(TBTtransmit, p = 0.084), revealed predictor factors such as classification, the use of
home remedies, age, education, and English as the primary household language to be
significant. The null hypothesis (H0) for RQ2 is rejected in favor of the alternative
hypothesis (HA), “there are differences in factors relating to treatment seeking and
adherence for TB in Armenian versus non-Armenian populations in LA County”.
When exploring differences in the two populations, the qualitative component
revealed some similarities and differences in responses. Amongst the 10 Armenians and 8
non-Armenians interviewed, both populations had vague knowledge relating to route of
transmission, degree of infectivity, molecular properties, and incidence. Both also
believed that there “should be” a treatment available but didn’t have any details on
regimen; however, only the Armenian population acknowledged vaccine availability.
When exploring perceptions and feelings, the Armenian population expressed more
empathy, an overt willingness to help someone with the disease, desire to seek treatment
or urge others to seek treatment, and seek spiritual guidance and outside education for
themselves or others. The non-Armenian population appeared more trepid, less willing to
help others and urge them to seek treatment, and less open to seek spiritual guidance;
however, they were very willing to educate themselves about the disease. Both groups
had a similar distribution of individuals who seek spiritual guidance upon receiving news
of a disease diagnosis for either themselves or close family/friends and those who don’t.
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Interpretation of the Findings
Results from this study confirm, and extend, the very limited knowledge relating
to TB awareness and barriers to treatment seeking and adherence in an Armenian
population. In an extensive report by Grigoryan et al. (2008), TB knowledge and attitudes
of Armenians living in Armenia were assessed. Of those interviewed, 91% could identify
TB but only half knew how it was transmitted. Additionally, the vast majority did not
realize that TB was a public health problem, could not identify symptoms, and believed
that they and their loved ones were not at risk. Social stigma was also high, where
roughly 20% keep their family’s TB status a secret. Furthermore, TB patients were illinformed about the duration of treatment and the consequences regarding non-compliance
or interrupted treatment (Grigoryan et al., 2008).
In both the quantitative and qualitative components of this study, > 90% of
respondents were aware of TB; with the qualitative component revealing that majority of
the participants were uninformed regarding transmission, and 63.6% of the quantitative
participants aware that coughing and sneezing are the primary mode of transmission. In
regards to treatment, 61.8% of respondents from the quantitative component had no idea
about duration of treatment and 54.5% didn’t know if the treatment was effective. The
lack of familiarity regarding treatment was also supported by the qualitative study,
though similar trends were also seen in the non-Armenian counterparts.
Fears relating to social stigma didn’t seem as apparent in either the quantitative or
qualitative components of this study; however, very few respondents either had the
disease or knew of someone who had it. In the quantitative component, 90.9% felt if
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someone had TB, it could happen to anyone and was not attributable to race or was a
punishment by God. In the qualitative study, most Armenians would be empathetic to
those with TB, would be eager to help, and would urge the patient to seek treatment
immediately; however, the non-Armenian contingent were more trepid, less eager to help,
and would stay isolated from the patient. The proactive response in Armenians is contrary
to what was reported by Ige and Lasebikan (2011) where family members of patients
reported increased depression and helplessness.
Schneider et al. (2010) explored reasons for delaying TB treatment in patients in
Armenia where significant factors included weight loss and fatigue, the inability to
recognize TB symptoms, and referral after the first doctor’s visit. In the qualitative
component of this study, the majority of Armenian respondents reported that they would
immediately seek treatment upon receiving a positive diagnosis and would urge close
family and friends to do the same; however, their inability to recognize symptoms as TB
or utilize home remedies first may in actuality result in delays in seeking treatment. In the
quantitative aspect of this study, 61.8% of Armenians identified coughing as the most
common symptom of TB; however, other characteristics such as bleeding, loss of
appetite, and fatigue were far less recognizable. Because coughing is a common symptom
of many diseases and 76.4% also utilize home remedies, individuals may delay
consulting with a physician for proper diagnosis and treatment. Therefore, the findings by
Schneider et al. (2010) and this study suggest that enhanced knowledge regarding
recognizing signs and symptoms of TB, along with improved medical care and staff
would dramatically improve disease outcomes in the Armenians living in the United
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States and Armenia. Furthermore, it is evident that the lack of studies relating to TB in
Armenian populations perpetuates the problem of poor disease outcomes.
The social ecological model serves as a strong theoretical foundation in social
epidemiology, particularly for improving infectious disease outcomes, by explaining
potential causal relationships between disease and social and biological conditions
(Krieger, 2001) and addressing complex community-based problems relating to health
disparities (Green et al., 2005; Reifsnider et al., 2005). As depicted in Figure 1, SEM
addresses four inter-related factors: (a) the individual and risk behaviors (e.g.,
knowledge, attitudes, beliefs); and (b-d) interpersonal relationships, community and
environment, and societal /cultural norms, such as social interactions, social constructs,
social structure, and public policy (California Department of Public Health, n.d.; CDC,
2009b). All levels constructively work together to positively influence change.
SEM has been widely used in TB studies addressing transmission, treatment and
prevention, including health disparities, ethnic differences, socioeconomics, immigration,
and psychosocial factors amongst various populations both nationally and internationally.
Myers et al. (2006) utilized an ecological approach for exploring TB transmission in
California by focusing on racial/ethnic distribution, immigration, education level,
employment status, poverty, and crowding obtained from U.S. Census data and related
them to new TB cases. Using pediatric cases as a measurement of transmission, it was
found that pediatric TB cases were elevated in lower median incomes, racial/ethnic
minorities, and immigrants. While this study explored such factors in an Armenian
population, the ability to find causation and link them to new TB cases in LA County is
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difficult and beyond the scope of this study due to the classification of Armenians as
White/Caucasian for census data. Due to Armenians’ declared willingness to help others
in the qualitative component as compared to non-Armenians, this would be interesting to
explore how it may impact population-specific treatment adherence efforts.
Other groups have utilized SEM to investigate the impact of various ecological
factors (particularly poverty, SES, knowledge, and ethnic differences) on TB treatment
adherence in a variety of populations in the United States and abroad (Barr et al., 2001;
Harling et al., 2008; Hawker et al., 1999; Holtgrave & Crosby, 2004; Marx et al., 2007;
Tupasi et al., 2016). Murray et al. (2011) incorporated mathematical modeling with SEM
to further explore the dynamics associated with social, environmental and biological
determinants of TB in an effort to improve intervention strategies. Here, associations
between TB infection and smoking, indoor air pollution, alcohol use, diabetes, nutrition,
crowding, migration, aging, and economic trends were projected. Tupasi et al.’s study
conducted in the Philippines (2016) further supports some of these findings where
alcohol abuse was a significant limiting factor in MDR-TB treatment adherence.
However, none of these studies explicitly discuss any such factors in relation to an
Armenian population living either in the U.S. or in their native country. Findings from
this study reveal there are some significant differences in knowledge and compliance in
Armenian versus non-Armenian participants and therefore population-specific education
and treatment efforts may improve disease outcomes.
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Limitations of the Study
One limitation of the study was the population size surveyed for the quantitative
component. Prior to launching the online survey, an a priori power analysis was
conducted based on an effect size of 0.363, derived from relevant literature. From this, it
was estimated that 100 Armenians and 100 non-Armenians be surveyed to achieve
significant power. After eight months of purposive recruiting, 55 Armenians and 72 nonArmenians were enrolled and completed the survey. An additional three were eliminated
for living outside LA County and 14 more were lost to attrition and incomplete surveys,
most of which were Armenians who failed to respond to any questions relating to TB.
Challenges with recruiting were likely due to the vastness of LA County and difficulties
penetrating the Armenian community, despite providing all recruitment and survey
materials in Armenian. To address this limitation, a post-hoc power analysis using G*
Power 3 calculator software (version 3.1.4) and logistic regression test (α = 0.05, OR =
0.347 for “TB route of Transmission” as dependent variable with the weakest significant
p value, 0.05), was conducted and a satisfactory power analysis > 0.90 was attained.
Another limitation relates to instrumentation. An original survey and
questionnaire was generated to ensure cultural sensitivity and relevance to the Armenian
community. This presents some challenges because, as an original questionnaire,
assurances regarding its validity and cohesiveness may be lacking. Both were made
available in English and Armenian, with accuracy of translations for the Armenian
versions verified by an outside native Armenian speaker. A pilot study of the online
survey was performed to ensure questionnaire appeal, ease of comprehension, and
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comfort level within the online environment. The online environment for the quantitative
survey may limit those who participated as a result of electronic access; however, the
face-to-face nature of qualitative survey helps overcome this limitation. The online
environment also allowed for participants to conduct searches to answers prior to
responding, thereby biasing results; whereas the face-to-face interviews eliminate this
possibility but instead introduces the possibility of recall bias. This was particularly
evident with discrepant responses relating to TB transmission, where 63.6% of
respondents from the online survey believed it was through coughing or sneezing,
whereas the majority in the qualitative study had no idea.
Another specific limitation linked to instrumentation is data coding that occurred
post-data collection and pre-data analysis. Despite conducting pilot testing of the online
questionnaire prior to conducting the survey and checking the coded responses for errors
externally in SPSS following data collection, unanticipated problems during analysis
became evident. This is a consequence of the respondent’s potential to make multiple
selections or fill in responses for certain TB-specific questions, SQs 22, 34, 35, and 37.
As can be seen in Tables 9, 10, and 12, these key questions had an abundant number of
response combinations which complicated and convoluted the analysis. It is likely that
more factors may have been found to be significant when conducting bivariate and
multivariate analyses if only single answers were allowed and/or these questions were
broken up into multiple questions.
A final limitation of this study effects generalizability or transferability which is
attributed to ethnography. This study not only focuses on a particular population,
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Armenians, but is even more selective for those living in LA County. LA County houses
the second largest population of Armenians in the world, aside from Armenia itself (Hayk
the Ubiquitous Armenian, 2012), it is therefore believed that the study involved a
representative pool. However, the social and economic factors impacting the study may
not be generalizable to Armenians living in other parts of the country or world. This is
evident when comparing demographic characteristics of the Armenian to the nonArmenian population surveyed (Table 13, Appendix M). If this study is replicated or
expanded upon, it is recommended that alterations be made to account for populationspecific attributes, such as culture and demographics.
Recommendations for Future Research and Practice
This study fills the gap in understanding TB knowledge and barriers to treatmentseeking and adherence behaviors in an Armenian population living in LA County.
Although the data are limited, some significant discoveries were found and may therefore
be useful for implementing public health strategies specific for an Armenian community.
From both the quantitative and qualitative component of this study, it is evident that the
majority of Armenians trust their physician’s ability to effectively diagnose and treat
tuberculosis. Furthermore, upon diagnosis they would seek treatment immediately and
adhere to the treatment under a physician’s care. Therefore, it is very important to enroll
physicians and healthcare workers as stakeholders for information dissemination,
program planning, evaluation, and execution, particularly those practicing in
communities heavily populated by Armenians. Within this, the physicians and healthcare
workers will also stress the important of adherence and work with local spiritual leaders
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to reinforce this message since Armenians are reportedly spiritual individuals and seek
spiritual guidance along with physician care.
While physicians will be an important entity of an Armenian TB-specific public
health program, information dissemination prior to contraction of the disease is also
paramount so that disease symptoms can be identified earlier and transmission prevented
within the community. Data from this study suggests that Armenians have varying
avenues of knowledge relating to the disease from non-Armenians which can be
leveraged. Armenians stated that television and family and friends were their main source
of TB knowledge. Furthermore, the qualitative interviews revealed that the majority of
Armenians listens to, watches, and reads media that are on Armenian stations and in their
native language. Therefore, public service announcements should be developed in
Armenian, utilizing culture-specific elements, and disseminated using the aforementioned
media avenues detailing disease characteristics, transmission risks, and the benefits of
treatment adherence. Because Armenians also reportedly gain their knowledge from
family and friends, the dissemination of information gained from Armenian-specific
media may begin to snowball as more Armenians become informed and spread the
information to others. Armenians have tight familial bonds and are eager to help each
other; therefore the potential to spread the disease through inadequate care or incomplete
treatment can be leveraged through media, and further enforced through physicians and
local spiritual leaders.
While this study provides evidence for Armenian-specific public health efforts,
further research needs to be conducted in Armenian populations living in LA County,
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other parts of the United States, and worldwide in order to improve generalizability. Due
to increased access to the population of interest, studies conducted by medical facilities in
LA County, more specifically in SPA-2, would further enhance the scope and outreach
touched upon by this study, and would be beneficial in order to expand the knowledgebase. The expansion of such studies relating to this topic has potential public health
implications for TB, as well as other infectious diseases.
The ability to use data from this study and relate them back to TB case reporting
and incidence in LA County is a hurdle. Current TB case reporting in California is up to
date due to extensive reporting mandates. LA County is responsible for 30.5% of the
reported cases in California with 18% of these cases found in Glendale and surrounding
cities within SPA-2 (County of Los Angeles Public Health, 2015). The City of Glendale,
has experienced the largest influx of Armenians nation- and world-wide, making it the
second largest Armenian community on the planet, behind only Yerevan, Armenia While
the number of TB cases within SPA-2 has not been classified as Armenian or nonArmenian, the implication that many of these cases are attributed to Armenians is based
upon their prevalence in the community and disease incidence in their native country.
Therefore, in order to get a true assessment of TB cases attributed to Armenians, it is
recommended that a separate racial category for Armenians be included on medical forms
in the area as was done for the quantitative survey. This may facilitate improving disease
outcomes in Armenians by incorporating trends revealed by this study. Support for this is
demonstrated by a study conducted by Myers et al. (2006) which utilized SEM to explore
TB transmission in California. Using the U.S. Census data for California, ecological
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variables such as racial/ethnic distribution, immigration, education level, employment
status, poverty, and crowding were incorporated and related to new TB cases, using
pediatric cases as a measurement of transmission. Overall, lower median incomes,
racial/ethnic minorities, and immigrants were found to have higher rates of pediatric
tuberculosis.
Finally, for those conducting additional studies it is recommended that the TBspecific survey questions be simplified so that the respondents cannot select or write in
multiple responses. This became a limitation when analyzing the data. As evident in
Tables 9, 10, and 12, the ability to select multiple responses introduced many
combinations of possible answers, thereby convoluting results and revealing more factors
of significance, particularly when conducting bivariate and multivariate analyses.
Implications
Literature exploring TB is expansive and covers topics relating to disease
epidemiology, improved diagnostics, hurdles associated with drug resistance, problems
associated with adherence, and at-risk populations. The latter is more focused on general
susceptible populations (e.g., HIV positive, the incarcerated, homeless, immigrants, and
the poor) with little emphasis on specific cultures where family and traditions may have
profound influences on TB knowledge and treatment seeking and adherence behaviors.
Armenians are a susceptible population with strong family influences; however very few
studies have focused on this group living in their native country or those who have
immigrated to other countries. Therefore, this research fills the gap in understanding
treatment-seeking barriers in this susceptible population, with potential public health
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implications for other diseases in addition to TB. Implications for social change involve
decreasing TB prevalence in the Armenian population within the United States and
potentially within native Armenia through more effective disease management, resource
allocation, and patient care efforts.
The SEM incorporates key principles from community- and individual-based
approaches of prevention with an emphasis on the environment. Due to the uniqueness of
this study, it serves to impact TB disease management in the Armenian community
primarily at the first two or three levels: individual, interpersonal, and community. It can
serve as a foundation for future studies to eventually lead to customized social public
policy to effectively influence change in this at risk population.
Conclusion
TB is one of the world’s deadliest, yet curable, diseases, with an estimated 6.0
million new cases and 9.6 million total individuals who fell sick with the disease in 2014,
5.4 million of which were men, 3.2 million were women and 1.0 million were children. In
total, there were 1.5 million TB-associated deaths, ranking alongside HIV as the leading
cause of death worldwide, primarily afflicting those living in low and middle-income
countries (WHO, 2015). Armenia, in particular, is adversely affected by TB and
complications associated with the emergence of MDR-, XDR- and TDR-TB strains. The
WHO has designated Armenia as one of the 18 high priority countries for TB control
amongst the WHO’s European Region and the top 27 in MDR-TB burden countries in the
world (Hayrapetyan, 2012). The Armenian population in LA County, where TB
incidence is higher than national averages (CDC, 2013; County of Los Angeles Public
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Health, 2015), is the second largest Armenian community in the world, second only to
Yerevan (Hayk the Ubiquitous Armenian, 2012). Therefore, implications are that many
of the TB cases are attributed to Armenians living in the region of California.
Review of the literature and TB incidence and mortality reports suggests that
Armenians are a highly susceptible population due to high national incidence of MDRTB, inadequate health care, poor disease surveillance, poor disease education, poverty,
and emigration/immigration (Bakalian, 2011; Hayrapetyan, 2012; Truzyan et al., 2015;
Vink et al., 2005); however, very few epidemiological or prevention studies have been
dedicated to this group living either in Armenia or the United States. To the best of my
knowledge, none of the studies conducted focus on Armenians residing in the United
States where knowledge regarding access to health care, particularly relative to TB, may
be lacking. Therefore, this study filled the gap in the literature for this underserved, atrisk population.
Using a concurrent mixed-methods study including surveys (quantitative) and indepth interviews (qualitative), Armenians and non-Armenians living in LA County were
interviewed to gain a better understanding regarding TB knowledge and barriers to
treatment. An understanding of differences in physical, psychosocial, cultural, or
behavioral factors and beliefs may impact TB knowledge, treatment seeking and
treatment adherence in Armenians living in LA County from non-Armenian populations,
potentially influencing public health approaches to effectively treating and decreasing TB
incidence in this population. For the quantitative component of the study, bivariate chisquare analysis revealed that factors with the greatest significance and strength relate to
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how the two populations learned about the disease and how compliant with a doctor’s
instructions participants would be if diagnosed, resulting in an effect size of 0.434.
Multivariate multinomial logistic regression analysis revealed predictor factors such as
classification, the use of home remedies, age, education, and English as the primary
household language to be significant.
The qualitative component of the study further corroborated many of the findings
from the quantitative component where, although the populations were aware that TB
exists, knowledge relating to TB mode of transmission, global incidence, and treatment
properties (e.g., duration, effectiveness, and specific types) was generally lacking. One
major reported difference between populations was that the Armenian population was far
more eager to help others and urge them to seek treatment upon receiving a positive
diagnosis, whereas non-Armenians express the lack of willingness to physically assist
patients. This is also counter to a study conducted by Ige and Lasebikan (2011) in a nonArmenian population where family members of patients reported increased depression
and helplessness. In this study, the culturally-based inquiry regarding the presence of
kapoot ach in their residence revealed all of the Armenian participants had at least one.
Such a trend may be useful when developing TB awareness and treatment programs for
this at-risk group.
This study serves as the first step in understanding perceived barriers to TB
treatment-seeking and treatment adherence in Armenians living in LA County, with the
goal of positively impacting TB patient outcomes through improved, population-specific
public health efforts. Implications for positive social change include evidence to inform
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more effective disease management, resource allocation, and patient care efforts to help
decrease TB prevalence in the Armenian population within the United States and
potentially native Armenia. Regardless of location, this will rely on the involvement of
Armenian stakeholders including physicians and healthcare workers, spiritual leaders,
and Armenian media sources to disseminate ethnically-sensitive information within the
community.
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Appendix B: Qualitative Interview Guide, Armenian translation

Հիմնական պատմական տեղեկութիւններ — Հայ Մասնակցողներ
1. Դուք Հայաստանե՞ն գաղթած էք։
ա.
բ.

Որք՞ան ժամանակէ կ՝ապրիք Ամէրիկայի Միացեալ Նահանգներ։
Ներկայիս ո՞րմէկ քաղաքը կ՝ապրիք։

2. Հայերեն գրել ու կարդալ գիտէ՞ք։ Որ՞քան լաւ։
3. Ձեր տան մէջ հայերէն կը խօսի՞ք։
ա.

Որ՞քան հաճախ։

4. Դուք Հայերեն գրականութիւններ կը կարդա՞ք։ Հայկական հեռուստահաղորդումներ կը
դիտէ՞ք « օրինակ Հայկական Դելեթայմ» կամ հայկական ռատիոժամ մտիկ կ՝ընէ՞ք։
ա.

Եթէ այո, որ՞մէկը եւ ո՞րքան յաճախ։

5. Դուք կը նախընտր՞էք հովանավորել գործի հաստատութիւններ, կամ բնտրել
մասնագիտական օգնութիուններ «օրինակ, բժշկական սպասարկութիւններ» մասնաւոր
հայերու համար?
6. Կը մասնակցի՞ք համայնքային գործունէութեան կամ կազմակէրպութեան «օրինակ։
Հայկական Եկեղէցի, Արարատ Տուն, Մասիս Կիլտ» Որ՞մէկը
7. Ձեր ընտանիքին մէջ կապույտ աչքեր ունեցող կ՞այ

Ընդհանուր պատմական հարցարան
1. Ո՞ր Տարին ծնած ես։
2. Ի՞նչ է քու ամուսնական վիճակդ։
3. Հաճիս նկարագրէ բնակավայրդ։
ա.

Անձնակ՞ան Է Թէ վարցու։

4. Քա՞նի անձ կը բնակի ձեր տան մէջ
ա.

Հաճիս նկարագր՝է հարաբերութիունը, սեռը, իւրաքանչիւրին տարիքը։

5. Ին՞չ են ձեր ամենաբարձր ուսման մակարդակը։
6. Ին՞չ գործով կ՝զբաղիք։
7. Ին՞չքան է ձեր տարեկան եկամուտը «առանձ տուրքի»։
8. Բժշկական ապահովագրութիւն ուն՞իք։

174
9. Տարին քա՞նի անգամ կ՛այցելէք ձեր տեղական բժիշկին։
ա.

Դուք կը վստահի՞ք ձեր բժիշկին ։

10. Եթէ դուք կամ ընտանիքի անդամներէն կամ ընկերներէն մէկը ախտորոշել է ոեւէ

մէկ

տեսակի հիւանդուդութեան, կը դիմ՞էք հոգեւոր առաջնորդութեան?
11. Եէթէ

հիւանդ

զգակ,

կը

նախնտր՞էք

տնային

միջոցներ

օգտագործել,

«օրինակ

մերսումներ, խոտաբույսեր, բուսական կամ համեմուած թեյեր» Ո՞րմէկը։
ա.

Եթէ այո՝, կը նախնտր՞էք տնային բուսական միջոցները փռրձել նախքան բժիշկի

դիմելը։
բ.

Եթէ նույնիսկ բժիշկի երթաք կը շարունակէ՞ք տնային միջոցները օգտագործել

միեւնոյն ժամանակ։

Թռքախտի «TB» ճշգրիտ հարցեր
1. Դուք ծանօ՞թ եք Թոքախտի հիւանդութեան։
ա.

Եթէ այո, ին՞չ գիտէք թոքախտի մասին, եւ ին՞չ միջոցով կը փոխանձուի։

բ.

Թոքախտը փոխանձ՞իք է։ Նկարագրէ՝։

2. Տեղեկացած է՞ք վերջին լուրերը թոքախտի վերաբերեալ։
ա.

Ամէրիկայի միեացեալ նահանգներու մէջ։

բ.

Տարբեր երկիրներու մէջ։ Ո՞րմէկը։

3. Բուժել՞ի է Թոքախտի հիւանդութիւնը։
ա.

Ին՞չ գիտէք բուժումի մասին։

բ.

Կը կարծէ՞ք մարդիկ հաւատարմութեամբ կը բուժուին թէ ոչ սպառնալիքով։

4. Եթէ Թոքախտի մասին նշուի ձեր ընտանիքէն, ընկերներէն, կամ ալ տեղեկութիւններէն
մէկուն, ին՞չ կ՛ըլլայ ձեր նախնական արձագանքը եւ զգացմունքները հիւանդութեան
նկատմամբ։
5. Ե՞թէ Թոքախտ էք կամ այդ հիւանդութիւնը ունեցա՛ծ էք անցեալին։ ի՞նչ կ՛զգաք։
6. Եթ՞է ոեւէ մէկը ձէր ընտանիքի անդամներէն, ընկերներէն կամ գործնկերներէն մէկը
թոխախտ ըլլայ, Ի՞նչ պիտի ըլլայ ձեր զգաձմունքնէրը այդ իրադարձութեան նկատմամբ։
7. Ձէր ընտանիքէն ոեւէ մէկը Թոքախտի հիւանթութիուն ուն՞ի։ Եթէ այո, ձեր վերաբէրմունքը
կը փոխ՞ուի անձին հանդէպ։
ա.

Նկարագրէ՝ ունեցած սգացումներդ անձին հանդէպ իր ախտաճանաչումէն ետք։
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8. Արդե՞օք տեղեակ էք Լոս Անճելոսի մէջ գտնուող Թոքախտանոցներու եւ կամ բուժող
ծառայութիուններու մասին։
ա.

Եթէ ոչ, ուրեմըն եթէ տեղեկութիուններ կարելի ըլլան, «թերեվս հայերենով, միայն

հայերու համար» կ՚ուզէ՞ք հետազոտել կարդալով հիւանդութեան մասին եւ բաժնեկցիլ
ուրիշներու հետ ձեր գաղութէն ներս։
9. Դուք տեղեակ է՞ք ոեւէ համայնքային աջակցութեան խումբերէն որոնք կ՚զբաղուին
Թոքախտի հիւանդութեան առնջութեամբ?
ա.

Եթէ այո, նկարագրէ՝։
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Appendix C: Quantitative Survey, Armenian translation

Հիմնական տեղեկութիուններ
1.

2.

Քա՞նի տարեկան էք։
ա.

18-20

բ.

21-30

գ.

31-40

ե.

51-60

զ.

61-70

է.

70 եւ աւելի

Իգական

բ.

Առական

Սեռ
ա.

3.

4.

դ.

Ո՞ր ցեղի կը պատկանիս։
ա.

ճերմակ, Ոչ-Սպանախոս կամ Լադին

բ ճերմակ, Հայեր

գ.

ճերմակ, Սպանացի կամ Լադին

դ.Սեւ, Աֆրիկեան Ամերիկացի

ե.

Ասիացի

զ.

Ամերիկացի Հնդիկ/Բնիկ Ալասքացի

է.

Բնիկ Հավայացի կամ խաղաղ Ովկիանոսցի

ը.

Երկու կամ աւելի ցեղեր, Հայեր

թ. Երկու կամ աւելի ցեղեր, Ոչ-Հայեր

Ին՞չ էք ծագումով
ա.

Ոչ- Սպանացի, Լադին, կամ Սպանացի ծագումով

բ.

Մեքսիքացի, Մեքսիքացի-Ամերիկացի, չիքանօ

դ.

Գուպացի

գ.

Բորդորիքացի

ե. Տարբեր Սպանացի, Լադին, կամ Սպանացի ծագումով օրինակ ( Արժանթինցի,
Գոլոմպիացի, Տոմինիքացի, Սալվատորցի).
5.

Որ երկիրէն էք ծագումով (լեցուցէք խնդրեմ) ____________________

6.

Քան՞ի տարի է կ՛ապրիք Ամէրիկայի Միացեալ Նահանքները։

7.

ա.

1 տարիէն պակաս

գ.

6-10 տարիներ

ե.

20 եւ աւելի տարիներ

բ.
դ.

1-5 տարիներ

11-20 տարիներ

ներկայիս որմէ՞կ քաղաքը կ՛ապրիք։
ա.

Կլէնտել

գ.

Պըրպէնք

բ.
դ.

Բասատենա/Հարաւային Բասատենա

Սան Ֆէրնանտօ

ե.

Սանդա Մոնիքա/

41-50
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Արեւմտեան Լոս Անճելոս

զ.

Տաունի / Մոնթեպէլլօ / Սաութ կէյդ

է.

Ուրիշ_______
8.

9.

ին՞չ է ձեր ամուսնական կարգավիճակը։
ա.

Միայնակ, չ՛ամուսնացած

դ.

Այրիացած

ե.

բ.

Ամուսնացած

գ.

Բաժնուած

Զատուած, Մեկուսացած

Ձեզմէ զատ քա՞նի հոգի կ՛ապրի ձեր տան մէջ։
ա.

0

բ.

1

գ.

դ.

5-6

ե.

6 եւ աւելի

2-4

10. Նկարագրէ՛ իրենց հարաբերութիւնները ձեր նկատմամբ։ «ընտրել»

11.

ա.

Ամուսինը

դ.

Տարեց ծնողներ կամ մեծ հայր եւ մեծ մայր

14.

15.

16.

Եղբայր/Քոյր

ե.

Ուրիշ___________

Այո

բ.

Ոչ

Հայերէն

բ.

Սպաներէն

գ. Ոչ

դ.Ուրիշ _________

Ին՞չ են ձեր ուսման ամենաբարձր կրթութիունը։
ա.

Երկրորդական

դ.

Միջին Մասնագիտութիուն / Մասնագիտական կրթութիուն

բ.

Քոլէճ

գ.

Բակալաւրի աստիճան

Ին՞չ գործով կ՛զբաղուիք։
ա.

Անգործ

դ.

Ուսանող

զ.

Բանւոր «հմուտ կամ ոչ հմուտ աշխատող»

բ.

Թոշակառու
ե.

գ.

Պահող

Մասնագիտական «բժիշկ, իրաւաբան, ուսուցիչ»

Որ՞ն է ձեր ընդհանուր տարեկան եկամուտը։ «նախատուրք»
ա.

0-$25,000

բ.

$25,000-40,000

գ.

$40,000-60,000

դ.

$60,001-80,000

ե.

$80,001-100,000

զ.

$100,000 եւ աւելի

Բժշկական ապահուագրութիւն ունի՞ք։
ա.

17.

գ.

Ուրիշ լեզուներ կը խօսի՞ք ձեր տան մէջ։
ա.

13.

Երեխաները

Ձեր ընտանիքին հիմնական լեզուն Անգլեր՞էն է։
ա.

12.

բ.

Այո

բ.

Ոչ

Կը վստահի՞ք ձեր առաջնային խնամքի բժիշկին։
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ա.
18.

Այո

բ.

Ոչ

գ. Գաղաբար չունիմ

Եթէ դուք կամ ձեր ընտանիքի անդամներէն եւ ընկերներէն մէկը հիւանդանա, կը դիմէ՞ք

հոգեւոր առաջնորդութեան։
ա.
19.

Այո

բ.

Ոչ

Եթէ հիւանդանաք, կը նախնտր՞էք տնային միջոցներ օգտագործել։ Օրինակ «մրսումներ,

խոտաբույսեր, բուսական կամ համեմուած թէեէր»
ա.

Այո

բ.

Ոչ

Թոքախտի (TUBERCULOSIS) ճշգրիտ հարցեր
1. Լսա՞ծ էք Թոքախտի հիւանդութեան մասին։
ա.

Այո

բ.

Ոչ

2. Ին՞չպէս լսած էք Թոքախտի մասին։ «ընտրէ»
ա.

Հեռոստատեսիլ

բ.

Համաձանձ

դ.

Ընտանիքի անդամներէն կամ բարեկամներէն

գ.
ե.

Օրաթերթ

Ուրիշ_________

3. Կը հաւատա՞ք որ Թոքախտը ժամանակակից օրուա առողջապահական խնդիր է Ամէրիկայի
Միացեալ Նահանքներու մէջ։
ա.

Այո

բ.

Ոչ

4. Կը հաւատ՞աք որ Թոքախտը ժամանակակից օրուա առողջապահական խնդիր է
միջազգայինօրէն։
ա.

Այո

բ.

Ոչ

5. Ին՞չպէս Թոքախտի հիւանդութիւնը կը փոխանձուի։
ա.

Հազալով

բ.

Փռնգտալով

գ.

դ.

Սերական կապով

ե.

Կրդութիուն / ջուր կուլ տալով

զ.

Անհաւասարակշրութիւն տաքի եւ պաղի

Շոշափելով

է.

Չենք գիտեր

փռնգտալը

գ.

Ախորժակի կորուստ

Արիւնահոսութիուն

զ.

Չենք գիտեր

6. Ի՞նչ են Թոքախտի ընդհանուր ախտանիշը։
ա.

հազալը

բ.

դ

Յոգնածութիուն ե.

7. Դուք գիտ՞էք թէ մատչելի բուժումներ կան Թոքախտի հիւանդութիւնը բուժելու։
ա.

Այո

8. Որ՞քան է բուժման տեւողութիւնը։

բ.

Ոչ
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ա.

3 օր

բ.

7 օր

դ.

6 ամիսէն աւելի ե.

Չենք գիտեր

գ.

Մէկ ամիս

գ.

Չենք գիտեր

9. Թոքախտի բուժման հարիւր տոկոս արդիւնաւ՞էր է։
ա.

Այո

բ.

Ոչ

բ.

Ոչ

10. Թոքախտը բուժել՞ի հիւանդութիւն է։
ա.

Այո

գ.

Չենք գիտեր

11. Եթէ Թոքախտի մասին խօսուի ընտանիքիդ կամ ընկերներուդ միչեւ եւ կամ ալ լուրերու
ընթաձքին, ի՞նչ կ՛ըլլայ ձեր նախնական ցուցմունքները եւ զգացումները։
ա.

Վախցած

դ.

Անոգնական

բ.

Տեղեկացած

գ.

Անտարբեր

12. Դուք կամ ոեւէ մէկը ձեր ընտանիքէն ունեցա՞ծ է Թոքախտի ախտաճանաչում։
ա.

Այո

բ.

Ոչ

13. եթէ այո, ին՞չ զգացիք։ «ընտրել»
ա.

Վախցած

բ.

Տեղեկացած

դ.

Անօգնական

ե.

Ճնշուած

գ.

Անտարբեր

14. ին՞չ պատճառներ կրնան գործակից ըլլալ Թոքախտի հիւանդութեան հետ։ «ընտրէ»
ա.

Աղքատութիւն

բ.

Արտաքին ծնունդ

գ.

Միավ կարգավիճակը

դ.

Թմրադեղերի պատ պատմութիւն

ե.

Ցած հասարակական կարգ

զ.

Սէռական կողմնորոշում

է.

Հոգեկան հիւանդութիւն

ը.

Կրօնք

ժ.

Տարածուած հիւանդութիւն

լ.

Անհաւասարակշրութիւն տաքի եւ պաղի մ. ազատազրկման

ի.

թ.

Ծխել

Բուժելի հիւանդութիւն

15. Եթէ ոեւէ մէկը Թոքախտի հիւանդութիւն ունի կը կարծէ՞ք թէ «ընտրէ»
ա.

Ան հաւանաբար սխալ բան մը ըրած է, օրինակ դեղերու օգտագործում

բ.

Աստուծոյ կողմէն պատիժ

գ.

Ան հիւանդութիւնը ունի ցեղային հետին պատճառով

դ.

Կրնայ ոեւէ մէկուն պատահիլ
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Համաձայն չեմ

Գաղաբար
չունիմ

Համաձայն եմ

Ամբողջութեա
մբ համաձայն
եմ

Եթէ դուք Թոքախտի
հիւանդութիւն ունիք,

Բնաւ
համաձայն

16.

1

2

3

4

5

Կը վստահի՞ք ձեր բժիշկին՞
Բուժման վերաբերեալ կը
համապատասխանէք
բժիշկներուն հրահանքներուն
Կը նախնտրէ՞ք բուժուիլ
հիւանդանոցէն դուրս,
անձնական բուժարաննէրու
մէջ. Ընտրել վարի
ցուցակէն։

17. Եթէ կը նախնտրէք բուժուիլ անձնական բուժարաններու մէջ, ու՞ր կը դիմէք։ Ընտրել
ցանկացածը «ընտրէ»
ա.

քայրոբրէքթըր

բ.

Աքուփանքչըր

գ.

Հոմոբադիք

դ.

Բժիշկ/սննդաբան

ե.

Կրօնական/եկեղեցական առաջնորդ

զ.

Կենցաղային միջոցներ, օրինակ «դեղաբոյսեր, թեէր, եիւղեր»

զ.

Ոչ մէկը

18. Դուք տե՞ղեակ էք Թոքախտի բուժարաններու եւ մատուցուած ծարայութիւններու մասին Լոս
Անճելոսի շրջանին մէջ։
ա.
19.

Այո

բ.

Ոչ

Եթէ ոչ, եւ եթէ տեղեկութիւնները մատչելի են, կը նախնտր՞էք աւելի հետազոտել եւ
կարդալ այդ հիւանդութեան մասին եւ տեղեկացնել ուրիշներուն ձեր համայնքէն ներս։
ա.

20.

Այո

բ.

Ոչ

Դուք տե՞ղեակ էք հասարակական աջակցութեան խումբերու մասին որ կը զբաղուի այս

հիւանդութեամբ ձեր համայնքէն ներս։
ա.

Այո

բ.

ոչ
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Appendix D: Informed Consent Form (Qualitative)
Informed Consent Form
Title of Project: Differences in treatment seeking and treatment adherence factors for
tuberculosis in Armenian versus non-Armenian populations of Los Angeles County
Name of Researcher: Tanya M Ferguson
You are invited to take part in a research study regarding tuberculosis knowledge and
perceptions. The researcher is inviting Armenians and non-Armenians who reside in Los
Angeles County to be in the study. This form is part of a process called “informed
consent” to allow you to understand this study before deciding whether to take part.
This study is being conducted by a researcher named Tanya M. Ferguson, who is a
doctoral student at Walden University.
Background Information:
The purpose of this study is to explore current knowledge and perceptions relating to
tuberculosis, including the required course of treatment for disease cure.
Procedures:
If you agree to be in this study, you will be asked to:
• Participate in an-depth face-to-face interview, roughly 60 minutes in length.
Interviews will be recorded for accuracy purposes.
• Your involvement will only require one interview; however, if there any answers
that require clarification by the researcher, the researcher reserves the right to
contact you by phone.
Here are some sample questions:
1.
Are you familiar with the disease, tuberculosis (TB)?
a. If yes, please describe what you know about it, including modes of
transmission.
2.
Is TB infectious to others? Please describe.
3.
Is TB a treatable disease?
a. What do you know about the treatment?
b. Are any of these factors a deterrent for seeking or adhering to treatment?
Which ones?
4.
If TB is mentioned by family, friends, or news reports, what are your initial
reactions and feelings?
Voluntary Nature of the Study:
This study is voluntary. Everyone will respect your decision of whether or not you
choose to be in the study. No one will treat you differently if you decide not to be in the
study. If you decide to join the study now, you can still change your mind later. You may
stop at any time.
Risks and Benefits of Being in the Study:
Being in this type of study involves some risk of the minor discomforts that can be
encountered in daily life, such as stress. Being in this study would not pose risk to your
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safety or wellbeing. However, if you are dealing any kind of problem regarding this
research please call the toll free, 24-hour hotline of the Centers for Diseases Control and
Prevention Lifeline at 1-800-273-TALK (1-800-273-8255); TTY: 1-800-799-4TTY
(4889) to talk to a trained counselor.
The goal of this study is learn more knowledge and perceptions relating to tuberculosis
and tuberculosis treatment in Armenian and non-Armenian populations living in LA
County. Tuberculosis has great public health implications. A better understanding of key
factors that may serve as barriers will improve patient management and disease
outcomes.
Payment:
As gratitude for your participation, participants will receive a one-time $10 prepaid gift
card which will be presented at the termination of the interview.
Privacy:
Any information you provide will be kept confidential. The researcher will not use your
personal information for any purposes outside of this research project. Also, the
researcher will not include your name or anything else that could identify you in the
study reports.
Contacts and Questions:
You may ask any questions you have now. If you have questions later, you may contact
the researcher via cell phone at xxx-xxx-xxxx or email to xxxxxxxxxxx. If you want to
talk privately about your rights as a participant, you can call Dr. Leilani Endicott who is
the Walden University representative and is available to discuss this with you. Her phone
number is xxx-xxx-xxxx. Walden University’s approval number for this study is 04-2414-0230517 and it expires on 04-2015.
The researcher will provide you with a copy of this signed consent form to keep as a
record of your participation in the interview.
Statement of Consent:
I have read the above information and I feel I understand the study well enough to make a
decision about my involvement. By signing below, I understand that I am agreeing to the
terms described above.
Printed Name of Participant
Date of consent
Participant’s Signature
Researcher’s Signature
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Appendix E: Informed Consent Form (Qualitative, Armenian translation)
Տեղեկացուած համաձայնութեան ձեւ
Վերնագիր Ծրագրի։

Տարբերութիւնները բուժման նպատակին եւ բուժման պահպանման

գործոնները Թոքախտի հիւանդութեան ընդեմ ոչ հայ բնակչութեան Լոս Անճելոսի շրջանին.
Հետազոտողի Անունը։ Դանիա Մ. Ֆըրկըսըն
Դուք հրաւիրուած էք մասնակցելու հետազոտական ուսումնասիրութեան վերաբերեալ Թոքախտի
(tuberculosis) գիտելիքներու եւ պատկերացումներու։
Հետազոտ Tanya M. Ferguson կը հրաւիրէ բոլոր հայերը եւ ոչ հայերը որոնք կը բնակին Լոս
Անճելոս քաղաքի մէջ որպէսզի մասնակցին Թոքախտի ուսումնասիրութեան. Այս ձեւը գործընթացքի
մէկ մասն է որ կը կ՛ոչուի «Տեղեկացուած Համաձայնութիւն» որ թոյլ կ՛ուտայ հասկնալու այս
ուսումնասիրութեան նախքան որոշում առնելը մասնակցելու կամ ոչ։
Այս ուսումնասիրութիւնը իրականացուած է հետազոտող Դանիա Մ. Ֆըրկըսընի կողմէն
Տոքթորական գիտական ուսանող Ուալտըն (Walden) համալսարանի մէջ։
Ընդհանուր Տեղեկութիւններ
Նպատակը այս ուսումնասիրութեան հետազոտել ներկայիս գիտելիքներն ու ընկալումը
վերաբերուած Թոքախտի հիւանդութեան ինչպէս նաեւ անհրաժեշտութեան պարաքային պէտք եղած
լուծումը։
Ընթացքներ
Եթէ դուք համաձայն էք մասնակցելու այս ուսումնասիրութեան, ձեզմէ պիտի պահանջուի
•

Մասնակցիլ դէմ առ դէմ հարցազրոյցի 60է վայրկեան տեւողութեամբ։ Հարցազրոյցները
կ՛արձանագրուի ճշտութեան նպատակով։

•

Ձեր մասնակցութիւնը կը պահանջէ միայն մէկ անգամ հարցազրուցել բայց եթէ ոեւէ հարցում
պէտք է որ պարզաբանել, հէտազոտողը իրավունք ունի ձեզ հետ հեռախօսով կապ պահել
յստակացնելու համար։

Այստեղ կը գտնէք նման հարցումներ։
1. Դուք ծանօթ է՞ք Թոքախտի հիւանդութեան։
ա. Եթէ այո, հաճիս նկարագրէ՝ ինչ որ գիտես անոր մասին ինչպէս նաեւ եղանակի
փոխանձման։
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2. Թոքախտը փոխանձ՞իկ հիւանդութիւն է։ Բացատրէ։
3. Թոքախտը բուժե՞լի հիւանդութիւն է։
ա.

Ի՞նչ գիտէք բուժման մասին։

բ.

Ոեւէ մէկը կա՞յ այդ գործոններէն որ սպարնալիքով զսպման կը փնտռէն կամ

հաւատարմօրէն բուժման? Որ գործոնները։
4. Եթէ Թոքախտի մասին նշուի ձեր ընտանիքէն, ընկերներէն, կամ այլ տեղեկութիւններէն,
ին՞չ կ՛ըլլայ ձեր նախնական արձագանքը եւ զգացումները։
Կամաւոր Բնոյթը Ուսումնասիրութեան
Այս ուսումնասիրութիւնը կամաւոր է։ Իւրաքանչիւրին անձ պիտի յարգէ ձեր որոշումը, եթէ
մասնակցիք կամ ոչ, տարբեր վարւելակերպ պիտի չ՛ունենաք, իսկ եթէ որոշէք մասնակցիլ նոյնպէս
կրնաք միշտ փոխել ձեր միտքը եւ չի շարունակել այս ուսումնասիրութեան։
Վտանքները եւ Օգուտները Ուսումնասիրութեան Մասնակցելու
Այս տեսակի ուսումնասիրութեան մասնակցիլը կը վտանգէ յառաջացնելով մանր
անհանգստութիւններ առօրեայ կեանքէն ներս. Օրինակ ջղային դրութիւններ բայց չի վտանգեր ձեր
ապահովութիւնը եւ կամ բարեկեցութիւնը։
Այսուամէնայնիւ եթէ ոեւէ մէկ հարց կամ խնդիր ունենաք այս հետազոտութեան առնչութեամբ, կը
խնդրենք հեռաձայնել 24 ժամ ձրի թիւով հիւանդութիւնները վերահսկողութեան եւ
կենսապահովման կանխարգիլման կեդրոնը, թիւն է 1-800-273-8255, իսկ լսել անկարողներու
համար թիւն է 1-800-799-4889։ Միշտ պիտի կրնաք խօսիլ մարզուած խորհրդատուի հետ։
Այս ուսումնասիրութեան նպատակն է գտնել եւ սորվիլ աւելի շատ գիտելիգներ եւ
պատկերացումներ Թոքախտի առնջութեամբ եւ անոր բուժմանը հայերու կամ ոչ հայերու գտնուող
Լոս Անճելոսի շրջանին մէջ։
Թոքախտի հիւանդութիւնը (Tuberculosis) ունի մեծ նշանակութիւն եւ առողջապահական
հետեւանքներ։ Աւելի լաւ հասկնալու ենք հիմնական գործոննէրուն որոնք կը ծարայէն հիւանդին
խոչնդոտները բարելաւելով ինչպէս նաեւ կարավարման եւ ելք գտնելու հիւանդութեան։
Վճարում
Որպէս երախտագիտութիւն, մասնակցողները մասնակցելու համար կ՛ստանան մէկ անգամ $10
Ամէրիկեան տոլար իբրեւ նուէր գարդով որ կը տրուի հարցազրոյցը աւարտելէն ետք։
Մենութիւն / Գաղտնութեան պահպանման
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Ոեւէ մէկ տեղեկութիւն գաղտնի կը պահուին, հետազոտիչը չ՛օգտագործեր ձեր անձնական
տեղեկութիւնը նպատակէն դուրս. Նաեւ հետազոտողը չի պարունակեր ձեր անունը կամ
ինքնութիւնը ուսումնասիրութեան հաղորդումներէն։
Կապեր եւ հարցումներ
Եթէ ոեւէ մէկ հարցում ունիք, կրնաք հիմա հարցնել։ Հետաքային եթէ հարցեր ունենաք, կրնաք
հետազոտին հասնիլ հեռաձայնելով xxxxxxxxxxxxx կամ գրել հետեւեալ հասցէով
xxxxxxxxxxxxxxxx եթէ ուզէք անձամբ խօսիլ ձեր մասնակցողական իրաւունքի մասին դուք կրնաք

հեռաձայնել Dr. Leilan Edincott որ ինք Walden համալսարանի ներկայացուցիչն է, եւ միշտ
պատրաստ է լսել ձեզ։ Իր հերախօսի թիւն է xxxxxxxxxxxxxxxxxxx։ Walden համալսարանի
ուսումնասիրութեան հաստատումի թիւն է, 04-24-14-0230517 կ՛աւարտի 04-2015 թուին.
Հետազոտողը ձեզի պիտի տրամադրէ կրկնօրինակ մը ստորագրուած համաձայնութեան ձեւէն ձեր
մօտ ունենալու և պահպանելու ձեր հարցազրույցի մասնակցութեան բանաձեւը։
Համաձայնութեան Հաշուետուութիւն
Ես կարդացի վերի գրուած տեղեկութիւնները, գիտակցելով պարունակութեան կրնամ որոշում առնել
իմ ներգրաւածութեանս մասին. Ստորագրելով ստորեւ, ես կը համաձայնիմ պայմաններուն ինչպէս
որ նկարագրուած է վերի գրութեան մէջ։
Տպագիր։ Անունը Մասնակիցի։
Թուականը Համաձայնութեան։
Մասնակիցի Ստորագրութիւնը։
Հետազոտի Ստորագրութիւնը։
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Appendix F: Informed Consent Form (Quantitative)
Informed Consent Form
Title of Project: Differences in treatment seeking and treatment adherence factors for
tuberculosis in Armenian versus non-Armenian populations of Los Angeles County
Name of Researcher: Tanya M Ferguson
You are invited to take part in a research study regarding tuberculosis knowledge and
perceptions. The researcher is inviting Armenians and non-Armenians who reside in Los
Angeles County to be in the study. This form is part of a process called “informed
consent” to allow you to understand this study before deciding whether to take part.
This study is being conducted by a researcher named Tanya M. Ferguson, who is a
doctoral student at Walden University.
Background Information:
The purpose of this study is to explore current knowledge and perceptions relating to
tuberculosis, including the required course of treatment for disease cure.
Procedures:
If you agree to be in this study, you will be asked to:
• Participate in an online survey, roughly 15 to 20 minutes in length.
Here are some sample questions:
1.
Have you heard of the disease tuberculosis (TB)? A. yes, b. no
2.
How have you heard about TB:
a. TV, b. Internet, c. family or friends, d. newspaper/magazine e. other
3.
Do you believe that TB is a modern day health problem in the US? a. yes, b. no
4.
Do you believe that TB is a modern day health problem internationally? a. yes,
b. no
5.
How is TB transmitted?
a. Coughing, sneezing, b. touching, c. sexual contact, d. food/water ingestion, e.
don’t know
Voluntary Nature of the Study:
This study is voluntary. Everyone will respect your decision of whether or not you
choose to be in the study. No one will treat you differently if you decide not to be in the
study. If you decide to join the study now, you can still change your mind later. You may
stop at any time.
Risks and Benefits of Being in the Study:
Being in this type of study involves some risk of the minor discomforts that can be
encountered in daily life, such as stress. Being in this study would not pose risk to your
safety or wellbeing. However, if you are dealing any kind of problem regarding this
research please call the toll free, 24-hour hotline of the Centers for Diseases Control and
Prevention Lifeline at 1-800-273-TALK (1-800-273-8255); TTY: 1-800-799-4TTY
(4889) to talk to a trained counselor.
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The goal of this study is learn more knowledge and perceptions relating to tuberculosis
and tuberculosis treatment in Armenian and non-Armenian populations living in LA
County. Tuberculosis has great public health implications. A better understanding of key
factors that may serve as barriers will improve patient management and disease
outcomes.
Payment: None.
Privacy:
Any information you provide will be kept confidential. The researcher will not use your
personal information for any purposes outside of this research project. Also, the
researcher will not include your name or anything else that could identify you in the
study reports.
Contacts and Questions:
You may ask any questions you have now. If you have questions later, you may contact
the researcher via cell phone xxx-xxx-xxxx or email to xxxxxxxxxxxx. If you want to
talk privately about your rights as a participant, you can call Dr. Leilani Endicott who is
the Walden University representative and is available to discuss this with you. Her phone
number is xxx-xxx-xxxx. Walden University’s approval number for this study is 04-2414-0230517and it expires on 04-2015.
Please print or save this consent form as a record of your participation in the survey.
Statement of Consent:
I have read the above information and I feel I understand the study well enough to make a
decision about my involvement. By completing the survey, I understand that I am
agreeing to the terms described above.
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Appendix G: Informed Consent Form (Quantitative, Armenian Translation)
Տեղեկացուած Համաձայնութեան ձեւ
Վերնագիր Ծրագրի։ Տարբերութիւնները բուժման նպատակինեւ բուժման պահպանման Թոքախտի
հիւանդութեան հայերու մէջ ընդեմ ոչ հայ բնակչութեան Լոս Անճելոսի շրջանին մէջ։
Հետազոտի անունը Tanya M. Ferguson
Դուք հրաւիրուած էք մասնակցելու Թոքախտի (tuberculosis) հետազոտական
ուսումնասիրութեան վերաբերեալ գիտելիքներու եւ պատկերացումներու։ Հետազոտողը կը հրաւիրէ
հայերը որոնք կը բնակին Լոս Անճելոսի շրջանին մէջ որպէսզի մասնակցին ուսումնասիրութեան
հետազոտութեան։ Այս ձեւը մէկ մասն է գործընթացքի որ կը կ՛ոչուի «Տեղեկացուած
Համաձայնութիւն» որ թոյլ կ՛ուտայ հասկնալու սոյն ուսումնասիրութիւնը նախքան մասնակիցին
մասնակցելու որոշում առնելը։
Այս ուսումնասիրութիւնը իրականացուած է հետազոտ Դանիա Մ. Ֆըրկըսընի (Tanya M.
Ferguson) կողմէն Բժշկական Գիտական Ուսանող Walden Համալսարանի մէջ։
Ընդհանուր Տեղեկութիւններ
Նպատակը այս ուսումնասիրութեան հետազոտել ներկայիս գիտելիքներն ու ընկալումը
վերաբերուած Թոքախտի հիւանդութեան ինչպէս նաեւ անհրաժեշտութեան պարաքային պէտք եղած
բուժումը։
Ընթացքներ
Եթէ դուք համաձայն էք մասնակցելու այս ուսումնասիրութեան, ձեզմէ պիտի պահանչուի
•

Մասնակցիլ համաձանձի միջոցով։ Հետազոտութիւնը կը տեւէ մօտաւորապէս 15-20
վայրկեան։

Այստեղ կը գտնէք նման հարցումներ
1. Դուք ծանօթ է՞ք Թոքախտի հիւանդութեան (TB)։
ա.

Այո

բ.

Ոչ

2. Ին՞չ ձեւով լսած էք Թոքախտի մասին։
ա.

Հեռատեսիլ

դ.

Օրաթերթ/ամսաթերթ

բ.

Համաձանձ
ե.

Ուրիշ

գ.

Ընտանիք/բարեկամ
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3. Կը հաւատ՞աք թէ Թոքախտը ժամանակակից օրուայ առողջապահական խնդիր է Ամէրիկայի
Միացեալ Նահանքներու մէջ։
ա.

Այո

բ.

Ոչ

4. Կը հաւատա՞ք թէ Թոքախտը (TB) ժամանակակից օրուայ առողջապահական խնդիր է
միջազքայինօրէն։
ա.

Այո

բ.

Ոչ

5. Ին՞չպէս Թոքախտը կը փոխանձուի։
ա.

Հազալով/փռնգտալով

բ.

դ.

Կրթութիւն/ջուր կուլ տալով

Շոշաբելով
ե.

գ.

Սեռական կապով

Չ՛ենք գիտեր

Կամաւոր Բնոյթը Ուսումնասիրութեան
Այս ուսումնասիրութիւնը կամաւոր է, իւրաքանչիւր անձ պարտաւոր է յարգել մասնակիցին
որոշումը, եթէ անձ մը չի մասնակցի այս ուսումնասիրութեան, տարբեր վարմունք պիտի չունենայ
չի մասնակցելու համար. Իսկ եթէ որոշէք մասնակցիլ, յետաքային եթէ ձեր միտքը փոխէք, կրնաք
ձեր աշխատանքին վերջ տալ ոեւէ մէկ ժամանակ։
Վտանգները եւ օգուտնեէը ուսումնասիրութեան մասնակցելու
Այս տեսակի ուսումնասիրութեան մասնակցիլը կը վտանգէ յառաջացնելով մանր
անհանգստութիւններ առօրեայ կեանքէն ներս. Օրինակ ջղային դրութիւններ բայց չի վտանգեր ձեր
ապահովութիւնը եւ կամ բարեկեցութիւնը։
Այսուամէնայնիւ եթէ ոեւէ մէկ հարց կամ խնդիր ունենաք այս հետազոտութեան առնչութեամբ, կը
խնդրենք հեռաձայնել 24 ժամ ձրի թիւով հիւանդութիւնները վերահսկողութեան եւ
կենսապահովման կանխարգիլման կեդրոնը, թիւն է 1-800-273-8255, իսկ լսել անկարողներու
համար թիւն է 1-800-799-4889։ Միշտ պիտի կրնաք խօսիլ մարզուած խորհրդատուի հետ։
Այս ուսումնասիրութեան նպատակն է գտնել եւ սորվիլ աւելի շատ գիտելիգներ եւ
պատկերացումներ Թոքախտի առնջութեամբ եւ անոր բուժմանը հայերու կամ ոչ հայերու գտնուող
Լոս Անճելոսի շրջանին մէջ։
Թոքախտի հիւանդութիւնը (Tuberculosis) ունի մեծ նշանակութիւն եւ առողջապահական
հետեւանքներ։ Աւելի լաւ հասկնալու ենք հիմնական գործոննէրուն որոնք կը ծարայէն հիւանդին
խոչնդոտները բարելաւելով ինչպէս նաեւ կարավարման եւ ելք գտնելու հիւանդութեան։
Վճառում։

Անվճառ
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Մենութիւն/Գաղտնութեան պահպանման։
Ոեւէ մէկ տեղեկութիւն գաղտնի կը պահուին, հետազոտիչը չ՛օգտագործեր ձեր անձնական
տեղեկութիւնը նպատակէն դուրս. Նաեւ հետազոտողը չի պարունակեր ձեր անունը կամ
ինքնութիւնը ուսումնասիրութեան հաղորդումներէն։
Կապեր եւ հարցումներ
Եթէ ոեւէ մէկ հարցում ունիք, կրնաք հիմա հարցնել ։ Հետաքային եթէ հարցեր ունենաք, կրնաք
հետազոտին հասնիլ հեռաձայնելով xxx-xxx-xxxx կամ գրել հետեւեալ հասցէով
xxxxxxxxxxxxxxxxxxxx եթէ ուզէք անձամբ խօսիլ ձեր մասնակցողական իրաւունքի մասին դուք

կրնաք հեռաձայնել Dr. Leilan Edincott որ ինք Walden համալսարանի ներկայացուցիչն է, եւ
միշտ պատրաստ է լսել ձեզ։ Իր հերախօսի թիւն է xxx-xxx-xxxx Walden համալսարանի
ուսումնասիրութեան հաստատումի թիւն է, 04-24-14-0230517 կ՛աւարտի 04-2015 թուին.
Կը խնդրեմ տպել կամ պահպանել այս համաձայնութեան ձեւը որպէս արձանագրութիւն ձեր
քննաչափութեան մասնակցութեանը։
Համաձայնութեան Հաշուետուութիւն
Ես կարդացի վերի գրուած տեղեկութիւնները, գիտակցելով պարունակութեան կրնամ որոշում առնել
իմ ներգրաւածութեանս մասին. Ամբողջացնելով համաձանձային յետազոտութիւնը, կը հասկնամ որ
ես համաձայն եմ վերի նկարագրուած պայմաններուն։
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Appendix H: Recruitment Invitation, Quantitative

Participants
needed for online
research study
Wanted: Volunteers to help investigate differences in tuberculosis knowledge and
perceptions for Armenians and non-Armenians residing in Los Angeles County
Who is Eligible?
• Armenians and non-Armenians residing in Los Angeles County
• At least 18 years of age
• Read and write English and/or Armenian fluently (an Armenian version will be
available online)
You will be asked to:
• Provide informed consent
• To participate in an online multiple-choice survey (approx. 15-20 minutes)
This study is being conducted by Tanya M. Ferguson, a doctoral student in Public Health
at Walden University. The title of the project is “Differences in treatment seeking and
treatment adherence factors for tuberculosis in Armenian versus non-Armenian
populations of Los Angeles County”. All information provided will remain confidential.
If you have any questions, please contact Tanya M. Ferguson at
xxxxxxxxxxxxxxxxxx. If you are interested in participating, please go
to xxxxxxxxxxxx or scan here:

TB Study2
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Appendix I: Recruitment Invitation, Qualitative

Participants
needed for
research study
Wanted: Volunteers to help investigate differences in tuberculosis knowledge and
perceptions for Armenians and non-Armenians residing in Los Angeles County
Who is Eligible?
• Armenians and non-Armenians residing in Los Angeles County
• At least 18 years of age
• Read and write English and/or Armenian fluently (a translator will be available)
You will be asked to:
• Sign an informed consent form
• Participate in a face-to-face interview (approx. 1 hour), with a potential for
follow-up questioning if necessary*
*Participants will receive a pre-paid $10.00 cash card as compensation immediately following the
completion of the study.

This study is being conducted by Tanya M. Ferguson, a doctoral student in Public Health
at Walden University. The title of the project is “Differences in treatment seeking and
treatment adherence factors for tuberculosis in Armenian versus non-Armenian
populations of Los Angeles County”. All information provided will remain confidential.
If you have any questions or are interested in participating, please
TB Study1
contact Tanya M. Ferguson at xxxxxxxxxxxxxxxxxx or scan here:
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Appendix J: Quantitative Recruitment Invitation, Armenian Translation

Մասնակիցներ պէտք են
համաձանձային հետազոտական
ուսումնասիրութեան համար
Կ՛ուզուին. Կամաւորներ օգնելու հետաքննութեան Թոքախտի (Tuberculosis) առնջութեամբ
գիտելիքներու եւ պատկերացումներու տարբերութիւնները Լոս Անճելոսի մէջ բնակող հայերու եւ
Լոս Անճելոսի մէջ չի չբնակող հայերու միջեւ։
Ո՞վ Իրավունք ունի։
•

Հայերը եւ ոչ հայերը որոնք կը բնակին Լոս Անճելոս քաղաքի մէջ

•

Անոնք որոնք առնուազն 18 տարեկան են։

•

Անգլերէն գրել կարդալ գիտնալ եւ կամ շատ լաւ հայերէն (Հայերէն տարբերակ պիտի գտնէք
համաձանձի միոցով)

Պիտի խնդրուի ձեզմէ
•

ներկայացնել տեղեկացուած համաձայնութիւնը

•

Մասնակցիր բազմակի ընտրութիւն հետազոտութեան հարցերուն համաձանձի միոցով (մօտաւորապէս 15
– 20 վայրկեա տեւողութեամբ)։

Այս ուսումնասիրութիւնը իրականացուած ա Դանիա Մ. Ֆըրկըսընի (Tanya M.
Ferguson)-ի Հանրային Առողջապահութեան Գիտութիւններու Թեկնածու
Ուսանող Walden համալսարանիմէջ։ Ծրագրի Վերնագիրն է « Տարբերութիւնը

Թոքախտի
Ուսումնասիրութիւն2

բուժման նպատակին եւ բուժման հաւատարմութեան Թոքախտի (Tuberculosis)
հիւանդութեան» Լոս Անճելոսի շրջանի մէջ ապրող Հայ եւ ոչ Հայ բնակչութեան
միջէւ։ Տրուած բոլոր տեղեկութիւնները կը մնան գաղտնի
Եթէ ոեւէ մէկ հարցումներ ունիք, դիմեցէք Դանիա Ֆըրկըսընի Tanya M.
Ferguson-ին, համաձանձային հասցենէ xxxxxxxxxxxxxxx Եթէ հետաքրքրուած էք, մասնակցելու համար
դիմեցեք հետեւեալ հասցէին`
xxxxxxxxxxxxxxxxxxxx Կամ տուեալներու յաջորդաբար ընթերցումով (or scan).
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Appendix K: Qualitative Recruitment Invitation, Armenian Translation

Մասնակիցներ պէտք
են հետազոտական
ուսումնասիրութեան համար
Կ՛ուզուին. Կամաւորներ օգնելու հետաքննութեան Թոքախտի (Tuberculosis) առնջութեամբ
գիտելիքներու եւ պատկերացումներու տարբերութիւնները Լոս Անճելոսի մէջ բնակող հայերու եւ
Լոս Անճելոսի մէջ չի չբնակող հայերու միջեւ։
Ո՞վ Իրավունք ունի։
•

Հայերը եւ ոչ հայերը որոնք կը բնակին Լոս Անճելոս քաղաքի մէջ

•

Անոնք որոնք առնուազն 18 տարեկան են։

•

Անգլերէն գրել կարդալ գիտնալ եւ կամ շատ լաւ հայերէն գիտնալ (եթէ պէտք է թարգմանողը միշտ ուժի
մէջ է)։

Պիտի խնդրուի ձեզմէ
•

Ստորագրել տեղեկացուած համաձայնութիեան ձեւը

•

Մասնակցիլ դէմ առ դէմ խորին հարցազրոյցի (մօտաւորապէս 1 ժամ) հետ հնարավորութիւն հետագայի
հարցաքննութեան եթէ անհրաժեշտ է

•

* Մասնակցողները մասնակցելու համար կ՛ստանան մէկ անգամ $10 Ամէրիկեան տոլար իբրեւ նուէր
գարդով որպէս երախտագիտութիւն որ կը տրուի հարցազրոյցը աւարտելէն ետք։
Այս ուսումնասիրութիւնը իրականացուած ա Դանիա Մ. Ֆըրկըսընի (Tanya M. Ferguson)-ի Հանրային
Առողջապահութեան Գիտութիւններու Թեկնածու Ուսանող Walden համալսարանիմէջ։ Ծրագրի
Վերնագիրն է « Տարբերութիւնը բուժման նպատակին եւ բուժման
հաւատարմութեան Թոքախտի (Tuberculosis) հիւանդութեան» Լոս Անճելոսի

Թոքախտի

շրջանի մէջ ապրող Հայ եւ ոչ Հայ բնակչութեան միջէւ։

Ուսումնասիրութիւն1

Եթէ ոեւէ մէկ հարցում ունիք կաք հետաքրքրուած էք մասնակցութեան հարցով,
դիմեցէք Դանիա Ֆըրկըսընի Tanya M. Ferguson-ին հետեւեալ էլէքդրօնային
գրութիւնով xxxxxxxxxxxxxxxxxxxxxx (or scan) կամ տուեալներու
յաջորդաբար ընթերցումը
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Appendix L: Quantitative Survey Code Book
Survey SPSS Variable
Q#
Name
1
Consent

Variable

Values or Explanation

Consent

1 = Yes
2 = No
1 = 18-20
2 = 21-30
3 = 31-40
4 = 41-50
5= 51-60
6 = 61-70
7 = 71+
1 = Male
2 = Female
1= White, Non-Hispanic/Latino;
Caucasian, Non-Latino
2 = White, Armenian
3 = White, Hispanic/Latino;
Caucasian, Latino
4 = Black, African American
5 = Asian
6 = American Indian/Alaska Native
7 = Native American/Pacific Islander
8 = 2 or more races, Armenian
9 = 2 or more races, non-Armenian
1= Non-Hispanic, Latino, or Spanish
Origin
2=Mexican, Mex American, Chicano
3= Puerto Rican
4=Cuban
5= Other Hispanic, Latino, or Spanish
Origin (e.g., Argentinian, Columbian,
Salvadoran, Dominican)
Birth Country (fill-in)
1 = < 1 year
2 = 1 to 5 years
3 = 6-10 years
4 = 11-20 years
5 = > 20 years
1=Glendale
2=Pasadena/South Pasadena
3=Burbank
(table continues)

2

Age

Age

3

Gender

Gender

4

Race

Race

5

Ethnicity

Ethnicity

6
7

Origin
YrsUS

Country of Origin
Years living in US

8

CityReside

Current city
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9

10

11

12
13

14

15

16

17

4=San Fernando
5=Santa Monica/West LA
6=Downey/Montebello/S. Gate
7=Other (fill in)
MaritalStat
Marital Status
1=Single, never married
2=Married
3=Divorced
4=Widowed
5=Separated
PeopleHH
# in Household
1=0
2=1
3=2-4
4=5-6
5= >6
HHRelation
Household
1=Spouse/Partner
relationship
2=Child
3=Sibling
4=Elderly parents or grandparents
5=Other (fill-in)
EnglishHHLang English Primary
1=Yes
Language
2=No
OtherHHLang
Other spoken
1=Armenian
language in
2=Spanish
household
3=None
4=Other (fill-in)
Education
Education Level
1=High School
2=Some college
3=Bachelor’s degree
4=Graduate/Professional Degree
Occupation
Occupation
1=Unemployed
2=Retired
3=Homemaker
4=Student
5=Professional
6=Manual Laborer
HHincome
Annual Household 1=$0-$25K
income
2=$25001-$40k
3=$40,001-60k
4=$60,001-$80k
5=$80,001-$100k
6= >$100k
HealthIns
Have Health
1=Yes
insurance
2=No
(table continues)
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18

19
20
21
22

23
24

25

26

27
28

29

PCPTrust

Trust Primary Care 1=Yes
Physician
2=No
3= Don’t have one
SpiritGuid
Seek Spiritual
1=Yes
Guidance
2=No
HomeRem
Use Home
1=Yes
Remedies
2=No
TBHear
Heard of TB
1=Yes
2=No
TBHearSource Source of TB
1=TV
knowledge
2=Internet
3=Family/Friends
4=Newspaper/Magazine
5=Other (fill-in)
<More than 1 can be selected>
TBHealthProbUS Modern day health 1=Yes
problem-US?
2=No
TBHealthProbInt Modern day health 1=Yes
problem2=No
worldwide?
TBTransmit
Mode of
1=Coughing/Sneezing
Transmission
2=Touching
3=Sexual Contact
4=Food/Water Ingestion
5=Smoking
6=Imbalance of hot/cold
7=Don’t know
TBSymptom
Most common
1=Coughing
symptom
2=Sneezing
3=Loss of Appetite
4=Tiredness/fatigue
5=Bleeding
6=Do not know
TBtreatavail
Aware of available 1=Yes
treatment
2=No
TBtreatlength
Treatment length
1=3 days
2=1 week
3=1 month
4=> 6 months
5=Do not know
TBtreateffective Treatment 100%
1=Yes
effective
2=No
3= Don’t Know
(table continues)
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30

TBcurable

31

TBreactions

32

TBDx

33

TBDxFeel

34

TBAssocFactor

35

TBcausepercept

36A

TBWhatifA

36B

TBWhatifB

Curable disease?

1=Yes
2=No
3= Don’t Know
Initial
1=Frightened
reactions/feelings 2=Informed
3=Indifferent
4=Helplessness
Tb diagnosis
1=Yes
person/friend/family 2=No
Feelings regarding 1=Frightened
diagnosis
2=Informed
3=Indifferent
4=Helpless
5=Depressed
<More than 1 can be selected>
Factors associated 1=Poverty
with TB
2=Foreign-Born
3=HIV status
4=Drug History
5=Low Social Class
6=Sexual Orientation
7=Mental Illness
8=Religion
9=Common Disease
10=Curable Disease
11=Smoking
12=Imbalance of Hot/Cold
13=Incarceration
<More than 1 can be selected>
Perceptions
1=Did something wrong
regarding TB status 2=Punishment by God
3=Disease due to race
4=It could happen to anyone
<More than 1 can be selected>
3 scenarios
1=Strongly agree
(strongly agree2=Agree
strongly disagree) 3=No opinion
4=Disagree
A)Trust Doctor
5=Strongly Disagree
3 scenarios
1=Strongly agree
(strongly agree2=Agree
strongly disagree) 3=No opinion
4=Disagree
(table continues)

199
B)Compliance
TBWhatifC
3 scenarios
(strongly agreestrongly disagree)
C)Seek outside
treatment
TBalttherapyseek Alternate treatment
sources

5=Strongly Disagree
36C
1=Strongly agree
2=Agree
3=No opinion
4=Disagree
5=Strongly Disagree
37
1=Chiropractor
2=Acupuncturist
3=Homeopathic Dr/Nutritionist
4=Religious / church leader
5=Massage therapist
6=Home remedy
7=I wouldn’t
<More than 1 can be selected>
38
TBtreatfacilityLA Aware of TB
1=Yes
facilities LA county 2=No
39
TBfacilityInform Read about TB if
1=Yes
info provided?
2=No
40
TBSocsupportgrp Aware of
1=Yes
community social 2=No
support groups?
Missing values = 999
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Appendix M: Demographics Comparison for Quantitative Survey
Table 13
Descriptive Statistics – Demographic Variables for an Armenian and Non-Armenian
Population Living in Los Angeles County (n = 127)

Classification
Gender
Male
Female
Age
18-30
31-40
41-50
>50
Race
White, Non-Hispanic/Latino
White, Armenian
White, Hispanic/Latino
Black, African American
Asian
2 or more, Armenian
2 or more, non-Armenian
Ethnicity
Non-Hispanic, Latino, or Spanish Origin
Mexican, Mexican American, Chicano
Cuban
Other Hispanic, Latino, or Spanish Origin
(e.g., Argentinian, Columbian, Salvadoran,
Dominican)
Country of Origin
Armenia
Canada
Egypt
El Salvador
European Countries
Hong Kong
Iran
Japan
Lebanon

No. of Individuals
Armenian (%)
55 (43.3)

No. of Individuals
non-Armenian (%)
72 (56.7)

22 (40)
33 (60)

26 (36.1)
46 (63.9)

17 (30.9)
22 (40)
7 (12.7)
9 (16.4)

15 (20.8)
27 (37.5)
21 (29.2)
9 (12.5)

6 (10.9)
37 (67.3)
0
0
0
12 (21.8)
0

49 (68.1)
0
10 (13.9)
1 (1.4)
8 (11.1)
0
4 (5.6)

48 (87.3)
1 (1.8)
0
6 (10.9)

61 (84.7)
8 (11.1)
1 (1.4)
2 (2.8)

4 (7.3)
0
1 (1.8)
0
0
0
3 (5.5)
0
9 (16.4)

0
1 (1.4)
0
1 (1.4)
2 (2.8)
1 (1.4)
0
1 (1.4)
0
(table continues)
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Mexico
Philippines
Turkey
United States
Years in United States
≤ 20 years
> 20 years
City Residing In (LA County)
Glendale
Pasadena/South Pasadena
Burbank
San Fernando
Santa Monica/ West Los Angeles
Downey / Montebello / South Gate
Other
Alhambra
Altadena
Azusa
Canoga Park
Cerritos
Claremont
Glendora
Hollywood
La Crescenta
La Habra
La Verne
Long Beach
Los Angeles
Monrovia
North East LA
Northridge
Norwalk
Pomona
Porter Ranch
Reseda
San Dimas
San Gabriel
Santa Clarita
Shadow Hills
South Bay
Sun Valley
Sunland
Tujunga

0
0
1 (1.8)
37 (67.3)

1 (1.4)
2 (2.8)
0
63 (87.5)

11 (20)
44 (80)

3 (4.2)
69 (95.8)

6 (10.9)
16 (29.1)
2 (3.6)
2 (3.6)
3 (5.5)
2 (3.6)
24 (43.6)
0
1
0
1
0
0
0
0
1
1
0
0
0
0
0
4
1
1
3
1
0
0
1
1
1
1
1
2

3 (4.2)
15 (20.8)
3 (4.2)
0
5 (6.9)
2 (2.8)
44 (61.1)
4
2
1
0
2
5
3
2
0
0
1
5
8
1
1
0
0
3
0
0
2
1
0
0
0
0
1
0
(table continues)
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Upland
Venice
Winnetka
Marital Status
Single, never married
Married
Divorced
Widowed
Separated
Number of People in Household (excluding
self)
0
1
2-4
5-6
>6
Household Relation
Spouse/ Partner
Spouse/Partner, Child
Spouse/Partner, Child, Elderly parent/
grandparent
Spouse/Partner, Child, Other
Spouse/Partner, Elderly parent/
grandparent, other
Spouse/Partner, other
Child
Child, Elderly parent/grandparent
Sibling
Sibling, Elderly Parent / grandparent
Elderly Parent / grandparent
Other
Friend
Housemate / Roommate
Niece
Whole family
English Primary Spoken Household
Language
Yes
No
Primary Household Language (non-English)
Armenian
Spanish
None

0
1
1

1
0
0

23 (41.8)
30 (54.5)
1 (1.8)
0
1 (1.8)

30 (41.7)
37 (51.4)
3 (4.2)
1 (1.4)
1 (1.4)

4 (7.3)
5 (9.1)
42 (76.4)
4 (7.3)
0

11 (15.3)
20 (27.8)
39 (54.2)
1 (1.4)
1 (1.4)

9 (17.6)
20 (39.2)
1 (2)

28 (45.9)
19 (31.1)
0

0
0

1 (1.6)
2 (3.3)

1 (2)
3 (5.9)
1 (2)
1 (2)
9 (17.7))
2 (3.9)
4 (7.9)
1
3
0
1

0
3 (4.9)
0
2 (3.3)
2 (3.3)
3 (4.9)
1 (1.6)
2
1
1
0

35 (63.6)
20 (36.4)

71 (98.6)
1 (1.4)

40 (72.7)
0
11 (20)

0
8 (11.1)
61 (84.7)
(table continues)
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Other
Arabic
Armenian, Russian
German
Korean
Mandarin
Russian, Turkish
Turkish, Arabic
Educational Level
High School
Some College
Bachelor’s Degree
Graduate/Professional Degree
Occupation
Unemployed
Retired
Homemaker
Student
Professional (e.g., lawyer, doctor, teacher)
Manual Laborer
Annual Household Income
$0-$40,000
$40,001-$100,000
>$100,000
Health Insurance
Yes
No
Trust Primary Care Physician
Yes
No
Don’t have one
Seek Spiritual Guidance
Yes
No
Use Home Remedies (herbs, teas, etc)
Yes
No

4 (7.3)
1
1
0
0
0
1
1

3 (4.2)
0
0
1
1
1
0
0

7 (12.7)
14 (25.5)
15 (27.3)
19 (34.5)

0
12 (16.7)
31 (43.1)
29 (40.3)

2 (3.6)
2 (3.6)
6 (10.9)
12 (21.8)
30 (54.5)
3 (5.5)

2 (2.8)
2 (2.8)
3 (4.2)
6 (8.4)
56 (77.8)
3 (4.2)

13 (23.6)
17 (30.9)
25 (45.5)

8 (11.1)
25 (34.7)
39 (54.2)

51 (92.7)
4 (7.3)

69 (95.8)
3 (4.2)

45 (81.8)
1 (1.8)
9 (16.4)

65 (90.3)
2 (2.8)
5 (6.9)

24 (43.6)
31 (56.4)

13 (18.1)
59 (81.9)

42 (76.4)
13 (23.6)

42 (58.3)
30 (41.7)

